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Body dysmorphic disorder (BDD) is still poorly recognised with a dearth of research 
into treatment. This is the only known study to date to evaluate the implementation of 
the National Institute for Health and Clinical Excellence (NICE) guidelines 
recommended treatment for BDD in clinical practice as well as providing qualitative 
data of both patients and clinicians (NICE, 2006). 
  
Aim:   
 
The study aims to evaluate current recommended treatments for Body Dysmorphic 
Disorder utilised in a specialist service for BDD. In addition the study elicits the 
experiences of patients receiving treatment and the clinicians providing the 
treatment. This provides a basis to assess if refinements are to be made to treatment 




A mixed methods approach was employed with quantitative data from patients 
treated for BDD collated from the Trust’s database and examined with intention to 
treat analysis. Thematic Analysis (TA) was used to analyse data from semi-
structured interviews conducted with clinical staff and patients to elicit their 




The clinical data indicated impairment in patients’ functioning plus high risks and 
substance misuse. Treatment outcomes of NICE recommended CBT and medication 
(Selective Serotonergic Reuptake Inhibitors and augmentation) produced significant 
improvements in BDD symptoms in patients with severe symptoms at baseline. 
Patients also showed significant improvements in depression and overall functioning. 
However despite improvements symptoms were not completely eliminated and one 
group treated by the service (Level 6 outpatients) showed minimal to no 
improvement on all symptom measures. Both clinician and patient participants 
expressed dissatisfaction with the lack of sufficient knowledge and expertise for 
treating BDD. Both groups also placed high value on the therapeutic relationship. 
However clinicians interviewed indicated a higher dissatisfaction with current 




The experiences of patients provided a different perspective to the findings in the 
quantitative phase. Their view of improvements was based on their functioning and 
overall quality of life. Clinicians’ perspectives provided insight into other options for 
treatment which are lacking and could provide substantial support for current 
recommendations. Given the evidence base for recommended treatments is still 
limited, it is essential to include qualitative data in evaluating effectiveness of 
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1.1. Overview of the chapter   
 
This chapter begins with a brief outline of the main symptoms and presentation of 
body dysmorphic disorder (BDD). It then goes on to explain some of the reasons for 
the study as well as the earlier understanding of BDD and how it is positioned in 
contemporary society. This is followed by a journey through the development of the 
National Institute for Health and Clinical Excellence Guidelines for Obsessive 
Compulsive Disorder (OCD) and BDD describing the background to the inclusion of 
BDD in the guidelines (NICE, 2006). Furthermore it considers how these guidelines 
have influenced the recognition and treatment for BDD. This chapter will briefly 
explore implications of BDD within society. This will be further illustrated in view of 
more recent political changes driven by the financial effects of body image concerns. 
This chapter concludes with a description of the aims and objectives of the study.  
 




Body dysmorphic disorder (BDD) is described as excessive and persistent 
preoccupation with appearance and specific body parts accompanied by marked 
distress. Both the Diagnostic and Statistical Manual of Mental Disorders (DSM-V, 
2013) and the International Classification of Diseases (ICD-11, 2018) describe the 
main criteria similarly. The DSM-V (2013) and ICD-11 (2018) categorises BDD under 





Unfortunately there are no prevalence studies of BDD in the UK. However there 
have been prevalence studies conducted in the US and Germany. A nationwide 
study was conducted in the US which administered the BDD interview schedule to 
2,048 participants (Koran, Abujaoude, Large et al., 2008). It was found that 2.4% 
(49) met the DSM IV criteria. Two German studies, showed a prevalence of 1.7% in 





Germany showed a prevalence of 1.8% (45) in a sample of 2510 (Buhlmann, 
Glaesmer, Mewes et al., 2010). A community survey of 673 participants was 
conducted in Florence, Italy, which focused on somatoform disorders (Faravelli et al., 
1997). The findings indicated a 1-year incidence of 0.7% for BDD. A study conducted 
amongst a University student sample of 395 in South Africa indicated an incidence 
rate of 5.1% (Dlagnikova, van Niekerk, 2015). These studies indicate this condition is 
far from being a rare disorder and given its debilitating nature, it demands more 
attention. 
 
1.2.2a Gender Prevalence 
With regards to gender prevalence, findings are varied. Some studies have shown a 
higher rate of BDD in females whilst others have found BDD to be as common in 
males as in females (Koran et al., 2008; Rief et al., 2006; Phillips, 1996; Phillips et 
al., 2001; Tyagi, Govender, Drummond, 2012). However treatment outcome studies 
generally show a higher proportion of females in the samples than males. Possibly 
the disorder is more readily recognised in females or that it is more socially 
acceptable for females to present with concerns about their appearance. This is 
another area needing more research. 
 
1.2.2b Ethnicity  
From using global search engines it appears studies into ethnicity and BDD are very 
limited and there are no known cross-cultural studies published thus far. Most of the 
literature concerns body image in a broader context rather than solely BDD. Just one 
study was found regarding BDD in an ethnic diverse population sample of 1041 
participants at an American University (Boroughs, Krawczyk, Thompson, 2010). The 
study reported that incidence of BDD in Caucasian Americans was above the 
prevalence of the total sample whereas the estimated occurrence was lower for 
Latinos, Asian Americans and African Americans.  
 
1.2.2c Sexual Orientation 
A study into BDD prevalence in different sexual orientation groups found that lesbian 
or sexual minority females had the highest scores on measures of BDD compared to 
heterosexuals and gay or sexual minority males (Boroughs et al., 2010). 





females and gay men had similar levels of BDD symptoms. At the time of this study 
there was no epidemiological literature found on transgender populations. 
 
Epidemiology studies conducted at dermatology clinics show rates of 12% to 14% of 
patients screening positive for BDD (Phillips et al., 2000; Conrado, Hounie, Diniz et 
al., 2010). Similarly studies of patients presenting for cosmetic surgery showed 7% 
to 15% met the criteria for BDD (Sarwer, Wadden, Pertschuk et al., 1998;   
Aouizerate, Pujol, Grabot et al., 2003).  
 
1.2.3 Presentation of BDD 
 
Due to the shame and embarrassment most people with BDD experience, they are 
rarely forthcoming about their concerns (Phillips, 2005). It has also been reported 
that individuals may have had the problem for an average duration of 10-15 years 
before diagnosis (Veale et al., 1996; Phillips and Diaz, 1997). Often they are 
misdiagnosed due to presenting with symptoms similar to other disorders (Phillips, 
2000). Additionally sufferers of BDD often have comorbid depression (Phillips, 1998; 
Phillips, 1999; Phillips, Coles, Menard, Yen, Fay, 2005). Furthermore due to their 
belief that the problem is a physical rather than psychological one, most people with 
BDD will seek out cosmetic surgery rather than mental health services (Phillips, 
Dufresne, Wilkel et al., 2000; Conrado, Hounie, Diniz et al., 2010; Sarwer, 
Pertschuk, Wadden, et al., 1998; Aouizerate, Pujol, Grabot et al., 2003). 
 
People with BDD are often preoccupied with their perceived flaw to the exclusion of 
most other aspects of their lives (Phillips, Quinn and Stout, 2008; Phillips, Menard, 
Fay et al., 2005). The preoccupation results in extensive “safety behaviours” to 
attempt to reduce their distress (Phillips, 2005). Safety behaviours are described as 
“actions that aim to prevent catastrophe in a feared situation and reduce harm” 
(Salkovskis, 1985). These actions take the form of using camouflage such as wigs, 
copious amounts of makeup, hats, scarves, sunglasses; avoidance of social 
situations; adopting mannerisms which the individual believes will draw attention 







1.2.4 Areas of Preoccupation 
 
Individuals with BDD may be preoccupied with any feature but it is commonly found 
that concern tends to be skin, nose and hair (Phillips, Grant, Siniscalchi et al., 2001; 
Phillips, 1986). The focus tends to be on features more apparent to others although 
preoccupation can be of any area of the body. Also multiple features are often of 
concern to varying degrees (Phillips, 2004).  
 
With regard to areas of concern a study into gender differences in BDD showed 
males and females presented with more similarities than differences (Tyagi et al., 
2013). The only statistically significant differences were in preoccupation with 
breasts, hips, skin (face and body) and hair (face and body, except head). These 
findings were similar to results in an earlier study on gender differences (Philips, 
Diaz, 1997). 
 
However one form of BDD called muscle dysmorphia tends to affect males more 
than females (Pope et al., 1997; Pope et al., 2000). The individual is preoccupied 
with concerns about their muscular development being insufficient (APA, 2013). 
Studies have shown that sufferers of muscle dysmorphia have higher incidence of 
substance misuse, particularly anabolic steroids (Leone, Sedory, Gray, 2005). They 
are also found to have a higher risk of suicide and have a poorer quality of life 
compared to those with other forms of BDD (Pope et al., 2000; Phillips, 2005). 
 
Ethnicity and culture may have an influence on features of concern for example; 
eyelids were a common concern amongst a Japanese sample which is less common 
in studies of Western populations (Ishigooka, Iwao, Suzuki et al., 1998).  
 
1.2.5 Functional impairment 
 
Physical appearance and body image is of interest to most individuals, however in 
BDD this is a major concern which is taken to extremes. Behaviours to attempt to 
cope with their distress are time-consuming, interfere with daily activities and have a 
significant impact on the individual’s functioning (Phillips, Quinn, Stout, 2008). In 





1993; Phillips, Didie, Menard et al., 2006). Studies report consistently high levels of 
unemployment, single marital status, and hospitalisation (Phillips, Menard, Fay et al., 
2005). 
 
1.2.6 Risk factors 
 
There is a high risk of suicidality related to BDD with reported rates of 70% to 80% 
experiencing suicidal ideation, with 24% to 28% attempting suicide (Phillips et al., 
2005; Phillips, 2007). The numbers of completed suicides are not clear but a study in 
a dermatology clinic described a series of 16 BDD cases of completed suicides 
(Cotterill, Cunliffe, 1997).  
 
In addition to risks to self in BDD, literature highlights the limited attention given to 
risks to others especially healthcare professionals, despite the evidence (Lucas, 
2002). A survey regarding BDD in cosmetic surgery settings was carried out on 
members of the American Society for Aesthetic Plastic Surgery (ASAPS) (Sarwer, 
2002). Findings indicated 40 percent reported being threatened, mainly by litigation 
and some physically (Sarwer, 2002). In a similar study a survey of dermatologic 
surgeons indicated that 12 percent of surgeons reported threats of litigation or 
physical violence (Sarwer, Spitzer, Sobanko, et al., 2015). Furthermore cases of 
violence perpetrated against cosmetic surgeons in Russia and the United States 
drew attention to BDD in the media on an international level (Amos, 2015; Dolgin, 
2015).  
 
One also needs to consider the risks BDD sufferers may pose to children in their 
care (NICE, 2006: 10.1.5.3; 10.1.5.4).  A global literature search has not revealed 
any known published studies about risks to children living with a parent suffering 
from BDD. Although from clinical practice and anecdotal evidence from colleagues, 
child protection and safeguarding issues have been raised in some patients with 
BDD. Risk assessments highlighted concerns of neglect and placing children at risk 
due to the patients’ preoccupation with their appearance. In addition, this raises the 
question of what the psychological impact may be of growing up in an environment 
where one’s care-giver is consumed by their appearance concerns. Given the 





into these factors. Studies that have been found following a search for risks to 
children have been focused on risk factors for developing BDD (Albertini, Phillips, 
1999; Buhlmann, Marques, Wilhelm, 2012). Indeed studies into general risk factors 
in BDD are very limited, requiring more attention. 
 
In addition to the above risks, there is one that is more particular to BDD than any 
other psychiatric disorder. “DIY surgery” or self-inflicted surgery refers to people 
attempting to make changes to their physical features by themselves (Veale, 2000).  
Self-inflicted surgery is a damaging and shocking measure of the level of frustration 
and distress the individual with BDD experiences in relation to their perceived flaw 
(Phillips et al., 2005; Phillips, et al., 2006). This should not be confused with self-
harming behaviour as the psychological process is quite different (Veale, 2000; 
Favazza, Rosenthal, 1993; Chapman, Gratz, Brown, 2006). 
 
1.3 History of BDD  
 
Recognised as far back as the 1800s, Italian psychiatrist Enrico Morselli first devised 
the term dysmorphophobia in 1891, which he described as a: 
 
“Subjective feeling of ugliness or physical defect which the patient feels is 
noticeable to others, although the appearance is within normal limits. The 
dysmorphophobic patient is really miserable in the middle of his daily routines, 
everywhere and at anytime, he is caught by the doubt of deformity.” (Jerome, 
2001:103). 
 
Dysmorphophobia was further described in Kraepelin’s works (1909 – 1915). The 
most well-known case of BDD was named the “Wolf Man” who was engrossed by 
imagined flaws of his nose (Freud, 1959; Brunswick, 1971).  
 
Dysmorphophobia first appeared in the Diagnostic and Statistical Manual of Mental 
Disorders (DSM III) in 1980. There were no accompanying diagnostic criteria and it 
was cited as an example of an “atypical somatoform disorder”. The DSM III-R (1987) 
first used the term “Body Dysmorphic Disorder” as a diagnosis. BDD was 





hypochondriacal disorder in the International Classification of Diseases (ICD-10) in 
1992. In both diagnostic manuals the main criteria is described as excessive 
preoccupation with appearance and specific body parts accompanied by marked 
distress.  
 
A more recent shift has seen the DSM V and ICD-11 classified BDD under 
Obsessive Compulsive and related disorders (APA, 2013; WHO, 2018). Furthermore 
repetitive behaviour, degrees of insight and muscle dysmorphia was included in 
diagnostic criteria, which helps to differentiate BDD from disorders with similar 
symptoms (Krebs, Fernández de la Cruz, Mataix-Cols, 2017).  
 
1.4. Motivation for the study    
 
My experience of treating patients with BDD and witnessing the devastating impact 
the disorder has on their lives as well as their loved ones inspired this study. Before 
working in the specialist service for OCD/BDD, it was rare to see patients with BDD 
in my clinical practice. Even during the first years of working in the specialist service 
patients with BDD were still a minority, with referrals for BDD few and far between 
and skills in treating this disorder were still developing with limited literature available 
on effective treatments (Phillips, 2000).  
 
The turning point for me was treating a young female patient who was referred by a 
surgeon who had already performed reconstructive surgery on her. The patient had 
only been seen in dermatology settings until she caused the first serious damage to 
herself and required reconstructive surgery. This brought her to the attention of a 
mental health professional. The initial surgery had been a success, however due to 
her psychological difficulties the patient could not cope with the healing process and 
caused herself further damage. This resulted in her requiring major surgical 
procedures on a more complex level. However the surgeons felt the risk was too 
great to operate again until she was psychologically stable.  
 
Working with this case which was BDD in its extreme was a compelling experience. 





increasing awareness of this illness and ensuring people with BDD get the most 
effective treatment at the earliest stage.  
 
Despite the NICE guidelines for OCD/BDD highlighting the need for early recognition 
of BDD and the most appropriate treatment pathways, there is still a lack of 
understanding of the disorder, even within mental health services (NICE, 2006; 
Phillips, 2000). This is further demonstrated in six studies conducted in mental health 
settings, including inpatient facilities, which screened adult and adolescent patients 
for BDD. The results of these studies are presented in Table 1 indicating the number 
of patients found to have BDD. Interestingly, none of these patients had a previous 
diagnosis of BDD recorded in their medical records. One might infer that these 
patients did not disclose their BDD symptoms to healthcare professionals previously 
possibly due to embarrassment but also that the healthcare professionals may not 
have routinely screened for BDD in their assessment (Phillips, 2005; Phillips et al., 
2008; Veale et al., 2015).  
 
Table 1: Screening for BDD in mental health settings  
 
Author               Sample      Diagnosed with BDD 
Phillips et al., (1996) 80 11 
Zimmerman, Mattia (1998)        500 16 
Grant et al.,(2001) 122 16 
Dyl et al., (2006) 208 14 
Conroy et al., (2008) 100 16 
Veale et al., (2015) 432 25 
 
Furthermore the specialist service conducted a survey of NHS Health Care Trusts 
across London and the rest of the UK to explore the care pathway for identifying and 
treating BDD. Out of the eight NHS Trusts that responded, there were only two that 
were able to demonstrate a service pathway for BDD although this was specifically 
linked to Dermatology clinics rather than stand-alone specialist services. This 
instilled in me the desire to contribute to increasing awareness and recognition of 






This brought my focus to the specialist service for OCD/BDD and the treatments 
provided. The NICE guidelines for OCD and BDD provided much needed direction 
for recognition and treatment of BDD (NICE, 2006). The NICE guidelines for 
OCD/BDD (2006) recommend five simple questions to help healthcare professionals 
assess for BDD (Appendix C). This is an element of “recommended good practice 
based on the clinical experience of the Guideline Development Group” (NICE, 2006). 
These questions could help to identify at risk individuals and could improve the care 
pathway for early intervention. The healthcare professional does not need to be an 
expert in BDD to ask these questions.  
 
However the guidelines have probably made the most impact on services already 
treating BDD, although these services are limited. There is one consortium of NHS 
England funded specialist services mainly based in London i.e. South West London 
and St George’s Mental Health NHS Trust (SWLSTG), The Maudsley, The Bethlem 
and access to two inpatient beds at The Priory in North London with the OCD service 
in Queen Elizabeth ll Hospital in Welwyn Garden City providing specialist 
psychopharmacological treatment. These services with limited resources provide 
assessment and treatment to patients across the United Kingdom.  
 
There is also a dearth of research into the disorder plus its treatment. The main 
literature describing treatment for BDD has come from US studies on treatment 
outcomes, which includes psychological, pharmacological as well as cosmetic 
surgery interventions. The treatment studies will be discussed in further detail in the 
literature review chapter. 
 
For the most part mental health and healthcare services do not regularly consider 
BDD when conducting initial assessments or consultations (Phillips, 2000; Phillips, 
2006; Phillips et. al., 2008). The specialist service aims to collaborate with other 
services on a national level to address this disparity. Using the stepped care model 
as a basis to redefine the operational structure, the service was commissioned with 
specific focus on OCD and BDD (Figure 1). The service operates mainly on steps 5 
and 6 although consultation, training and supervision are provided from steps 1 to 4 
(Fig. 1).  The service is cited by NICE as a model for putting the recommendations 





Figure 1. *The Stepped Care Model (OCD/BDD NICE guidelines, 2006) *This model 
is adapted to show only treatment as related to adults as the service does not treat children and adolescents. 
 
 
Who is responsible 
for care?           
   What is the focus?                What do they do? 
Step 6 




OCD or BDD with 
risk to life, severe 
self-neglect or 
severe distress or 
disability 
 
Reassess, discuss options, care 
coordination, SSRI or 
clomipramine, CBT (including 
ERP), or combination of SSRI or 
clomipramine and CBT 
(including ERP), augmentation 
strategies, consider admission 
or special living arrangements 
Step 5 
Multidisciplinary care 
with expertise in 
OCD/BDD 
 
OCD or BDD with 
significant 





response or relapse 
Reassess, discuss options. 
SSRI or clomipramine, CBT 
(including ERP), or combination 
of SSRI or clomipramine and CBT 
(Including ERP); consider care 
coordination, augmentation 
strategies, admission, and social 
care. 
Step 4 
Multidisciplinary care in 
primary or secondary care 
 
OCD or BDD with 
comorbidity or poor 
response to initial 
treatment 
Assess and review, discuss options. 
CBT (including ERP), SSRI, alternative 
SSRI or clomipramine, combined 
treatments. 
Step 3 
GP, primary care team, 
primary care mental health 
worker, family support team 
 
Management and 
initial treatment of 
OCD or BDD 
Assess and review, discuss options. Brief 
individual CBT (including ERP) with self-help 
materials (for OCD), individual or group CBT 
(including ERP), SSRI, or consider combined 
treatments; consider involving the family/carers 
in ERP. 
Step 2 
GP, practice nurses, school 
health advisers, health visitors, 





Detect, educate, discuss treatment options, 
signpost voluntary support organisations, 
provide support to individuals/families/ 
work/schools, or refer to any of the appropriate 
levels 
Step 1 
Individuals, public organisations, NHS 
Awareness and 
Recognition 
Provide, seek and share information about OCD 
or 







1.5. Background to NICE (2006) guidelines for OCD/BDD  
 
The re-classification of BDD in the DSM V (2013) has been long awaited. Indeed it 
was long overdue as BDD was categorised under somatoform disorders but 
treatment was more aligned with OCD. BDD was still classified under 
hypochondriacal disorder in the International Classification of Diseases (ICD-10, 
1992). However the revision of the ICD-10 (1992) and release of the ICD11 (2018) 
has brought about the hoped for consensus in the classification of BDD (Veale, 
Matsunaga, 2014).  
 
One may ask why BDD has been included in the OCD spectrum disorders? Why not 
align with a disorder that is concerned with body image, such as eating disorders? 
BDD and eating disorders share similar clinical presentation, in particular, concerns 
about body shape, disturbed body image, behaviours such as over-exercising and 
camouflaging (Kittler et al., 2007; Hrabosky, et al., 2009). However it is the 
differences that set these two disorders apart. In studies comparing BDD and eating 
disorders it was found that patients with eating disorders were preoccupied with 
weight (Kittler et al., 2007; Rosen et al., 1998). Even if the focus is on a part of the 
body such as the waist or stomach, the main concern is the weight around that area. 
In contrast in patients with BDD the concern is the body part and less or no concern 
about weight. Psychologically the two groups differ as well with patients with BDD 
having more negative self-perception and poorer self-confidence as well as more 
impaired functioning in all areas of their lives due to concerns about appearance. 
Patients with eating disorders scored higher on psychological symptoms on the Brief 
Symptom Inventory (BSI) than patients with BDD. The BSI is concerned with 
psychological symptoms in all areas 
 
The main difference however is the recommended pharmacological as well as 
psychological treatments for both these disorders, which take divergent paths (Didie 
et al., 2010; Ipser, Sander, Stein, 2009; Phillips, et al., 2008; Yager, Devlin, Halmi et 
al., 2006). This comes back to the pairing of BDD with OCD in the NICE guidelines. 
The similarities between OCD and BDD are documented more than other disorders 





eating disorder (Phillips, McElroy, Hudson, et al., 1995; Phillips, Pinto, Menard, et al., 
2007; Chosak, Marques, Greenberg, et al., 2008). According to the literature there 
are a total of 11 studies comparing BDD and OCD and three comparing BDD and 
eating disorders (Phillips, et al., 2010). In perusing the literature just one study was 
found that discussed the relationship between social anxiety and BDD (Fang, 
Hofmann, 2010). No studies were found to compare BDD with any other disorder 
including somatoform disorder which it was previously categorised under in the DSM 
IV and the ICD-10 (APA, 1994; WHO, 1992; Phillips, et al., 2010). 
 
Direct comparative studies into OCD and BDD were conducted using the Yale-
Brown Obsessive-Compulsive Scale (YBOCS) and a modified version for BDD 
(BDD-YBOCS) (Goodman et al., 1989; Phillips et al., 1997). The symptoms of 
intrusive thoughts and compulsive behaviours which are shared between these two 
disorders did not show any significant difference on the scales (Phillips, et al. 1998; 
Phillips, et al. 2007). This indicates there are key similarities between OCD and BDD 
symptoms (Table 2). However in BDD there is a difference in the meaning attributed 
to the thoughts and compulsions. With BDD the focus is on negative self-perception 
but compulsions do not necessarily follow the same pattern of reducing anxiety as it 
usually does in OCD (Veale, et al. 2001).  
 
Table 2: Similarities and differences between BDD and OCD. 
Similarities between BDD and OCD Differences between BDD and OCD 
• Intrusive unwanted thoughts 
• Thoughts are anxiety –causing. 
• Repetitive behaviours in response to 
thoughts have a compulsive quality e.g. 
application of make-up, checking 
particular feature.  
• Reassurance-seeking from others and by 
using behaviours such as checking. 
(Phillips, et. al., 2007). 
 
 
• Poorer insight than OCD sufferers 
(Phillips et al. 2007; Eisen, Phillips, 
Coles, et al., 2004; Phillips et al., 
2006; Mancuso, Knoesen, Castle, 
2010). 
• Compulsive behaviour has more 
emotional regulation function rather 
than the anxiety reduction role in 
OCD (Jacofsky, Santos, Khemlani-
Patel, et al., 2016; Diefenbach, 






Although the research into pharmacological treatments for BDD is limited, the 
evidence thus far has shown the same treatments for OCD and BDD have proved 
effective, in particular treatment with SRI/SSRI medication (Hollander, Allen, Kwon, 
et al., 1999; Phillips, Albertini, Rasmussen, 2002; Phillips, 2006). Similarly 
psychological treatments namely CBT has been shown to be efficacious for both 
OCD and BDD (Williams, Hadjistavropoulos, Sharpe, 2006; Ipser et al., 2009). This 
seemingly completes the circle bringing OCD and BDD together under the one 
guideline. Those championing the cause of BDD welcomed the guidelines for 
bringing BDD into focus (BDD Foundation, 2013; OCD Action).  
 
This is definitely a step forward for BDD although an in-depth perusal of the NICE 
guidelines shows BDD very much in the shadow of OCD. Indeed the NICE 
guidelines references 67 papers relating to BDD compared with 643 regarding OCD 
(NICE, 2006). There are firm foundations for the treatment of OCD as evidenced in 
the numerous research studies available. Conversely for BDD there are no definitive 
psychological treatment models and no conclusive evidence regarding 
pharmacological interventions. There is currently no medication specifically licensed 
for treatment of BDD (FDA, 1998; MHRA, 2004). Incidentally the evidence update of 
the NICE guidelines for OCD/BDD reported on 16 papers, all regarding only OCD 
(NICE, 2013).  
 
From a perusal of the literature, there appears to have been only three studies that 
have directly compared BDD and OCD: Phillips et al., (1998); Frare, Perugi, Ruffolo 
et al., (2004) and Phillips et al., (2007). The differences between these disorders 
have implications for treatment approaches, especially with regards to poorer insight 
in individuals with BDD.  Studies have shown that 2% of individuals with OCD have a 
delusional or absent degree of insight as compared with 27% - 60% of individuals 
with BDD (Phillips, et al., 2007; Eisen, et al., 2004; Phillips, et al., 2006; Mancuso et 
al., 2010).  
 
Clinical practice working in the specialist OCD/BDD service has provided first-hand 
experience of the difference in the degree of insight between these two disorders. 
Engaging patients with BDD in treatment requires a different approach than with 





psychological in nature. Instead they see the problem as a physical one (Phillips, 
Dufresne, Wilkel, et al., 2000; Conrado, Hounie, Diniz, et al., 2010; Sarwer, Wadden, 
Pertschuk, et al, 1998; Aouizerate, Pujol, Grabot et al., 2003). This brings into 
question the use of NICE guidelines for two disorders which appear very similar 
(Table 2) but without sufficient research evidence for treatments for BDD. Can the 
treatments shown to be effective for OCD also be used for BDD? 
 
1.6. BDD in the social context 
 
One could question whether BDD is a media cultivated disorder given that as a 
society we are constantly bombarded with images in every forum of what is 
considered the physical appearance to aspire to. The cosmetic industry earns 
billions in revenue based on the desires of both men and women striving for that 
elusive perfect look. The United States is the largest cosmetic market with revenue 
of 53.7 billion US dollars in 2011 and an estimated 62.46 billion US dollars for 2016 
(Statista.com, 2011). A breakdown of the cosmetic sales according to product type 
showed 35.3% was skincare in 2014 (Statista.com, 2014). 
 
In addition more availability to cosmetic surgery with competitive marketing has 
shown an increase of people seeking surgical procedures. In 2015 there were 
51,140 people in the UK seeking cosmetic surgery, indicating a rise of 12.6% from 
2014 (BAAPS, 2015). The role of the media in this increase can be queried again 
with television programmes such as Extreme Makeover, Ten Years Younger and 
Cosmetic Surgery Live being aired to a public mesmerised by the possibilities of new 
technologies offering enhanced beauty. A survey investigated how much 42 patients 
seeking cosmetic surgery for the first time were influenced by plastic surgery 
television shows. The findings indicated that four out of five patients stated they were 
influenced to seek cosmetic surgery by television programmes and almost a third 
described the degree of influence to be "very much" or "moderately" (Crockett 
Pruzinsky, Persing, 2007). 
 
However a literature review regarding the motivation for seeking cosmetic surgery 
determined that factors such as body image, bullying, BDD, education and culture 





2008). Furthermore BDD has been documented in patients since the 1800s as 
mentioned in the history of BDD. At the time psychoanalysis was a strong influence 
on treatment for example the case of the “Wolfman” and the focus was on analysis of 
dreams and familial relationship dynamics (Freud, 1959; Brunswick, 1971). Thus 
BDD is not a new concept and media and society’s responses to image promotion 
cannot be held solely responsible despite the impact it may have on people with 
BDD. Therefore we have to explore further into the psychological and biological 
domains bearing in mind that BDD sufferers do respond to psychological and 
pharmacological interventions (Phillips, 2005).  
 
1.7. Economic and political implications of BDD 
 
Body image concerns have been marginalised for a long time. However the medical 
scandal of the Poly Implant Prostheses (PIP) breast implants failures brought body 
image problems including BDD into sharp focus (Keogh, 2012). This incident then 
led to body image concerns being raised in parliament (APPG, 2012). Organisations 
such The British Association of Aesthetic Plastic Surgeons (BAAPS) followed suit by 
announcing their intention to fund long term research into recognition and treatment 
of body image disorders including BDD and highlighting the possible effects of 
unregulated advertising of cosmetic surgery (BAAPS, 2012). The Department of 
Health (DoH) is also reviewing cosmetic procedures in the UK including advertising 
that may be considered to influence or impact on body image concerns (DoH, 2013). 
The Scottish Government has also set up a committee to address concerns about 
cosmetic surgery (Scottish Government, 2015). A major development in recognising 
body image concerns was the recent guidance published by the General Medical 
Council (GMC) on 12th April 2016 for doctors who provide cosmetic interventions, 
both surgical and non-surgical. One of the key aims is to ensure the psychological 
needs of the patient. The guidance came into effect on 1st June 2016. 
 
These developments for body image concerns including BDD are long overdue.  
However one has to question whether the interest in BDD and body image would 
have been raised if the economic implications had not been so high. In October 2012 
the cost to the NHS for consultations and scans for women who had faulty breast 





following surgery (Smith, 2012). Although 95% of the implants were carried out by 
private practice, the NHS had to step in to address the problem (Horton, 2012). 
Where the media has played a role in promoting the ideal appearance, it has 
ironically also been useful to bring attention to body image problems with the focus 
on the cosmetic surgery industry following the PIP scandal. The increased scrutiny 
highlighted quality issues of implants by the Silimed brand that has had their CE 
(Conformité Européene) Marking suspended whilst the MHRA investigates (BAAPS, 
2015). In addition the Trilucent implants an alternative to silicone have also been 
found to be defective and recalled due to adverse physical symptoms experienced 
(Rizkalla, Webb, Chuo et al., 2002). 
 
Unfortunately the drive to clamp down on unnecessary cosmetic procedures may 
have a bearing on how patients with BDD are identified and provided with the 
appropriate treatment (Nassab, 2015). Patients may be reluctant to engage with 
psychological or psychiatric services when they have been refused the treatment of 
their choice which is cosmetic surgery (Crerand, Franklin, Sarwer, 2006). It is also 
important to note that refusal to perform a procedure will not deter the often 
desperate BDD sufferer who will continue to seek surgery even incurring substantial 
debts and risking poor procedures (Phillips, 2005). “Shopping” abroad for cosmetic 
surgery has become a more regular occurrence which often places more demand on 
healthcare services (BAAPS, 2015).  
 
A survey into patients seen by NHS plastic surgeons following problems with 
cosmetic surgery conducted outside the UK indicated a total of 215 patients 
presented to NHS (British Association of Plastic, Reconstructive and Aesthetic 
Surgeons (BAPRAS), 2011). This was reported by 62 of the consultants who 
responded to the survey. Out of these patients, 145 (74%) required treatment for 
post-operative complications and 50 (26%) expressed dissatisfaction or concerns 
with appearance.  
 
In addition to the pressure on NHS resources, there are the wider implications of the 
impact of BDD in society. The correlation with severe BDD symptoms and impaired 
functioning is described as a common feature (Phillips et al., 2005). The 





society results in more demands on the welfare system and a larger number of 
individuals without a supportive social network (Phillips et al., 2008). The duration of 
the disorder is often several years before any treatment is sought during which time 
the individual with BDD has often had long periods of isolation and limited activities 
(Veale et al., 1996; Phillips et al., 1997). This makes it more difficult to rebuild their 
lives and can lead to further psychological distress with the realisation that a large 
part of their lives is lost to the disorder.  
 




The aims of the research will be:  
• To explore and evaluate the application of the NICE guidelines in treating 
BDD within the context of a specialist service.  
• To elicit and explore the experiences of clinicians treating patients with BDD 
and patients receiving treatment for BDD. 





• To identify interventions used by the specialist service in assessing and 
treating BDD. 
• To analyse and quantify clinical outcome from the specialist service. 
• To report patterns found in patients’ and clinical staff experiences. 
• To identify areas of effectiveness and those requiring improvement.  











1.9 Research Questions 
 
Do the implementations of the NICE guidelines for BDD contribute to clinical 
effectiveness? 
 
How do patients with BDD respond to and experience treatment that has been 
recommended by the NICE (2006) guidelines for BDD? 
 
What are the views of clinicians treating patients with BDD using the NICE (2006) 
guidelines as a frame of reference? 
 
 1.10 Summary 
 
It is abundantly clear that BDD is a debilitating disorder for the individual but also for 
their families (Phillips, 1991). Additionally the current social fascination with 
appearance and body image ideals projected across mass media has highlighted the 
increased difficulties for people with BDD as this reinforces their perceived flaws. 
There is a limited knowledge base for the many facets of the disorder including 
epidemiology studies.  
 
Since its inception the vision of the service has been for clinical excellence and 
patient satisfaction. This study plans to determine the treatment outcomes the 
service achieves in applying the NICE (2006) guidelines for BDD and what the 
experiences of patients and clinicians have been. In addition, the study aims to 
highlight factors that may be obstacles to providing the best treatment. Participants 
will have the opportunity to describe what they felt worked best and aspects they felt 
were less helpful. This could provide key indicators for the best ways to engage 
patients in treatment and interventions to enable continued progress following 
treatment. In addition, interventions found to be beneficial and not highlighted in the 
NICE guidelines, may serve to refine the treatment protocol for BDD for this service 
to possibly bridge the gaps that cause some interventions to be unsuccessful or 
result in dropouts and disengagement (NICE, 2006). 
The next chapter will review the literature including studies used as an evidence 













2.1. Purpose of the literature review 
 
The purpose of reviewing the published literature is to offer a theoretical foundation 
for the study. The chapter provides a comprehensive discussion of the background 
to the development of the NICE (2006) guidelines for OCD/BDD by evaluating the 
literature published globally. This gives credence to this study, illustrating the scarcity 
of research on treatment of BDD whilst providing the rationale for using a mixed 
methods design in this study. This in turn identifies key issues that contribute to the 
understanding of the data and findings presented in this study.  
 
2.2. Process of reviewing the literature 
 
A critical review of the literature was conducted by determining its purpose in line 
with the research questions of the study. Literature was evaluated according to 
relevance for the study (Table 3). Each source was read critically and data extracted 
regarding key concepts; strengths and limitations; arguments presented; credibility. 
This approach is in keeping with the critical stance taken in this study. The data was 
analysed and sources were organised according to patterns and themes. A table 
was used to consider how publications related to each other and formed the basis of 
the structure of the critical review (Graph 3). Gaps in the literature were identified 
and prominent authors were noted.  
 
The literature review aims to explore and appraise the main types of interventions 
used to treat BDD. To date there have been three meta-analysis (Williams et al., 
2006; Ipser et al., 2009; Harrison, et al., 2016). However one of these studies only 
describes randomised controlled trials of cognitive behavioural psychotherapy (CBT) 
(Harrison et al., 2016). In addition there is one literature review of treatments for 
BDD, focusing only on CBT (Prazeres, Nascimento, Fontenelle, 2013).  
 
There are just two long-term follow up studies (McKay, 1999; Veale, Miles, Anson, 
2015). The most striking feature of the literature review was there were so few 
papers available on treatments of BDD in comparison to other mental disorders that 
have dedicated NICE guidelines (e.g. NICE guidelines for depression, 2010). OCD, 





outcome studies than BDD (NICE, 2006). Although attempting to take different 
approaches, the metaanalysis and literature reviews have limited studies to work 
with thus the ability to provide new information is restricted.  
 
The process of conducting the literature search involved using the databases listed 
in Appendix D. Boolean terms were avoided to allow for a more specific array of 
papers to be identified relating to BDD. As not all search engines use the same 
Boolean rules, it is best not to use these operator words unless one knows exactly 
what the search is for e.g. the full title of a paper that was manually identified 
(Winder, 2007). Although literature reviewers for the Cochrane library use Boolean 
terms specific to each database, this was not practical with regards to available 
resources in this study (Higgins, Cochrane, 2011). To allow for linguistic differences 
in spelling of words, abbreviations were used and Americanised versions of words 
were added to the search terms.  
 
Studies were also identified by a manual search in the references of published 
papers and books on BDD. The published treatment outcome studies are evaluated 
and results compared to examine the most effective interventions. This establishes a 
basis for evaluating the implementation of the NICE (2006) guidelines for OCD/BDD. 
One of the limitations of this literature review is that only published studies were 
evaluated. Although a search for unpublished studies was carried out via databases 
and manual searches of books and papers, just one was identified: Chandler, 
Benson (2015). The review process involved a global search however the majority of 
studies are from the United States. Indeed one particular author (Phillips) is one of 
the world’s leading experts on BDD and has contributed a significant amount to the 
available literature on BDD thus is used as a reference extensively through this 
study. 
 
Although this is a critical review of the literature, a systematic approach was taken to 
ensure transparency and to address limitations. Furthermore the Critical appraisal 
skills programme (CASP) was used to identify the most relevant papers for this study 





2.2.1 Selection of studies 
Papers were considered eligible if they met the inclusion criteria in Table 3. 
 
Table 3: Eligibility criteria for selection of studies 
 
INCLUSION CRITERIA                                           EXCLUSION CRITERIA 
i) BDD was first included in the DSMIII-R 
as a diagnosis with criteria in 1987 and in 
the ICD-10 in 1992. Thus all papers 
regarding treatment outcomes of BDD 
from 1987 to current were considered 
relevant.  
Articles prior to 1987 were 
excluded as the diagnostic criteria 
for BDD was unclear. Editorials 
and letters were excluded using 
the CASP criteria. 
ii) All treatment related papers on BDD 
published in English. 
Non-English publications were 
excluded if the databases did not 
provide an automatic translation 
application, as translation of 
papers was not possible due to 
resource constraints. 
iii) All published treatment outcome 
studies of adult BDD sufferers and 
adolescents with BDD who were 
provided with the same treatment. 
 
iv) Articles where BDD is the primary 
diagnosis according to all versions of the 
DSM (APA, 1987; 1994; 2000; 2013) or 
the ICD (WHO, 1992; 1999; 2018). 
Body Integrity Identity Disorder 
(BIID) and olfactory reference 
syndrome.  




From the 140 published articles perused, 45 studies were identified as relevant 
(Appendix D). Studies that were reproduced elsewhere were considered as one 





on cognitive behavioural therapy (CBT), four on medications and one on 
computerized interpretation bias modification.  
 
Table 4: Excluded studies 
Number of excluded studies (N=96)         Reason for exclusion 
2              Letters to editors  
4              Children and adolescent studies 
7              Review studies 
15              BDD not the main diagnosis 
68              Descriptive, non-interventional studies 
 
2.3 Data Extraction  
 
The three main treatments were: psychological interventions, pharmacotherapy and 
medical procedures. The main psychological treatment was cognitive behavioural 
therapy (CBT) which included studies focusing only on exposure and response 
prevention (behavioural treatment); only cognitive therapy and both group and 
individual therapy. There was one additional treatment study using a cognitive 
modification approach. Pharmacological treatment studies are limited and the main 
medications used were Serotonergic Reuptake Inhibitor (SRI) and Selective 
Serotonergic Reuptake Inhibitor agents (SSRI). Medical procedures included 
electroconvulsive therapy (ECT), cosmetic surgery and minimally invasive 
procedures such as Botox and dental treatments. Variable types extracted from each 


















The studies are presented in chronological order in Appendix E (Psychological 
interventions), Appendix F (Pharmacotherapy), Appendix G (Medical procedures). 
This provides an overview of the specific data which can then be cross referenced 
with the discussion of the main treatments and the contribution these papers have 
made to this study. Signposting to the treatment studies will be noted as Appendix 
label followed by numerical listing of the paper e.g. Appendix E: 1. 
2.4 Overview of the development of the NICE guidelines for OCD/BDD  
The NICE organisation describes a set of core principles which underlies the 
development of all their guidelines (NICE, 2018; Appendix X). The guidance for 
OCD/BDD has a well-documented description of the methods used to develop the 
guideline. There is little doubt that all available information for OCD has been 
included and the guidance is extremely thorough in all respects for OCD. However 













Granted, the evidence base for BDD is not as prolific as OCD. The literature 
available regarding BDD at the time the guidelines were published were less than 70 
papers with over 600 for OCD. However there are other aspects for BDD which 
appear to have been overlooked such as the section describing the impact of OCD 
on family and carers (NICE, 2006: 3.5). Unfortunately similar information for carers 
and family of BDD sufferers was not provided. Perhaps this is due to there not being 
representatives from carers or families of sufferers with BDD being included although 
a representative for OCD carers and families was on the panel. Could it have been 
assumed that it was sufficient representation to cover both disorders? In addition 
there were no patient representatives for BDD to contribute alongside the two patient 
representatives for OCD (NICE, 2006: pg. 6-7).  
 
Having experience of working with both OCD and BDD sufferers, including within an 
inpatient setting, it is clear these patients do not present in the same way and their 
experiences are vastly different including the impact on their families and carers. 
One has to question whether it is fully representative of both disorders to have only 
patients with OCD contributing to the guidelines and similarly for carers/family 
members. Perhaps there may have been more parity between the representation of 
OCD and BDD if there were personal accounts from family/carers of BDD sufferers 
included as well. There were four accounts from family/carers of OCD sufferers and 
three from patients with OCD but just one from a patient with BDD (NICE, 2006: 
pg.47-72). This dearth of patient accounts is one of the driving factors for using 
mixed methods in this study. A recent publication of personal accounts of patients 
with BDD or their loved ones is the first of its kind to offer insight into their 
experiences (Schnackenberg, Petro, 2016). The positive reception given to this book 
highlights the need for more studies offering qualitative data which hold more 
meaning to sufferers of BDD and their carers as well as offering greater insight to the 
general public (BDD foundation conference, 2016). 
 
The NICE guidelines for OCD/BDD (2006) were updated in September 2013 which 
included new treatment studies for OCD. There were no new studies included on 







2.5 Overview of the main treatments for BDD  
 
With increased media exposure of body image concerns, BDD has drawn more 
attention in recent years (APPG, 2012; BAAPS, 2012; DoH, 2013; GMC, 2016). This 
has prompted more research and policy development into psychological treatments 
for body image concerns. However BDD has still not been the main focus of 
research until more recent media attention on the effect of cosmetic surgery and 
emergence of BDD concerns. The link between BDD and cosmetic 
procedures/surgery needs to be highlighted and is therefore included within this 
section on treatment. 
 
2.6 Psychological treatments 
 
Psychological treatments make up the bulk of the evidence base for managing BDD 
(Appendix D). Of this, CBT-based studies are in the majority. In addition, single 
publications were found on Eye Movement Desensitization and Reprocessing 
(EMDR); Psychodynamic Psychotherapy and Cognitive interpretation bias 
modification training within the time period investigated. The findings of the studies 
are displayed in (Appendix E).  
 
2.6.1 Cognitive Behavioural Therapy 
 
CBT is the first line treatment recommended by the NICE guidelines (2006) for BDD. 
Studies have used different formats e.g. CBT, CT, BT and delivered individually or in 
a group setting (Khemlani-Patel, Neziroglu, Mancusi, 2011; Veale, 1996). This 
section depicting CBT treatments for BDD patients is divided into a review of 
treatment studies (n=4); case studies (n=3); RCTs (n=7); comparative studies (n=1) 
and variations of standard CBT treatment interventions (n=8). One of the RCTs is 
also a comparative study but since RCTs are the gold standard for research, it 









2.6.1a Treatment Studies 
Two of the treatment studies were of BT and two were CBT based. Retrospective 
studies are often criticised for providing inferior evidence compared to prospective 
studies. This is mainly due to factors such as convenience sampling; selection bias; 
higher possibility of misclassification and recall bias (Sedgwick, 2014). However 
retrospective studies can be more appropriate when sample sizes are small and a 
disorder may be considered rare or is not easily recognised, as with BDD (Vassar, 
Holzmann, 2013). This also supports the use of retrospective data analysis in this 
study to evaluate the outcomes of treatment.  
 
A retrospective case note study on the outcome of BT for a sample of patients with 
BDD, showed improvement in 15 cases but 28% (n=6) were unimproved (Appendix 
E:5). It was also reported that patients with BDD did not respond as well to BT as 
patients with other disorders treated over the same time period. One of the 
recommendations was for future research to test whether adding CT to the treatment 
for BDD could lead to further improvement (Gomez-Perez, Marks, Gutierrez-Fisac, 
1994). The study also found that patients who previously had cosmetic surgery had a 
poorer outcome.  
 
Although at the time of its publication the study had the largest sample of patients 
with BDD (n=30), one would have expected a bigger sample considering patients 
were treated over a period of 19 years (Gomez-Perez et al., 1994).  Unfortunately 
the authors do not discuss the reasons for the low referral rate of BDD patients 
which would have provided useful comparative information. Most of the studies 
discussed in this section had small sample sizes but although this may be a seen as 
a limitation, it is also indicative of the nature of the disorder with BDD sufferers 
having difficulty seeking help. 
 
In recent years there has been increased public awareness of BDD due to media 
focus and celebrities talking about their experiences (Reuman, 2011; Lupkin, 2016; 
Wiseman, 2016). However people are still reluctant to seek psychological help for 
BDD (Vulink, Rosenberg, Plooij, et al., 2008; Ghadakzadeh, Ghazipour, Khajeddin, 





and diagnosed usually by age 16 (Phillips, Menard, Fay, Weisberg, 2005; Phillips, et 
al., 2006). Yet as found in the BDD specialist service and the literature, sufferers of 
BDD usually have the problem for many years before seeking help (Veale et al., 
1996; Phillips, Diaz, 1997).  
 
Another aspect of the study by Gomez-Perez, et al., (1994) was that all participants 
had co-morbid disorders and social avoidance. The presence of comorbid disorders 
in BDD sufferers is given little attention even though this could have consequences 
for treatment (Baer, Jenike, 1992). However a study investigating CBT for individuals 
with BDD and comorbid Axis I and Axis II disorders, demonstrated the effectiveness 
of CBT for BDD despite additional diagnoses (Neziroglu, McKay, Todaro, et al., 
1996; Appendix E: 8). There was no relationship found between number of 
personality disorders detected in subjects and the treatment outcome for BDD. 
Unfortunately the study lacked valid measures for depression and functionality 
relevant to evaluate the overall effectiveness of the treatment, particularly as both 
are factors to consider in BDD (Phillips, 1999; Phillips, et al., 2005; Phillips et al., 
2008).  
 
In a rare longitudinal study evaluating a BT and maintenance programme (relapse 
prevention and management) for BDD, patients (N=10) also had co-morbid anxiety 
and depression (McKay, Todaro, Neziroglu, et al., 1997). Findings indicated patients 
generally improved on BDD and depression symptoms, yet those in the maintenance 
group (N=5) continued to improve on measures of anxiety and depression post 
treatment and longer term (McKay, 1999).  
 
However the study did not have a control group and the sample was small which 
restricts conclusions about efficacy. There was limited demographic data and 
additional information on the clinical presentation of the subjects. Information about 
the age range of patients, the gender distribution and education level was provided 
but no information was provided on marital status, ethnicity or employment. Similarly 
clinical information was presented on areas of BDD concern but no mention is made 
of comorbid disorders, impact of BDD on levels of functioning, suicidality, previous 
treatment, concurrent medication or any previous nonpsychiatric treatments such as 





suggest that BT can provide a clinically meaningful decrease in BDD symptoms. It 
also highlights the importance of relapse prevention to possibly reduce the number 
of patients who require further episodes of treatment. This would help to lessen the 
burden on an already strained NHS in the UK (Bell, Jarvie, 2015). 
 
A further study into the effectiveness of CBT examined the treatment outcomes of 13 
patients which consisted of group treatment and additional individual treatment for 
three patients with higher symptom severity (Wilhelm, Otto, Lohr, et al., 1999). The 
subjects showed significant reductions in BDD symptoms on Y-BOCSBDD 
(Appendix E: 11).  
 
The authors note that due to the pressures by the organisations commissioning their 
services, group CBT was considered the more economically viable option (Wilhelm 
et al., 1999). However it is heartening to note that where indicated due to severity of 
patients’ presentation, the authors nevertheless conducted additional individual 
therapy. The results from the group treatment were similar to those found in 
individual treatment (Veale, 1996) with regards to reduction in symptoms. This was 
also found in an audit of group treatment of BDD conducted in the BDD specialist 
service (Chandler, et al., 2015, unpublished). There was no exclusion criteria based 
on comorbidity which allows for generalisation, despite the small sample size. It 
would have been useful if the authors had used measures of functionality to identify 
if any changes occurred following treatment, considering their description of the 
impact of BDD on the participant’s lifestyle (Wilhelm et al., 1999). 
 
Despite the positive results from the longitudinal BT study, there still remained a 
fairly large percentage that were unimproved in the other studies (Gomez-Perez et 
al., 1994; Neziroglu, et al., 1996; Wilhelm, et al., 1999). There were also inconsistent 
findings in the two BT studies with one reporting a much lower response rate 
(Gomez-Perez et al., 1994). One of the recommendations was for future research to 
test whether adding CT to the treatment for BDD could lead to further improvement 








2.6.1b Case Studies 
 
There were three case studies found all using different elements of CBT and also a 
variety of frequency and lengths of treatment. Similarly to the BT studies previously 
reviewed, the CT only treatment studies also showed some improvements but 
including BT was considered for added benefit. Efforts were made to compensate for 
the small sample sizes by ensuring gender groups were equally represented, 
demographic details were gathered and subjects were included if they had comorbid 
disorders. Unfortunately despite the small sizes of samples in these case studies, 
none included qualitative data on the patients’ experiences. This would have 
provided more clarity to understand the outcomes.  
 
In a study of five patients treated with ERP and CT, treatment was of varying length 
with some patients having intensive therapy five times per week and others having 
weekly sessions (Neziroglu et al., 1993). Although improvements were reported, the 
findings would have had more merit if they were compared and explained with 
regards to differences in severity and reasons for different lengths of treatment. The 
overvalued ideation (OVI) scores were reported however not all the BDD-YBOCS 
scores were stated. Also since it was a small sample size it was conceivable to have 
included an account of patient’s experiences to further explain the findings. 
 
The second case study examined the role of CT in treating BDD (Geremia, 
Neziroglu, 2001). Results indicated that CT resulted in statistically significant 
reductions in BDD symptoms in two out of four subjects (Geremia, et al., 2001). The 
rationale for some aspects of the design was not clarified such as assigning patients 
to separate groups of different duration for data gathering. Furthermore one of the 
patients who was reported to have significant reductions in BDD symptoms after 
treatment attempted suicide following a derogatory comment made by a psychiatric 
patient at the day programme. The improvement therefore has to be viewed with 
caution as the patient’s perception of themselves was clearly still extremely fragile. It 
can therefore be argued that the benefit of adding in behavioural techniques may 
help to prepare patients for eventualities such as this and provide a firmer foundation 






Still if using CT initially to engage the patient could increase compliance and produce 
some symptom reduction, it may be easier for the patient to participate in the more 
difficult behavioural exercises (Geremia et al., 2001). This may possibly explain the 
reports that subjects spontaneously exposed themselves to social situations as their 
BDD symptoms improved. Follow up was only of short duration (3-5 weeks post 
treatment) thus long term effects of the treatment could not be determined.  
 
In contrast, a single case study explored treatment of BDD using only BT 
(Rabinowitz, Neziroglu, Roberts, 2007). Pre-treatment the subject had BDD 
symptoms within the extremely severe range and depression symptoms within the 
severe range. Intensive treatment was conducted 5 days per week over 6 weeks. 
The patient also participated in group therapy once per week. This intensity of 
treatment is unusual but the authors believed this to be necessary due to the severity 
of the patient’s presentation and impairment in functioning.  
 
Following treatment the patient’s scores on Y-BOCSBDD dropped to moderate 
range and depression scores dropped to mild range. After one year of treatment the 
patient is continuing to have treatment twice weekly for 45 minute sessions to 
maintain the improvements he made. The patient was also on medication but the 
dosage of one medication was reduced during therapy and the other reduced and 
stopped without any adverse effects on symptoms. The level of intervention required 
prompts the question of whether the patient could have benefitted more from   
inpatient admission and whether that could have reduced the duration of the 
treatment.  
 
Currently there are no known studies examining inpatient treatment for BDD 
specifically but a study into inpatient treatment of OCD and BDD using CBT and 
medication revealed 42% reduction in symptoms at the end of treatment which is on 
average four months with a maximum of six months consisting of a combination of 
individual and group therapy (Drummond, Fineberg, Heyman, et al., 2008). 
Unfortunately the results were not independently reported for BDD. Also there are 
few inpatient facilities of this type available for treatment of BDD both in the UK and 






2.6.1c Comparative study 
 
In the first known study to compare CT and BT in treating BDD, participants (n=17) 
were assigned alternately to either CT or BT groups to determine whether there was 
benefit from adding in CT to BT in a combined approach following a treatment 
protocol (Khemlani-Patel et al., 2011). The CT group had treatment for 12 weeks 
followed by BT forming a combined treatment whilst the BT group had 24 sessions of 
only BT. Both treatments were found to be as effective in reducing BDD symptoms. 
However the sample was small; lacked a control group and blind assessment. The 
combined treatment of CT and BT was again no more significantly effective than BT 
alone (Appendix E: 15). This was an unexpected result as their hypothesis was that 
a combined treatment of CT and BT would result in significantly greater 
improvements than BT alone (Khemlani-Patel et al., 2011).  
 
A longer duration of treatment may show different outcomes particularly in 
functioning and quality of life as the onset of BDD may be many years before 
seeking treatment (Veale et al., 1996; Phillips, Diaz, 1997). Therefore a short course 
of treatment is insufficient time to address the overall impact of the disorder 
(Khemlani-Patel et al., 2011). This study addresses pertinent issues relating to the 
clinical presentation and treatment of BDD and makes recommendations for 
treatment of BDD beyond CBT to a more holistic approach including support for 
employment and training to improve social skills. 
 
2.6.1d Randomised controlled trials (RCT) of CBT 
 
From the literature reviewed there are seven RCTs of CBT treatments for BDD to 
date. All the trials presented encouraging results for the effectiveness of CBT.  
 
The first two RCTs were focused only on female participants (Rosen, Saltzberg, 
Srebnik, 1989 Appendix E: 2; Rosen, Reiter, Orosan, 1995 Appendix E: 6). 
Interestingly none of the patients dropped out in either study, considering it is often 
difficult to engage BDD sufferers in therapy (Marquesa, Weingarden, LeBlanca, et 
al., 2011). In the second study a cancellation policy was used if any member of the 





incentive using peer encouragement to attend each session. There is no indication if 
this or a similar incentive was also used in the first study. Although the results of both 
studies were promising, the findings were limited by the samples being exclusively 
female. This restricts the generalisability of the results of both studies, given the 
similarities in incidence and areas of preoccupation in both genders (Phillips et al., 
1997; Tyagi et al., 2013). In addition the studies’ findings are weakened by the 
predominant focus on body image concerns such as weight, size and body shape 
rather than BDD symptoms (Rosen, et al., 1989; Rosen, et al., 1995). 
 
Following on from this earlier work, a RCT randomly assigned patients (n=19) to 
CBT (n=9) or no treatment waiting list control group (n=10) for 12 weekly sessions 
and excluded patients whose primary concern was weight and body shape (Veale, 
Gournay, Dryden, et al., 1996; Appendix E: 7). The results were promising yet 
generalisability was limited by the high proportion of females (90%) similar to the 
previous RCTs as well as the small sample size and exclusion of delusional patients. 
Considering the incidence of delusionality in patients with BDD tends to be relatively 
high to the extent this criterion has been added to the DSM V and ICD 11 diagnostic 
criteria for BDD, these patients should be represented in the sample (Phillips, 2006; 
APA 2013; WHO, 2018). In addition there was no indication of the presence of 
concurrent psychotropic medication plus a lack of follow up ratings. 
 
There seemed to be a hiatus at this point in the CBT treatment studies on BDD with 
no further publications until more recently. A possible reason for this may be that 
experts in the field were considering different approaches to applying CBT to 
address inconsistencies with treatment outcomes. This is borne out in the more 
recent publications of CBT treatment trials. A treatment manual was developed 
expanding on standard treatment for BDD by adding in five flexible “modules” of CBT 
selected according to need (Wilhelm, Phillips, Fama, et al., 2011). The treatment 
was developed by bringing together the different proposed CBT models and 
neurocognitive studies (Wilhelm et al., 2010; Veale et al., 1996; Wilhelm, Neziroglu, 
2002; Deckersbach, Savage, Phillips, et al., 2000; Feusner, Townsend, Bystritsky, et 
al., 2007; Feusner, Moody, Hembacher, et al., 2010). This is an innovative approach 
bringing together the elements of CBT to devise a treatment package that addresses 





treatment regimes for additional symptoms that often co-exist with BDD such as 
skin-picking, hair plucking, muscularity or weight concerns and mood management. 
There was also a module on psychoeducation for those considering cosmetic 
surgery. 
  
This approach was then tested in a pilot study which showed improvements in BDD 
symptoms to the subclinical range (Wilhelm et al., 2011; Appendix E: 16). This pilot 
study was followed up with a RCT using the modular CBT treatment (CBT-BDD) 
manual (Appendix E: 20; Wilhelm, Phillips, Didie, et al., 2013). At the end of 24 
weeks the combined sample of treatment completers showed an average 55% 
decrease in BDD-YBOCS scores indicating 83% of the treatment completers were 
responders. The results of this study are unfortunately weakened by a lack of 
alternative treatment to compare efficacy especially given that the waiting list 
participants also showed improvements. Despite the limitations this paper describes 
a more comprehensive form of CBT treatment aimed at individualised care for 
different aspects of BDD as well as more global factors such as such as risk, 
motivation and patient satisfaction. 
 
In the initial study patient feedback was collated and themes reported (Wilhelm et al., 
2011). In the RCT reasons were provided for patients dropping out of treatment and 
direct quotes from patients were included. This was the only study to provide 
patients’ comments on experiences of completing treatment. All the comments were 
positive plus reasons reported for patients dropping out of treatment were not directly 
related to the treatment itself (Wilhelm, Phillips, Steketee, 2013). 
 
This is encouraging as there are often non-completers and non-responders in CBT 
studies, the reasons for which are rarely reported or discussed in the literature 
(Appendix E). For the purpose of improving treatment options for BDD sufferers 
positive responses need to be examined as much as negative ones to ascertain, 
from the patient’s perspective, what works and what is less helpful. In recent years 
incorporating qualitative information into studies is more commonplace as the 
importance of patient experience has been identified as a factor in improving 
effectiveness of service delivery (Boiko, Campbell, Elmore, et al., 2015; Weich, 






In a further shift from standard CBT, a RCT was conducted to investigate the 
effectiveness of using Metacognitive therapy (MCT) to treat BDD (Rabiei, Mulkens, 
Kalantari, et al., 2012).  MCT is based on a theory to treat generalised anxiety 
disorder but was broadened into a general treatment approach (Wells, Matthews, 
1994; Wells, 2000). This is the only study on MCT for treating BDD (Appendix E: 17). 
Metacognition refers to beliefs about thinking (Moses, Baird, 1998). Metacognitive 
therapy focuses on these beliefs which are considered to regulate thought processes 
and causes a pattern of response which maintains negative emotions, images or 
other intrusions (Wells, 2000).  
 
The use of the Thought Fusion Instrument (TFI) provided a measure of improvement 
in the symptoms of cognitive fusion which is described as a fusion of internal events 
with past experiences which impact on behaviour patterns (Hayes, Strosahl, Wilson, 
1999; Feusner, Yaryura-Tobias, Saxena, 2008; Neziroglu, 2010). This belief 
structure is often seen in BDD presentation and examining this was a useful 
contribution to the understanding of how therapy can impact on these belief 
structures (Cooper, Osman, 2007). Patient satisfaction was reported as moderate to 
high. Considering the limited qualitative information available in studies on BDD, it 
would have been valuable to have patients’ quotes reported. Nevertheless this study 
makes an important contribution to the body of knowledge about BDD treatment as 
no other literature on MCT and BDD was found. 
 
Likewise comparative studies for BDD were not available until relatively recently 
when CBT was compared to anxiety management (AM) (Veale, Anson, Miles, et al., 
2014; Appendix E: 19). The trial also reported on the outcome on delusionality and 
depression with treatment including imagery rescripting for distressing memories 
associated with the onset of BDD and habit reversal for skin picking. Unfortunately 
due to the discrepancy in the end points between the two treatment groups, the 
study could not conclude that CBT had greater efficacy than AM (Veale et al., 2014). 
In an exploratory study these patients were followed up from one to four years post 
treatment (Veale, Miles, Anson, 2015). Most of the patients were able to maintain 
their gains in follow up with 11 (28.2%) in full remission. One of the findings was that 





depression than those who did. However the findings have to be treated with caution 
as there were also ten patients who had received further psychological treatment 
after the initial study. Due to the retrospective design of the follow up study, the 
improvements cannot be conclusively linked to the initial CBT treatment.  
 
Generally the findings provide evidence for CBT in its combined format for treating 
BDD supporting the NICE guidelines’ recommendations (NICE, 2006). Still from the 
studies reviewed and literature on BDD there are patients who do not respond to 
treatment with CBT or who drop out of treatment early on (Marquesa et al., 2011). 
Some of the problem areas are: difficulty engaging patients in therapy, dropout rates, 
also motivation to change which is an important factor in ensuring engagement with 
CBT especially as the interventions are difficult (Folke, von Bahr, Assadi-Talaremi, et 
al., 2012). Participants with comorbid disorders were included in all studies but some 
neglected to provide measures to determine changes in symptoms such as 
depression as well as levels of functioning which tends to be most commonly 
associated with BDD (Nierenberg, Phillips, Petersen, et al., 2002; Phillips et al., 
2008). A combination of approaches appears to be beneficial and adjustments made 
to the standard treatments have shown positive impact (Wilhelm et al., 2011; Rabiei 
et al., 2012). However only two studies reported on patients’ experiences which 
would have given validity to positive outcomes in the other studies. The continued 
search for a treatment modality that works best has seen adaptations of standard 
CBT for BDD in the last few years. 
 
2.6.1e Adapting CBT treatment 
 
This section illustrates eight studies which have a basis in CBT and have been 
adapted or augmented to address some of the problem areas described above (Fig. 
3). There is one study of each intervention apart from imagery rescripting and 










Figure 3: Adaptations of CBT 
Content removed due to copyright reasons. 
 
• Behavioural and interpretative methods 
 
A case study of a university student with BDD found that although improvements 
were made in ERP, the patient became resistant to further exposure interventions 
and therapy became stagnant (Watts, 1990). Interpretative intervention was then 
introduced which takes the form of psychoanalytic treatment with the theory of the 
patient’s resistance to becoming an adult. Further ERP was conducted thereafter 
and the patient was also provided with cognitive interventions to enable him to 
challenge his thinking patterns and develop an acceptance of his physical 
appearance. Unfortunately there were no measures of symptomatology but then 
again, using a variety of psychotherapeutic methods does not lend itself easily to 
scientific measurement. The gains obtained with the use of ERP were clearly 
described. However with the addition of interpretative methods the patient was 
helped to overcome obstacles in traditional behavioural treatment and make 
additional progress.  
 
The literature often describes behavioural treatments as challenging (Hartmann, 
Greenberg, Wilhelm, 2016; Wilhelm, et al., 2013). There are times in clinical practice 
when a patient’s progress appears to plateau and continuing along the same track 
does not generate further improvement. One can question whether the addition of 
other interventions can be helpful in overcoming obstacles to progress. The nature of 
the treatments presented in this case study, although useful in this one case, make it 
difficult to replicate in a large scale study as it is an individualised treatment package 
for specific circumstances. It cannot be seen as generalisable although it is thought-
provoking for the concept of individualised packages of treatment.  
 
• Culturally adapted CBT 
 
Cultural influences and ethnicity is another area of very limited study in BDD (1.2.2b, 
pg. 11). An important issue in treating and engaging people with BDD from different 





et al., 2011). Incorporating ethnic identity and cultural backgrounds in treatment 
appeared instrumental in the subjects’ improvements. The results should also be 
considered in context of the use of medication. Subject A had a lower baseline score 
than Subject B and improved to no symptoms on medication however whilst Subject 
B was of higher severity and not on medication, he also improved to subclinical 
symptoms. The limitations of the study are having just 2 patients which make 
generalising findings very restricted. The authors also acknowledge that they were 
unable to control for confounding variables such as the impact of the therapist with 
regards to ethnicity and the therapeutic relationship (Weingarden, et al., 2011). 
 
This topic is largely neglected in the literature and this is the only known paper to 
discuss CBT for BDD from a cultural perspective. This is especially relevant where 
people have experienced actual discrimination and this may further impact on their 
perception of themselves. Ethnically appropriate physical features may be focused 
upon as a source of concern if the individual has difficulties with their ethnic identity 
(Ishigooka, et al., 1998).  
 
• Inference based therapy (IBT) 
 
According to the IBT approach, obsessions are doubts which are internally 
generated with an idiosyncratic reasoning process causing the individual to be 
unsure of their own senses and logical thinking (O’Connor, Ecker, Lahoud, et al., 
2012). IBT focuses on the reasoning process (inferential confusion) which creates 
the doubt and aims to change this to restore a more functional perception (O'Connor, 
Aardema, 2011). IBT was developed to enhance the cognitive approach for patients 
with BDD presenting with high OVI (Taillon, O’Connor, Dupuis et al., 2013).   
 
A study exploring the use of IBT for BDD showed significant improvement in BDD 
symptoms from baseline to post treatment (Taillon et al., 2013). There was also 
reduction in depression symptoms and OVI. However the Inferential Confusion 
Questionnaire (ICQ) showed no significant difference from pre to post treatment. 
Considering the concept of inferential confusion is the focus of IBT, the lack of 





authors attempt to explain the lack of change, their conclusion is that the ICQ needs 
to be modified to measure inferential reasoning in BDD.  
 
Although this study produced some improvements in BDD symptoms which were 
maintained at six month follow up, it was not proven superior to CBT from 
comparison of effect sizes (Taillon et al., 2013). Interventions such as IBT attempt to 
provide a different approach to some of the more complex aspects of BDD such as 
OVI. Although this is commendable, it may be more beneficial to develop a clearer 
understanding of BDD in all its complexity to inform development of the most 
effective treatment methods. As yet there is no definitive model to understand the 
mechanism of BDD although there are both psychological and medical conceptual 
models proposed as an explanation of BDD (Veale et al., 1996; Neziroglu et al., 
2004; Feusner et al., 2008).   
 
• Internet based CBT for BDD 
 
There are CBT based internet treatments already established for depression and 
anxiety disorders including OCD (Beating the blues; Fearfighter), however it has not 
been widely explored for BDD. Internet based CBT is an innovative, cost effective 
and widely accessible means of providing psychological treatment (Gratzer, Khalid-
Khan, 2016). NHS England has approved the use of BDD-NET as one of the 14 
digital products being evaluated (NICE, 2019).  
 
There have been recent innovations in investigating internet use to treat BDD 
(Enander, Ivanov, Andersson, et al., 2014; Gentile, La Lima, Flygare, et al., 2019; 
Appendix E: 24; 25). The findings of both studies were promising with significant 
improvement from baseline to post treatment with further gains made at 3 month 
follow up.  
 
Dropout rates were low in the first study with just one patient who disengaged 
(Enander, et al., 2014). In the second study seven dropped out which is in keeping 
with most of the psychological treatment studies reviewed (Gentile, et al., 2019; 
Appendix E). However in both studies participants also reported the treatment 





symptoms and deterioration of symptoms being most experienced (48% and 25% 
respectively; Enander, et al., 2014; Gentile, et al., 2019). Nevertheless overall patient 
satisfaction indicated the majority of the patients were pleased to very pleased with 
the treatments. The findings are promising for further controlled studies to be carried 
out. However some basic information was lacking in these studies such as the ease 
of use of the program; assessing the ability of patients to use technology; whether 
the age of participants has any bearing on technological skill. Also in the global study 
the majority of participants were from Western countries with easy access to 
technology and all spoke English. These are factors to be considered if further 
studies are planned. Also of note was the level of severity which was in the moderate 
range and patients were all self-referred which usually has more positive implications 
for motivation to change (Mataix-Cols, Cameron, Gega, et al., 2006).  
 
• Acceptance-based exposure therapy  
 
Similar to IBT, acceptance based treatment attempts to redress areas within CBT 
where patients show low response or drop out of treatment (Linde, Rück, Bjureberg, 
et al., 2015). In contrast to IBT however, the focus is primarily on the behavioural 
intervention of exposure rather than cognitive treatment. A pilot study evaluated the 
addition of psychoeducation and acceptance and defusion into exposure 
interventions (Linde, et al., 2015; Appendix E: 21). The acceptance and defusion 
aspects involve being aware of unpleasant emotions, thoughts or physical 
sensations without avoiding them or engaging in the misgivings created, but 
continuing with everyday activities. The aim is to develop a willingness to allow for 
and observe these experiences from a different perspective. Results showed 
clinically significant improvement in BDD maintained at six month follow-up. But most 
interesting was the dropout rate was just two patients. One of those was reported to 
have improved after two sessions and discontinued treatment and the other cited 
practical difficulties in attending the sessions (Linde et al., 2015). Given that 
exposure is already an established treatment method, there is no conclusive 
indication for the use of acceptance-based treatment (McKay et al., 1997; Khemlani-
Patel et al. 2011). Nevertheless it is the low attrition rate rather than symptom 
reduction that appears significant in this study. An intervention that can assist in 





Although the authors report feedback from patients this aspect of the study would 
have been more useful had patients’ experiences been recounted (Linde et al., 2011: 
pg. 15). This is a further validation for the need for qualitative studies in treatment for 
BDD.  
 
• Imagery Rescripting (ImR) 
 
Studies into the characteristics of BDD have uncovered a phenomenon in sufferers 
of BDD where they experience not just thoughts but negative images of their 
appearance (Osman, Cooper, Hackmann, et al., 2004). Furthermore BDD sufferers 
also describe more aversive memories relating to appearance e.g. bullying, 
derogatory comments, than non-BDD sufferers (Buhlmann et al., 2007; Buhlmann, 
2011). ImR has been used as an intervention alongside CBT (Rabiei et al., 2012; 
Veale, et al., 1996; Wilhelm, et al., 2013). A study was conducted to investigate the 
efficacy of ImR as a standalone treatment for patients with BDD linked to aversive 
past experiences (Willson, Veale, Freeston, 2015; Appendix E: 22). One of the 
striking aspects of this study is how quickly improvements occurred in those patients 
who responded. The efficiency of just one session resulting in change is of interest 
especially as BDD is considered a condition that is difficult to treat and takes several 
sessions to see any improvement (Cotterill, 1996; Wilhelm, et al., 1999; McKay 
1999).  
 
However three of the patients had previous CBT and two of those were responders 
to ImR. Despite the CBT being at least six months prior to the assessment for the 
study, improvements following CBT have been shown to continue into follow up at 
six or even 12 months post treatment (Gomez-Perez et al., 1994; McKay et al., 1997; 
Wilhelm et al., 2011). Therefore it is difficult to ascertain whether there was some 
influence from the previous treatment. On the other hand from the two patients who 
did not respond, one also had previous CBT. It is also a small sample from which 
findings cannot be generalised. Therefore this study does not provide conclusive 
evidence of the efficacy of ImR, although it is an interesting concept and should be 






Further study in the use of imagery rescripting was included in cognitive therapy to 
treat BDD where all patients in the sample had intrusive images relating to aversive 
memories (Ritter, Stangier, 2016, Appendix E: 23). Although improvements were 
reported, again the sample was small and there was no control group. However 
unlike the previous study, details of the patients who did not respond to ImR are 
provided, which is an important aspect to consider when wanting to replicate this 
research (Willson et al., 2015). The authors acknowledge that improvements could 
have been affected by other factors such as therapeutic alliance and as it was 
included in a package of cognitive therapy, it is difficult to assess the impact of ImR 
on its own (Ritter et al., 2016).  
 
These are the first studies to explore the use of ImR in BDD. Both studies raise 
queries for including this element as an intervention in CBT for BDD. The 
improvements shown may contribute to individualising treatment programmes for 
BDD in patients with a specific presentation.  
 
• Summary of adapted studies 
 
These studies used the basis of CBT to varying degrees with some adding and 
enhancing the field of CBT for BDD whilst others had a more tenuous connection 
(Fig. 3). From the six studies reviewed, two factors which could prove especially 
useful for future development in BDD treatment are internet based interventions and 
adapting treatment to be culturally sensitive. These aspects can be more widely 
beneficial to patients with BDD. However from the other studies, it appears that 
various interventions were trialed to test out theories of effectiveness (Watts, 1990; 
Taillon et al., 2013; Linde et al., 2015; Ritter et al., 2016; Willson et al., 2015). 
Although there were interesting findings which could possibly help in reducing 
attrition rates and lack of response, these studies have little to add to improve on 
CBT for BDD apart from where individual or specific circumstances may warrant 
these.  
 






Three additional psychological treatments of BDD were found in the literature. None 
of these are recommended in the NICE guidelines (2006) for treating BDD however 
with the limited body of knowledge available other avenues can still offer some 
insights. 
   
2.6.2a Psychodynamic therapy 
 
A case study using psychodynamic psychotherapy to treat a patient with BDD 
centred on the formulation of the patient’s relationship with her father (Bloch, Glue, 
1988). Through the therapeutic process, the patient was able to develop a positive 
transference and worked towards addressing her interpersonal difficulties and poor 
self-esteem (Bloch, et al., 1988). The paper has merit in describing the context in 
which psychodynamic psychotherapy could potentially be useful in treating BDD. In 
particular, cases where underlying family difficulties may play a part. However this is 
just one case where progress was found and the authors cite other studies reporting 
failed attempts to treat patients with BDD using psychodynamic psychotherapy 
(Bloch, et al., 1988; Beary, Cobb, 1981; Brotman, Jemke, 1984). Unfortunately there 
are no measures to rate the level of severity of symptoms at baseline, post treatment 
or follow up but measuring outcomes is associated with a CBT model rather than a 
Psychodynamic one. Although the emphasis is currently on measurable outcomes, 
there may still be potential benefit of Psychodynamic psychotherapy in specific 
cases (Department of Health, 2011).  
 
 
2.6.2b Eye Movement Desensitization and Reprocessing (EMDR) 
 
At a time when EMDR was still only a recent development and was mainly used to 
treat Posttraumatic Stress Disorder (PTSD) a trial was conducted to treat BDD using 
EMDR (Brown, McGoldrick, Buchanan, 1997).  
 
A common factor in six of the seven patients who responded to treatment was the 
presence of intense intrusive imagery which is often experienced in PTSD (APA, 
2000). Five patients reported the onset of BDD to follow on from a casual comment 





carried the intensity of a traumatic event with accompanying intrusive imagery 
(Brown et al., 1997). However not everyone subjected to chance remarks about their 
appearance will develop BDD. The authors consider that this perception may be 
influenced by the patient’s personality but do not elaborate further. Improvements 
were reported over a short series of treatments; between one and three sessions 
which was also found in the Imagery rescripting study (Willson et al., 2015). 
 
 The rapid response rate makes this a possible option to consider especially in BDD 
cases where there have been traumatic experiences (Veale et al., 2010). 
Unfortunately there are clinical and demographic aspects either unreported or 
lacking in clarity. There were no measures of symptom severity reported therefore 
there is no indication of how improvement was measured or what level of severity 
patients were at pre- treatment. It is also unclear who treated the patients and what 
their experience was in treating BDD. The authors express their surprise at the 
positive results obtained and recommend more rigorous studies are conducted into 
the use of EMDR in treating BDD.  
 
2.6.2c Modifying interpretation biases  
 
The use of technology in treatment has been a growing field and may prove an 
accessible and appealing medium for BDD sufferers (Enander, et al., 2014; Hedman, 
2014). A study evaluating the use of computerized treatment to reduce social 
evaluation and appearance-related interpretation biases in BDD was conducted with 
a sample of university students and community members (Summers, Cougle, 2016; 
Appendix E: 25). The findings indicated improvements in BDD symptoms for those 
participants with higher pretreatment scores (Summers, et al., 2016). Participants 
were in the mild range of pretreatment scores and it is questionable whether they 
had appearance concerns rather than a diagnosis of BDD. There were also no 
improvements on depression and anxiety symptoms. The study provides some 
additional information of interpretation biases in BDD however has little to add to 
treatment options especially for patients with moderate to severe BDD.  
 






There is undoubtedly some evidence from the literature reviewed that CBT is the 
most effective psychological treatment for BDD which is supported by findings in 
metaanalysis and literature reviews (Williams et al., 2006; Ipser et al., 2009; 
Prazeres, et al., 2013; Harrison, et al., 2016).  
 
However studies reviewed indicate there are still improvements to be made and 
there are still patients who do not respond to CBT or drop out of treatment (Appendix 
E). Limitations in most studies included small samples sizes and generally a higher 
proportion of females than males. Other issues also need to be addressed such as 
ethnic diversity and the need for the models of treatment to be adapted accordingly 
which has shown effectiveness in case studies (Weingarden et al., 2011).  
 
Several studies reviewed also explore variations on the standard CBT treatment in 
an attempt to remedy the shortcomings of traditional CBT. Internet based CBT for 
BDD produced results that appear promising as an alternative, cost effective and 
more accessible method of delivering CBT. Furthermore with onset of BDD being in 
adolescence, use of technology will be more appealing to the younger generation of 
BDD sufferers who are digital natives (Prensky, 2001). Treatments such as 
Metacognitive therapy show some promising results and may be an alternative to 
standard CBT for those patients unable to engage in the behavioural component of 
CBT. However none of the studies presented conclusive evidence for the addition of 
interventions or variations to standard treatment. Apart from ImR, all the adaptations 
in treatment were one-off studies. More attention should be given to enhancing the 
CBT model by considering a holistic view of the patient rather than what appears to 
be trials of novel interventions. 
 
One of the restrictions in reviewing the available literature is the use of a variety of 
different measures which makes outcomes across different studies difficult to 
compare (Graph 1). The BDD-YBOCS was used in 18 out of 24 papers reviewed; 
the BDI was used in 11 papers and the SCID in 10 papers. There was no 
consistency in the use of measures. Just eight studies used measures to rate 
patients’ levels of functioning and again there was no consistency with five different 
measures being used. Three measures were used in two studies each and two 






Graph 1: Measures of symptoms plus functioning: frequency scales used in 
literature reviewed  
 
 
A significant theme emerging from the literature review is the sense that treatment 
for BDD is trial and error. It is recognised that CBT although found to be effective, 
does not lead to complete remission of BDD symptoms (Phillips, Grant, Siniscalchi, 
et al., 2005). However the reasons for this are not being fully explored to enable a 
well-informed decision of how to proceed with treatment options to best treat BDD. 
Instead it could be suggested that researchers want to be the first to create a new 
improved version of CBT to treat BDD based on some of the one-off studies 
reviewed (Watts, 1990; Taillon et al., 2013; Linde et al., 2015). Although it is vital to 
provide effective treatment to people with BDD and any research into treatment 
efficacy is welcome, it is clear that BDD is still not sufficiently understood for a clear 
treatment model to be developed (Phillips, 1991). 
 
2.7 Pharmacological treatment 
 
There is currently no medication specifically licensed for treatment of BDD (FDA, 
1998; MHRA, 2004). Only a few studies have been conducted into pharmacological 


















(Phillips et al., 2008). The findings of the studies are in Appendix F. There are four 
RCTs, four open label trials, two case studies and one retrospective case note study. 
The focus in the literature has been mainly on Serotonergic Reuptake Inhibitor (SRI) 
and Selective Serotonergic Reuptake Inhibitor agents (SSRI) for treating BDD 
(NICE, 2006). There have also been investigations into augmentation of SSRI 
medication with dopamine blockades (antipsychotics) which have produced mixed 
results (Williams et al., 2006; Ipser et al., 2009).  
 
2.7.1a Serotonergic Reuptake Inhibitor (SRI) and Selective Serotonergic 
Reuptake Inhibitor agents (SSRI)  
 
One of the criteria for the OCD/BDD specialist service is that patients need to have 
been offered two trials of SSRI medication alongside CBT before being referred.  
 
“No RCTs have been conducted that compare an SRI or any other medication 
with CBT or a combination of the two. There are a few case reports of 
combination treatments highlighted in the psychological interventions but they 
do not assist in guiding clinical practice” (NICE, 2006: 7.3.13 pg. 189).  
 
Nevertheless given the high levels of distress and often comorbid conditions 
experienced by patients with BDD cared for by the service, the majority usually 
require SRI or SSRIs to enable them to engage in therapy. There is one study on an 
SRI and four on SSRIs included in this study (Appendix F).  
The first RCT investigating pharmacological treatment of BDD compared SRIs 
Clomipramine with Desipramine (Hollander, et al., 1999). Apart from general support, 
therapy was not provided thus allowing for a clearer indication of the medications’ 
effectiveness.  Participants (n=22) also had at least one comorbid disorder but this 
was reported to have no influence on treatment outcome similar to findings in 
psychological treatments (Neziroglu, et al., 1996; Wilhelm, et al., 2011). Despite the 
high dropout rate, this study provides a holistic view of the effectiveness of 
Clomipramine in treating BDD.  
 
Apart from the improvement in BDD symptoms, this trial produced findings 





showed equivalent and additional progress compared to nondelusional patients. This 
could mean patients with a delusional level of BDD may not require adjunctive 
antipsychotic medication. Considering the adverse effects and long term physical 
consequences of taking antipsychotics this would be a much preferred option for 
best practice (British National Formulary, 2009; NICE, 2014). Secondly 
improvements in functional impairment in a condition where patients are usually 
severely disabled gives hope that their quality of life can be improved (Frare, et al., 
2004; Phillips et al., 2006). Clomipramine was well tolerated and drop outs were not 
due to side effects.  
 
One of the limitations was a lack of placebo control which would have provided an 
efficacy standard against which to measure the treatment effect. Although, using 
another similar medication as an active control protects the double-blind. There was 
also no maintenance phase after the crossover which could result in participants 
carrying over the effects of the previous medication. This is often found in 
pharmacological interventions using a crossover design (Maclure, Mittleman, 2000).  
 
Despite the promising findings there have been no further investigations into the use 
of Clomipramine for BDD. However this paper paved the way to encourage further 
research and more rigorous RCTs of pharmacotherapy for BDD.  
 
The first SSRI studied in a RCT was Fluoxetine (Phillips, Albertini, Rasmussen, 
2002; Appendix F: 3). Delusional patients showed improvement in BDD symptoms to 
the same extent as nondelusional patients with fluoxetine, similar to previous study 
findings (Hollander et al., 1999). The time to noticed effect with Fluoxetine was slow 
despite the rapid increase in dosage; still the medication was well tolerated. Patients 
were excluded if they had previous medication from two weeks to six months prior to 
the trial depending on the agent. However six participants were concurrently 
receiving non-CBT based psychotherapy which started prior to the trial. Three of 
these patients were in the treatment group and three in the placebo group. The 
reasons for including these patients are not further elaborated and no separate data 
is provided on these patients to describe the impact of receiving therapy with 
medication or placebo. The results therefore may not be a true reflection of the 






The generalisability of the findings of this study is restricted by the exclusion of 
patients with suicidal ideation although this was in accordance with FDA regulations 
(FDA, 1998). Mild cases were also excluded to avoid results being skewed with 
possible responses to placebo which have been found in other studies (Coryell, 
Noyes, 1988; Wilcox, Cohn, Linden, et al., 1992). Nevertheless further investigation 
is warranted into patients with mild symptoms as a means to prevent worsening of 
the condition and aid in early intervention. This is especially given that people with 
BDD tend to present for treatment after a long duration of the disorder when the 
condition has deteriorated (Veale et al., 1996; Phillips, Diaz, 1997).  
 
The RCT of Escitalopram was the first prospective study on relapse prevention in 
BDD (Phillips et al., 2016). As with previous studies, BDD symptoms and functional 
impairment showed significant improvement. The striking results were the significant 
difference in time to relapse which was longer in the treatment group compared to 
the placebo group (Appendix F: 11). Given the OCD/BDD service routinely follows 
up patients for a year post treatment, relapse prevention is an important aspect of 
the work undertaken with each patient. 
 
Studies in open label trials of Citalopram and Escitalopram produced similar results 
(Phillips et al., 2003; Phillips, 2006). With both Citalopram and Escitalopram the time 
to response was similar to Clomipramine. Both agents produced significant 
improvement in BDD symptoms from baseline and significant improvement in 
functional impairment and quality of life. In addition significant improvements were 
found in BDD delusionality as well. These studies although not rigorous RCTs, still 
contribute to the possible effectiveness of SSRIs. 
 
2.7.1b Treatment with Serotonin Norepinephrine Reuptake Inhibitor (SNRI) 
 
The NICE guidelines states that most antidepressants, including venlafaxine should 
not normally be used to treat BDD without comorbidity (NICE, 2006). There have 






In the first case study full remission was reported however the stated improvement 
was unable to be tracked as there were no measures described (Amâncio, 
Magalhães, Santos, et al., 2002). Additionally previous treatment was psychotherapy 
but no indication was given of what type of psychotherapy it was (Amâncio, et al., 
2002). There was no discussion regarding other factors that could have played a part 
in improvements. Therefore no conclusive evidence for the use of Venlafaxine can 
be made from this paper.  
 
A second study used an open label trial where participants (n=10) had previous trials 
of SSRIs which were unsuccessful in treating their symptoms (Allen, Hadley, Kaplan 
et al., 2008). No psychotherapy of any type was provided. Venlafaxine showed 
effectiveness in reducing BDD symptoms from four weeks of the trial on less than 
optimum levels of Venlafaxine. This shows a link between drug trials with SRIs and 
SSRIs previously described which indicate improvements early on before optimum 
levels of medication were reached. However there were no significant improvements 
on any of the other measures of symptom severity including functionality and BDD 
delusional symptoms. Given these are vital symptoms to be addressed as well as 
the primary BDD symptoms, Venlafaxine does not appear to compare well to the SRI 
and SSRI medication reviewed.   
 
2.7.2 Dopamine blockade (antipsychotic) medication 
 
Augmentation with antipsychotics has been shown to be effective in treating OCD 
(NICE, 2006). Thus as the search for effective treatments for BDD continues, the 
adjunctive use of antipsychotic medication has become the next level to explore. The 
NICE guidelines included four studies on the use of antipsychotic medication for 
treating BDD (NICE, 2006). Three of these trials were deemed relevant for this study 
(Appendix F: 2, 7, 8). The one case report which was excluded was a letter to the 
editor which describes a patient with a primary diagnosis of bipolar disorder and 
depression with psychotic features (auditory hallucinations) and BDD symptoms 
successfully treated with Olanzapine. Using the CASP guidelines, this did not meet 
the criteria for inclusion in this study (CASP, 2018). There was a study included 
which was published after the NICE guidelines (2006) and the NICE guidelines 






Just one investigation was a placebo-controlled double-blind RCT using Pimozide to 
augment fluoxetine for treatment of BDD (Phillips, 2005a). It appears the motivation 
for using Pimozide was that it was used in studies previously, showing efficacy for 
BDD (Riding, Munro, 1975; Munro, Chmara, 1982). The results of the study were not 
promising (Appendix F: 6). Since then it has been found that Pimozide prescribed 
with fluoxetine can lead to bradycardia and is not recommended for concurrent use 
(Stahl, 2009). “Following reports of sudden unexplained death, an ECG is 
recommended before treatment” (British National Formulary, 2011:4.2.1, pg. 233). 
The additional information about Pimozide’s interactions and high levels of toxicity 
may have been unknown at the time of these studies. This paper highlights the need 
for a considered approach before embarking on drug treatment trials especially 
where the mechanism of a drug is questionable.  
 
The outcomes of other augmentation studies have been inconsistent and studies 
with a robust design are sparse (Phillips et al., 2001; Ipser, et al., 2009). A chart 
review of augmentation of SRIs with antipsychotics showed 15.4% effectiveness in 
trials whilst a study using Olanzapine to augment Fluoxetine resulted in minimal to 
no response (Phillips et al., 2001; Phillips, 2005b, Appendix F: 7). Contradictory to 
this are case reports which describe successful outcomes with the use of Olanzapine 
(Grant, Kim, Crow, 2001; Nakaaki, et al., 2008). Similarly a case report using 
Aripiprazole produced a positive outcome (Uzun, Ozdemir, 2010). However single 
case reports are limited with regard to clinical implications as findings are not fully 
representative of the population.  
However these single case results may bear more credence supported by the most 
recent retrospective case note study comparing a group given antipsychotic 
augmentation with a non-augmented treatment group (Rashid et al., 2015; Appendix 
F:10). Although a breakdown is given of the number of patients prescribed a 
particular antipsychotic this is not followed up by linking the improved or the non-
responsive patients to the medication. Therefore although the results are promising it 
would have been more useful to know which medication produced positive results 






Investigations into the efficacy of buspirone augmentation appear to be more 
promising (Phillips et al., 1996a, Appendix F: 2; Phillips et al., 2001). Both these 
studies reported positive results for Buspirone with minimal side effects and it is 
generally well tolerated. This data, while preliminary, suggests that buspirone 
augmentation of SRIs may be useful for BDD and warrant further investigation in a 
controlled trial.  
 
The OCD/BDD specialist service offers antipsychotic medication to augment SSRIs 
when considered necessary. This is usually due to the level of severity of the 
patients’ BDD symptoms and presence of co-morbid disorders. In addition most 
patients have had two or more trials of SSRI medication alongside CBT. The current 
circumstances regarding augmentation studies give the impression that it is very 
much trial and error with no clarity as to what will be most beneficial. The evidence in 
the literature for the use of antipsychotic augmentation is insufficient to determine if 
this will be a beneficial course for patients who do not respond to SSRIs (Williams et 
al., 2006; Ipser et al., 2009, Phillips et al., 2001, Phillips et al., 2006). Nonetheless a 
notable finding across studies with positive response was early improvements to 
symptoms before optimal dosage was reached (Phillips et al., 2001). This suggests 
treatment could be more cost effective and of a shorter duration if an appropriate 
psychotropic agent was identified specifically for treatment of BDD. At the time of 







Apart from Fluoxetine, all the trials of SRI, SSRIs and SNRI described a short time to 
response. All the trials reported the main symptoms of concern being successfully 
treated. The improvement in BDD symptoms is of course the primary focus but the 
additional impairment in functioning that often accompanies BDD is an important 
factor to be addressed. Most of these studies demonstrated improvements in 
functioning and quality of life. There was a mixed result for response levels of 






It was encouraging that there were no reported drop outs due to side effects in the 
medication trials of SSRI/SRI as these are the main agents showing any 
effectiveness. However despite noteworthy findings trials have not been replicated to 
produce a sound pharmacological evidence base for treating BDD. There seems 
little impetus in pursuing this form of treatment apart from one off trials. In addition 
the small sample sizes and high ratio of females to males restrict the generalisability 
of the findings. There also still remains a significant percentage of patients who have 
no or limited response to SSRIs/SRIs (Phillips, Albertini, Siniscalchi, et al., 2001).  
 
There are a number of deficiencies in the area of pharmacotherapy for BDD. The 
majority of studies have been case series or open label trials with just four 
randomised controlled trials (Ipser, et al., 2009). Most studies employed a full range 
of valid and reliable measures; however none included patient satisfaction 
questionnaires to determine the patients’ views of treatment which would be 
especially relevant given the physical effects of medication. One study provided the 
patients’ perspective although this resembled a brief case description rather than a 
report on the patient’s experiences in their own words (Phillips et al., 2016). This 
emphasises the relevance of this study’s design to provide a true reflection of the 
patients’ perspective alongside quantitative treatment data. 
 
Further research replicating studies with large samples is needed. No direct 
comparative studies have been done with other treatments which have been shown 
to be effective, such as CBT. Research into a comparison is necessary to 
understand the relationship between these treatments. This could better inform 
future directions in treatment strategies of BDD.  
 
Pharmacological studies are usually in accordance with the Food and Drug 
Administration regulations (1998) [FDA] or regulations by the Medicines and 
Healthcare products Regulatory Agency (2004) [MHRA] but as no medication is 
currently licenced for treating BDD, the studies seem to be experimental. Thus far no 
drug trial has been designed to obtain FDA or MHRA approval for BDD and yet NICE 
guidelines have included medication recommendations based on a handful of 





depression the medication of choice is usually a SSRI (Phillips, 1998; Phillips, 1999; 
Phillips, Coles, Menard, et al., 2005). Furthermore BDD has been classified under 
OCD spectrum disorders which show a response to SRI and SSRI medication. 
Therefore the initial course of pharmacotherapy for BDD will tend to follow the 
prescribing guidelines for disorders in this category. Thus the pharmacological 
treatments for BDD do not appear to be aimed at addressing the unique nature of 
the disorder but rather to treat those symptoms found in other disorders under the 
same classification. Again this highlights the need to establish a clearer 
understanding of the mechanism of BDD to better inform treatment.  
 
2.8 Medical treatment  
 
The inclusion of medical treatments is highly relevant for the study of BDD as there 
is a higher proportion of people with BDD who present to medical rather than mental 
health settings (Conrado, et al., 2010; Aouizerate, et al., 2003; Naylor, Parsonage, 
McDaid, et al., 2012).  
 
Seven studies were found to be relevant focusing on medical interventions and 
outcomes in patients with BDD. There are no RCTs in this area and just one study is 
prospective by design. Risks of physical injury due to self-inflicted or “DIY” surgery 
was also highlighted in one paper and described in another (Veale, 2000; Phillips, 
2001). There are two studies into long term follow up of BDD patients following 
cosmetic surgery. Results and details of the studies are in Appendix G. 
 
2.8.1 Cosmetic surgery and minimally invasive (MI) procedures 
 
Despite the literature suggesting cosmetic surgery is contraindicated for patients 
suffering with BDD both surgery and MI procedures in BDD cannot be ignored 
(Sarwer, et al., 2003; Mulkens, et al., 2006; Sarwer, et al., 2008; Biraben-
Gotzamanis, et al., 2009). In the current climate of mass media promoting the ideal 
body image and increased access to cosmetic and MI procedures, more people are 
opting for cosmetic procedures (Grabe, Ward, Hyde, 2008; BAAPS, 2015). The 





psychological disorders has been slow in emerging but finally serious attention is 
being given to this issue (DoH, 2013; Scottish Government, 2015; GMC, 2016).  
 
There is a more sizable research base on the psychological aspects of cosmetic 
surgery than expected (Sarwer, et al., 1998; Hasan, 2000; Grossbart, et al., 2003). A 
theoretical model regarding body image and cosmetic surgery has been developed 
to consider the psychological aspects of cosmetic surgery Sarwer, Pertschuk. 
Wadden, et al., 1998). The premise is that the physical reality of one’s appearance is 
the basis for one’s body image and can influence perceptions, behaviours and the 
choice to seek cosmetic surgery (Sarwer et al., 1998). This is not focused on BDD 
specifically but could provide insights to inform a model of BDD.  
 
A study specifically investigating outcomes of cosmetic surgery and self-inflicted or 
“DIY” surgery indicated a mixed response to surgery (Veale, 2000). Some 
participants (n=6) reported satisfaction however from this group they also had 
additional procedures or became preoccupied with other features thus suggesting 
the BDD symptoms remained clinically significant (Appendix G:1). Satisfaction rating 
decreased with repeated procedures whilst BDD symptoms measured by 
preoccupation levels increased as well as levels of impairment.  
 
Patients in the sample who reported self-inflicted surgery after they were unable to 
have surgery due to surgeon’s refusal or costs involved all expressed being unhappy 
at the results. A selection bias of treatment failures limits the credibility of the findings 
(Veale, 2000).  On the other hand, people who overcome BDD following satisfaction 
with cosmetic surgery are unlikely to seek mental health care for BDD (NICE, 2006).  
There were also a number of different procedures for different features which 
obscures the measure of success. A single procedure focusing on a particular 
feature in a large sample would provide more informative results.  
 
The retrospective nature of the data is described as a limitation however a 
prospective study with BDD patients undergoing cosmetic surgery raises ethical 
implications of surgeons operating on patients they are aware have BDD (Veale, 
2000; Freedman, 1987). The study also lacks any valid and reliable measures which 





Despite these weaknesses, this study brings into focus the need for further 
investigation into cosmetic surgery on patients with BDD and highlights risks 
involved which are specific to BDD.  
 
A large scale study evaluating the outcomes of cosmetic surgery/MI procedures 
indicated that severity of BDD symptoms was not changed following procedures 
(Phillips, Grant, Siniscalchi, et al., 2001). Although it was a large sample the 
participants were part of a research program specialising in BDD which limits 
generalisability (Phillips, et al., 2001). There may also be a bias towards participants 
who did not improve following cosmetic procedures which was also discussed in the 




Two studies specifically examining outcomes of rhinoplasty had similar findings 
(Veale, Haro, Lambrou, 2003; Felix, de Brito, Nahas, et al., 2014, Appendix G: 3, 8)). 
Post-surgery differences in a sample of non-BDD patients and patients with minimal 
symptoms of BDD indicated that there is a group of patients in the subclinical or mild 
BDD range that improve with cosmetic rhinoplasty (Veale, et al., 2003). This is an 
interesting finding as it raises the question of whether this is a valid treatment for 
patients with BDD at these levels of symptomology, in particular for rhinoplasty.  
 
A further study of rhinoplasty in patients diagnosed with mild or moderate BDD 
indicated similar positive results (Appendix G: 8; Felix, et al., 2014). Unfortunately it 
is unclear whether the patients were appropriately diagnosed with BDD using a 
reliable diagnostic tool (Crerand, Phillips, 2014). In addition the study reports that 
patients had actual nasal defects from mild to marked deformity. This in itself would 
call into question their diagnosis of BDD (APA, 2013; WHO, 2018). In addition the 
results report at 1 year follow up 21 patients experienced preoccupation with their 
perceived flaw between 1-3 hours per day and 10 for three or more hours per day. 
Although the findings indicate an improvement from baseline, there were still patients 
in the sample who continued to be preoccupied by their feature (Appendix G: 8; 
Crerand et al., 2014). However an interesting aspect of this study is the ethnicity of 





only study without an overrepresentation of Caucasian subjects. Although the role of 
ethnicity in the degree of satisfaction was acknowledged, there was no further 
examination of ethnicity in this study but this needs further investigation.  
 
• Longer Term Follow Up  
 
Longitudinal studies in treatment of BDD are rare but there have been two such 
studies in cosmetic surgery for BDD. Patients consenting to be followed up five years 
after they had requested cosmetic surgery indicated that the majority of the BDD 
group who received surgery did not improve (Tignol, Biraben-Gotzamanis, Martin-
Guehl, et al., 2007; Appendix G:5). Although cosmetic surgery appears inadvisable 
in BDD based on the lack of improvement over time contradiction was found in the 
patients’ reports of satisfaction in the procedures despite the lack of change in BDD 
symptoms. The study raises interesting points for further investigation. In particular 
the emergence of BDD in previously non-BDD patients following cosmetic surgery 
needs further investigation to identify the possible propensity of patients seeking 
cosmetic surgery to develop BDD. This could provide valuable insights for cosmetic 
surgeons to identify and screen for vulnerability to BDD. Additionally there was one 
subject who had a complete recovery from BDD following the surgery. There 
appears to be a very small proportion of BDD sufferers who respond to cosmetic 
treatment. The reasons for this need further exploration.  
 
The second follow up study examined shorter versus longer term outcomes in 
people with BDD who have surgery or other cosmetic procedures (Crerand, Menard, 
Phillips, 2010; Appendix G: 6). Although short-term improvement in appearance 
and/or preoccupation was reported this was not sustained, however there were 15 
patients who perceived long term improvements overall on BDD symptoms but this 
was not further explored (Crerand, et al., 2010; Appendix G: 6).  It would be 
interesting to note what led to their responses – if there were differences in their 
clinical presentation or if they had psychological or pharmacological treatment in the 
intervening years to treat BDD. Also notable was that rhinoplasty was the most 
common procedure received by the participants overall. With the previous studies on 





data into the responses of this group of participants (Veale et al., 2003; Felix et al., 
2014).  
 
The advantage of the cross sectional design was having a wide range of participants 
who provided data across different age groups as the sample also included 
adolescents. However a longitudinal design may have provided more specific 
information regarding changes over time to achieve more conclusive findings for 
outcomes. The retrospective nature of the study has to allow for differences over 
time but variables such as suicidality, functioning and depression were considered 
over lifetime without correlating this with time frames for surgery or other procedures. 
In addition since a measure of depression was not done at the time of follow up, the 
presence of depression could influence patients’ perceptions and affect the results.  
 
The reasons for not receiving surgery compared to other cosmetic procedures were 
explored indicating cost being the main reason the participants cited for not having 
surgical procedures. The doctors’ refusal was the second reason which appears 
contradictory as findings indicated surgical treatment was significantly less likely to 
be refused than any other cosmetic intervention (16 refused out of a total of 148 
procedures requested). It is suggested that surgeons may not be aware of the 
diagnosis or not consider surgery as contraindicated (Sarwer, 2002). Unfortunately 
no data was obtained from surgeons as to their reasons for refusal.  
 
It is not clear whether participants who showed no change or were worse at follow up 
were offered other treatments or if these patients were signposted to other services 
for treatment which raises ethical considerations of a duty of care. Although there are 
areas which need further exploration, this paper investigated cosmetic surgery in 
BDD more thoroughly than any other study. The paper also addresses limitations 
from the first study (Crerand, et al., 2005). There are no other large scale studies of 
long term outcomes and the comparison of procedures over short and long term. 
The study also included other appearance enhancing procedures such as Botox and 
cosmetic dental procedures, which tends to be overlooked in most studies. 
 






With the increasing exploration of pathophysiological models to understand BDD it 
was relevant to include medical interventions in the literature review (Feusner, 
Yaryura-Tobias, Saxena, 2008; Feusner et al., 2011). The search revealed the use 
of electroconvulsive treatment (ECT) to treat BDD although thus far the literature on 
the use of ECT in BDD is sparse and consists of one case study, a report on a case 
series and an editorial letter (Rapinesi, Serata, Del Casale, et al., 2013; Phillips, 
2005a; Carroll, Yendrek, Degroot, et al., 1994). 
 
The case series reported no response to ECT in eight cases of BDD treated (Phillips, 
2005a). Conversely an editorial letter described a case of major depression and 
psychosis with BDD who responded positively to ECT. Similarly a case study on the 
use of ECT in a patient with major depression, delusionality and BDD showed 
improvements where all other treatments had been tried unsuccessfully including 
CBT, SSRIs and augmentation with antipsychotics (Rapinesi, et al., 2013; Appendix 
G:7). However the BDD symptoms appear to be a comorbidity rather than the 
primary diagnosis and there are no measures of BDD symptom severity described. 
Furthermore the description of the patient’s symptoms fits more closely with muscle 
dysmorphia (APA, 2013; WHO, 2018). The description of aggression and 
unprovoked violence also raises questions about possible substance misuse, 
especially anabolic steroids which is noted to be of high incidence in sufferers of 
muscle dysmorphia (Leone, Sedory, Gray, 2005). Depression and delusionality may 
have exacerbated BDD symptoms. Therefore once the depression and delusionality 
abated, the BDD symptoms may have improved rather than being treated in its own 
right (Phillips et al., 2008; Phillips et al., 2005a). There is no conclusive evidence 
from this study for the use of ECT in treating BDD.    
 
The conclusion regarding the use of ECT at this time appears to be that it is 
beneficial when there is major depression with co-morbid BDD (Phillips et al., 2008). 
However this may be related to ECT resulting in improvement in the depression 
symptoms which then has a positive effect on the BDD symptom severity (Phillips, 
2005a). But there is no evidence for the treatment of BDD with ECT at this time 








Although most of the studies unequivocally suggest that cosmetic surgery is not an 
effective treatment strategy for BDD, a small percentage of patients with BDD 
responded favourably to cosmetic surgery in most of these studies (Crerand et al., 
2010; Veale et al., 2003; Felix et al., 2014). Regrettably none of the studies offered 
any further exploration of these phenomena. Further investigation into this may yield 
important insights which could influence treatment options for BDD across different 
levels of severity.  
 
At the current time, however the literature is largely in agreement that cosmetic 
surgery should be avoided in patients with BDD and could lead to worsening of 
symptoms (Phillips, 2001; Crerand, et al., 2005; Tignol et al., 2007; Crerand, et al., 
2010). There seems to be a bias towards failure in cosmetic procedures rather than 
objectively exploring treatment successes as well as failures. This approach seems 
to be geared towards proving cosmetic procedures are not beneficial for BDD 
patients which could narrow the options for exploring treatment for BDD. Although 
the trend is towards reducing unnecessary cosmetic procedures for people with 
BDD, there may be a group of people with BDD who can benefit from cosmetic 
procedures which needs to be explored. Not to do so may be denying a cohort of 
people with BDD the option to experience a remission from the disorder and 




Bringing together all three modalities of treatment studies reviewed, the general 
consensus in the literature appears to be that CBT is an effective psychological 
treatment for BDD whilst SSRI agents have a growing body of evidence for efficacy 
(Ipser et al., 2009). Studies indicate better outcomes with CBT than 
pharmacotherapy with improvements maintained over longer periods (Williams et al., 
2006). The views regarding the use of cosmetic surgery also draws a consensus but 
it is contrary to those expressed for psychological and pharmacological treatments. 
The prognosis for BDD patients receiving cosmetic surgery appears to be poor and 
although improvements are made, these are short term and not maintained over the 






However it has been noted that some patients with BDD experience remission from 
their symptoms following cosmetic surgery (Veale et al., 2003; Crerand et al., 2010; 
Felix et al., 2014 Appendix G: 6, 8).). Although this has only been found in a small 
number of patients, it is still worthy of further exploration. In addition reviewing all 
three modalities of treatment indicates the greater likelihood of patients with BDD 
being seen initially by medical or surgical teams rather than mental health services 
(Sarwer, et al., 1998; Aouizerate, et al., 2003). A comparison of the number of 
participants across the three treatment modalities reviewed in the literature is a stark 




The largest sample sizes in published studies were of medical interventions, in 
particular, cosmetic surgery studies. This may be unsurprising given the high 
prevalence of people with BDD who attend cosmetic surgery and dermatology clinics 
(Sarwer, et al., 1998; Phillips et al., 2000; Aouizerate, et al., 2003; Conrado, et al., 
2010). This also indicates the need for closer links between mental health services 
and general health care (DoH, 2011a). 
 




Graph 2: Comparison of number of participants in all 
modalities reviewed






*BI Behavioural interpretive intervention 
**IBT Inference based therapy 
***ABT Acceptance based treatment 
 
With regards to specific treatments, after CBT the second highest number of studies 
is of cosmetic surgery/ MI procedures (Graph 3). Perhaps this reflects researchers’ 
concerns about the current appeal of cosmetic surgery and people with BDD who 
may be drawn to seeking surgical rather than psychological help (BAAPS, 2015). 
A model describing the psychology of cosmetic surgery proposes the physical reality 
of appearance is a key aspect determining perception and behaviour (Sarwer et al., 
1998). In bringing together psychology and cosmetic surgery there may be new 
directions to be investigated. This may appear controversial in light of most 
recommendations for patients with BDD to steer clear of cosmetic surgery but the 
questions beg to be asked- what would the outcomes be for BDD treated with 
psychological therapy in conjunction with surgery? What would the impact be on long 
term outcome?  
 
Although it is more likely that any link between psychological therapies and cosmetic 
surgery will be aimed at screening patients preoperatively for BDD and refusing 
surgery to patients with BDD symptoms. The NICE guidelines make 
recommendations for individuals with suspected or diagnosed BDD seeking 





2006). This would appear to be the most appropriate course of action and to 
signpost the patient to alternative recommended treatments such as CBT or 
medication. It is hopeful that with the GMC guidelines for doctors offering cosmetic 
interventions highlighting psychological needs of patients, this will promote 
recognition of BDD symptoms (GMC, 2016). 
 
Nevertheless one of the challenges of treating BDD is the difficulty in engaging 
patients in psychological treatment early on (Phillips, et al., 1993). One of the 
recurrent themes across studies was a description of the long duration of the 
disorder (M=11 years) prior to psychological treatment being sought (Gomez-Perez 
et. al. 1994; Veale et al., 1996; Phillips, Diaz, 1997). Clinical evidence from the 
specialist BDD service also indicates this trend. This is an aspect of BDD that should 
be studied further, especially to promote early intervention. Engaging patients with 
BDD in psychological treatment is made particularly difficult when there is limited 
insight (Phillips, et al., 1993). 
 
Augmentation of SSRIs with antipsychotic medication to attempt to address this 
clinical presentation is still an area of limited research with only two studies showing 
any promise of improvements with augmentation (Phillips, 1996; Rashid et al., 2015). 
It is concerning that despite the lack of sufficient evidence augmentation of SSRI 
medication with an antipsychotic is recommended for treating BDD in the NICE 
guidelines (NICE, 2006: 7.4.2.8, pg. 191).  
 
In addition one of the main deficiencies of the studies reviewed is a lack of 
comprehensive qualitative data. Randomized controlled trials (RCTs) and 
quantitative studies have an important place in the assessment of the efficacy of 
treatments. However the focus is restricted to whether an intervention has a 
statistically significant effect. Thus a large amount of vital information goes 
unexplored. There is a lack of clarity to understand why interventions are successful 
or not and the reasons for the effect of the treatment. More importantly quantitative 
studies do not address the participants’ experiences of the intervention and do not 
include the clinicians’ experiences of providing an intervention. Although published 
studies suggest CBT is effective in treating BDD and in reducing the risk of relapse 





experiences of CBT and reasons for non-response in some subjects (Greenberg, 
Wilhelm, 2011).  
 
CBT lends itself to quantitative study and thus is more likely to generate more 
published work. The short term nature of the intervention can be an obstacle in 
treating BDD where the presentation is generally multifaceted. Some of the studies 
highlight this as an area to be considered as longer treatment may be more 
beneficial and acceptable to patients (Veale, et al., 1996; Khemlani-Patel, et al., 
2011). Unfortunately resource constraints and pressures from funding organisations 
have an influence on the length and duration of treatment provided (Wilhelm, et al., 
1999; Rabiei, et al., 2012). The emphasis is increasingly on cost effectiveness in 
health care provision and the search for interventions that show improvement within 
a short period of time (Mojtabai, 2005). Therefore CBT has been the focus of 
application across a number of disorders and in a variety of forms (Beck, 1997).  
 
One of the advantages of CBT is the malleable nature of its application e.g. internet 
CBT (Cuijpers, van Straten, Andersson, 2008; Andersson, Enander, Andren, et al. 
2012). The attraction of internet–based treatment is the increased accessibility of 
CBT for patients who may not engage with psychological treatment otherwise 
(Enander et al., 2014; Hedman, 2014). However there is the risk that by considering 
CBT as the “magic wand” for all disorders, other beneficial interventions may be 
overlooked to the detriment of best practice in patient care. Equally from the 
literature reviewed on CBT outcome studies, 11 out of 21 studies reported dropouts 
and non-responders (Appendix E). Thus CBT is not a one size fits all treatment and 
highlights the need for further exploration of reasons for treatment failure and 
dropout. On the other hand, CBT has still shown more promise than other 
interventions for BDD but further research is need to make this a more robust 
treatment option. 
 
This literature review only considered published works in English unless translation 
was available, which is a limitation for the study. One has to bear in mind that just 
because a paper is published, that does not make it good evidence. Also the focus in 
most scientific journals tends to be on RCTs or quantitative studies where there are 





which may not easily lend themselves to these methods may be lost such as Art 
Psychotherapy and Psychodynamic Psychotherapy. Also although there may appear 
to be gaps in information provided in studies, one has to consider the published work 
may not represent the original full work of the author/s as the published work has to 
adhere to publication guidelines regarding word count etc. But the reader can only 
evaluate what is made available. This may also be a restriction for NICE guidelines 
which is a useful guide to evidence-based treatments but can only include evidence 
from studies that have been published (NICE, 2006). 
 
In addition to the previous discussion, the process of conducting the literature review 
has ultimately revealed several patterns: 
• There is at present a lack of sufficient robust studies into treatment for BDD. 
• There are several domains in which treatment studies are being conducted 
and there is no integration between them. 
• Although there are several proposed models to understand the processes of 
BDD there is still no definitive model of BDD. 













3.1. Introduction  
This chapter describes the approach and methods used to evaluate the application 
of the NICE guidelines in treating BDD within the context of a specialist service. It will 
highlight the theoretical underpinnings that drive the particular design chosen for the 
study as well as clarify the rationale for the design and methods used.  
The study uses a mixed methods approach in order to provide a more complete 
understanding of the practical application of the NICE guidelines for BDD. The aim is 
to explore different types of data: descriptive data from analysis of standardized 
measures, as well as accounts of participants’ lived experiences acquired through 
semi-structured interviews. The qualitative data enriches the value of the quantitative 
data in considering how to refine treatment protocols where appropriate to improve 
effectiveness. The techniques used in analysis of the data are discussed and 
limitations highlighted. To ensure that the validity and credibility of the study is of the 
highest standard, the process will be described with as much transparency as 
possible. 
Ethical considerations in undertaking this study will be discussed especially with 
regards to the participants interviewed. This chapter will conclude with a critique of 
the methods to identify strengths and limitations.  
3.2. Theoretical perspectives 
The philosophical underpinning creates a foundation on which the design and 
methods of a study are based (Scotland, 2012).  
Two opposite methodological paradigms come together in this study:  
• Positivism/ Post-positivism which uses quantitative methods to analyse data 
to support a hypothesis (Creswell, 2003). 
• Interpretivism, which is on the other end of the continuum, uses qualitative 
methods to gather detailed information about participants’ experiences 
(Creswell, 1994). 
 
Bringing these approaches together in a mixed methods design offers multifaceted 






• Positivism and Post-positivism 
The principle of positivism recognizes only that which can be scientifically proven by 
measurement and observation (Morgan, Smircich, 1980). However positivism was 
criticised for the stance that an absolute truth can be obtained through only 
observation and measurement, leading to the rise of the post-positivist movement 
(Popper, 1963). Post-positivism takes a more pragmatic view, by recognising that 
observation is not without errors and will be influenced by the researcher’s own 
experiences, views, culture etc. (Trochim, 2006). Nevertheless, post-positivists still 
pursue observable and measurable data but causal relationships are sought, often 
using participants’ perspectives. Furthermore theories are tested to improve on them 
(Popper, 1959; Creswell, 2009).  
• Interpretivism 
The theory of interpretivism is that reality is a social product. It cannot be understood 
without including the perceptions and meanings given to particular social processes 
by the individuals of that social group (Orlikowski, Baroudi, 1991). Social sciences 
require a different approach than physical sciences which tend to be independent of 
the person (Bhattacherjee, 2012). In social science research the influence of the 
human element which includes researchers, cannot be denied (Weber, 2011). In 
contrast to positivism, the paradigm of interpretivism or phenomenology attempts to 
understand phenomena through accessing the subjective meanings given to them 
(Orlikowski et al., 1991).  
Given that the post-positivist stance also acknowledges the need to include human 
experience, using both these paradigms was most fitting. 
3.3 Methodological context 
3.3.1 Ontology 
This study will be carried out from a critical realist ontological position. Critical 
realism accepts the existence of reality that can be measured but also acknowledges 
the influence of human perception and cognition plus subjective experience in 





Critical realism identifies and analyses the psychological and social systems which 
make up the natural world (Bhaskar, 1998; Houston, 2001). BDD is influenced by our 
social reality, in particular, the idealised appearance and image coveted by society 
and promoted by mass media. It is argued that social reality exists collectively, 
because it is ideas, views, expectations shared by people (Searle, 1996). In this vein 
the social reality of BDD needs individual’s perceptions and views to be untangled 
from the perceived views of society, then acknowledged and explored.  Considering 
BDD is still largely misunderstood and underdeveloped it is essential to obtain 
patient experiences and perceptions to develop a clearer understanding of the 
disorder (Phillips, 2008). This could inform the way forward regarding engagement 
and treatment plus possible ways of prevention. Furthermore the views of the 
clinicians involved in treating these patients will provide an added facet towards 
understanding how patients respond to treatments. Given the research questions 
(pg. 29:1.9) it was most appropriate for this study to be situated along the critical 
realism continuum. This position determines what is able to be measured or what is 
knowable as well as on the other end of the continuum, the influence of human 
experiences. 
3.3.2 Epistemology 
The epistemological stance of this study follows both post-positivism and 
interpretivism involving a mixed methods approach which is consistent with critical 
realist ontology. Using both qualitative and quantitative methods is becoming more 
widely recognized for the valuable contributions each makes in research (Curry, 
Nembhard, Bradley, 2009). 
Thus quantitative methods lend itself to this approach as it can be used to 
mathematically verify knowledge obtained. However this study leans more towards 
the principles of post-positivism coming from a critical realist perspective. It is 
therefore important to use multiple measures and methods of observation to obtain a 
deeper understanding and reduce the margin of error. This method of evaluating 
practice is associated with a CBT approach and the medical model (Bakker, 2008). 
CBT and medication are the main treatments recommended by the NICE (2006) 
guidelines for BDD and are provided by the specialist service. The focus in CBT 





using validated measurement instruments (Bakker, 2008). Similarly in the medical 
model a range of validated symptom-led scales are used to assess response rates 
and calculate outcomes. The service uses both therapist-rated and patient-rated 
standardized measures to assess severity of clinical symptoms. This approach 
enables clinicians to have a clearer framework for evaluating the treatments and 
interventions they provide and identify areas which may not be as effective. This is 
the clinical context, however taking a broader view, there are pressures on the 
National Health Service (NHS) to provide evidence-based treatments and show cost-
effectiveness and rapid through-put (DoH, 2015). The Trust’s Quality Account 
(2015/2016) is in keeping with the requirements set out by the DoH to ensure 
compliance (DoH, 2015). Thus it is in the best interests of the service to provide 
measurable outcomes and a clearly mapped pathway of the patient’s progress 
through the service. Historically within this particular Trust there has been 
termination of some specialist services following service review by local 
commissioning bodies with one of the reasons quoted as a lack of measurable 
outcomes.  
To ensure this service evaluation was as comprehensive as possible, it was 
essential to explore the element of human experience. Interpretivism is a leading 
approach in qualitative research and pertains to the subjective nature of an 
individual’s perceptions of the world and the resulting internal mental representations 
(Ratner, 2008). Furthermore by eliciting patients’ and clinicians’ experiences, it is 
bringing forward an element that surpasses policies and procedures of governmental 
and Trust targets. The fundamental reason for providing the service is to improve 
people’s lives, thus it follows that their experience is central to any evaluation of the 
service for future improvements. This approach allows for additional information to 
be obtained and could offer different reasons for treatment outcomes which will 
enhance the understanding of the disorder and influence choice of interventions to 
treat it.  
These opposite epistemological positions complement each other as they can 









This study uses different research design elements within a case study approach 
(Appendix H). Case study can incorporate both quantitative and qualitative data 
collection in an in-depth exploration of phenomena with single or collective cases 
(Yin, 2009; Creswell, 2003). A convergent parallel design was most fitting as it 
provides straightforward procedures to collect and synthesise results in a mixed 
method study (Cresswell, 2015). Additionally the data collected from the three 
strands were complementary in nature which suits the use of the convergent parallel 
design to interface the different sets of data.   
 
The quantitative aspect involves survey research methods which are used to obtain 
data from participants that are representative of a population (Williams, 2007). As an   
analytic element it is used to identify; measure then evaluate effects of treatment on 
patients. This is used in designing outcome studies which investigate the end result 
of treatments or interventions (Jefford, Stockler, Tattersall, 2003). Outcomes 
research is pivotal in providing evidence-based treatments whilst allowing for quality 
of care to be evaluated and improved (Agency for Healthcare Research and Quality 
(AHRQ), 2015). The quantitative data analysis satisfies the post-positivist stance 
taken in this study for objective, scientific data regarding clinical outcomes, 
symptoms of severity and demographic illustrations. 
 
However qualitative methods can also be considered scientific in the process of   
seeking to answer specific questions plus using rigorous procedures in collecting 
and analysing data (Mack, Woodsong, Macqueen et al., 2005). Furthermore 
qualitative methods extend beyond this, as the analysis in this study illustrates, in the 
iterative process of data analysis as well as the interpretive approach to data 
gathered considering meanings participants ascribe to their experience. This brings 
together the underpinning paradigms the study is driven by thereby providing a 
comprehensive understanding of the research area. The study design incorporates 
both methods in a three phase process of data collection and analysis which is 







3.5 Data Analysis 
 
Quantitative data is stored and analysed on a Statistical Package for Social Sciences 
(SPSS v25) file. Descriptive statistics will be generated for the clinical data using 
paired t-tests. Thematic analysis (TA) is the method adopted for the process of the 
qualitative data analysis which will be used to contextualise the quantitative data. 
Qualitative data was gathered using semi-structured interviews which were audio 
recorded to ensure accuracy in transcription (5.2.1, pg. 130). Qualitative analysis 
involves coding the data, categorising and eliciting themes supported by extracts 
from the transcripts. Adopting a manual approach to data analysis was considered 
most appropriate, as it allows for the iterative and creative process of the 
researcher’s interpretation of the data. Although software for qualitative analysis is 
useful in organising and categorising data, it can restrict this process (Welsh, 2002).  
 
3.6 Thematic Analysis 
Thematic analysis (TA) focuses on identifying, analyzing and generating patterns or 
themes across datasets whilst describing data in rich detail (Braun, Clarke, 2006). 
Although the process of TA was described in texts on qualitative analysis, there were 
no definitive models for its use (Miles, Huberman, 1994; Boyatzis, 1998). Providing a 
framework for clarifying TA as a standalone method of qualitative analysis helped to 
address the undefined way that TA was generally described in the literature (Braun 
et al., 2006). Still despite its wide-spread use there is a lack of literature on TA which 
leads to queries about the credibility of this as a separate method (Nowell, Norris, 
White, Moules, 2017). However proponents of TA argue that through applying rigour 
and transparency, the trustworthiness and credibility of TA can be produced (Braun, 
et al. 2006; Alhojailan, 2012; Nowell, et al. 2017).  
Triangulation is significant in studies such as this which uses a combination of 
methods and different data sources (Patton, 1999). Participants in this study were 
from three different groups: outpatients, inpatients and clinicians who provided 
different perspectives that could be compared for similarities and variances. This 






3.7 Choosing Thematic analysis   
TA forms the basis of qualitative analysis for most types of approaches (Holloway, 
Todres, 2003). Given TA is a method of analysis rather than being tied to a 
philosophical underpinning it provides the flexibility to use it with different 
methodologies (Braun, Clarke, 2006). This is particularly useful in areas of 
healthcare that are lacking in research as is described in this study. It fits the aims of 
this study as it can be used to report the experiences of the participants and 
meanings they ascribe to their experiences from a critical realist perspective (Willig, 
1999). In this study TA allows for the use of a framework that is considered most 
appropriate to develop the links between themes and the research questions.   
Other approaches were considered for the study such as interpretative 
phenomenological analysis (IPA) and grounded theory (GT). TA shares the similarity 
of generating themes with both these approaches but their analysis is guided either 
by their underpinning methodology or to generate a theory (Glaser, Strauss, 1967). 
Therefore as these approaches did not fit the aims and objectives of this study, TA 
was considered most appropriate.  
3.7.1 Reporting thematic analysis of data 
The flexible nature of thematic analysis means it can be used with a critical realist 
framework (Braun et al., 2006). However it is essential to be explicit about the 
theoretical framework one is using and to ensure analysis is consistent with this as it 
could easily become vague and unstructured (Holloway et al., 2003).  
Thematic analysis goes beyond descriptive reporting to examine and interpret 
underlying meanings, views and beliefs (Braun et al., 2006). Furthermore in 
developing themes, the researcher actively engages in interpretation of the data 
content (Patton, 2002). It is proposed that reporting in the first person can be used to 
acknowledge the importance of the part played by the researcher in analyzing and 
interpreting the data (Foster, Parker, 1995). However in this study the analysis was 
reported explicitly as the researcher’s interpretation which felt more suitable and 
demonstrates authenticity. Furthermore the approach produces a report remaining 
true to the theoretical underpinnings of the study. It is postulated that TA satisfies the 
process of discovery emphasized in positivism/post-positivism by use of coding and 





the Interpretivism positon (Boyatzis, 1998). Advocates of TA clearly seek to establish 
TA as a standalone analytical method which has much to offer in qualitative analysis 
rather than just descriptive data especially as it forms the basis for most qualitative 
methods (Boyatzis, 1998; Aronson, 1994; Attride-Stirling, 2001; Braun et al., 2006). 
By reporting the data with the richness and depth allowed by using TA this study also 
supports this position. 
“The extracts in thematic analysis are illustrative of the analytic points the researcher 
makes about the data, and should be used to illustrate/support an analysis that goes 
beyond their specific content, to make sense of the data, and tell the reader what it 
does or might mean.” (Braun et al., 2006: 80) 
 
3.7.2 Thematic Analysis using the Six-Phase Process 
Analyzing the body of data and identifying codes then categories and generating 
themes is a cyclic process (Figure 4, pg. 91). Analysis followed an inductive process 
forming generalisations based on observations and meanings that the researcher 
ascribed to the data.  
For the purposes of transparency the process is described in detail in the following 
subsections. The TA approach used in this study follows the six-phase process 
developed by Braun et al. (2006). This was chosen for the structure and clarity it 
provides; moreover it is the only publication providing a clearly defined process of 
conducting thematic analysis without relating it to theoretical paradigms (Braun, 
Clarke, 2014).  
The body of data is in the form of transcripts providing vast amounts of information 
which need to be organised for relevance. Although the process is described in 
sequential steps, it is an iterative process revealing additional data to add to the 
analysis thus ensuring rigour and validity.   
1. Familiarisation with the data: Data gathered from semi-structured interviews 
were transcribed verbatim and read several times, to become closely familiar 
with its content. 
2. Coding: This phase involved identifying significant features of the data 
considered relevant to addressing the research questions. This required 





related data extracts for further analysis. A number of coding methods were 
considered and initially explored until the most appropriate methods were 
found that were most suitable in relation to the aims of the study (Fig. 4).  
3. Searching for themes: In this phase the collated data are further explored to 
identify patterns or possible themes. Data is then collated that may pertain to 
potential themes which are then further examined to determine the relevance 
of each potential theme. 
4. Reviewing themes: The potential themes are checked against the 
information in the body of data to ensure they are representative and that they 
address the research questions. This phase involves developing themes and 
may result in discarding, changing or combining themes.   
5. Defining and naming themes: In this phase each theme is analysed in 
greater detail and clarified with a title.  
6. Writing up: In this final phase, the detailed analysis is interwoven with 


































The route taken to arrive at a coding method is an integral part of the analysis which 
needs to be detailed, in particular, for transparency and future replication (Morgan, 
Krueger, 1997).  
 
The process of coding is summed up by Strauss: 
Any researcher who wishes to become proficient at doing qualitative analysis must 
learn to code well and easily. The excellence of the research rests in large part on 
the excellence of the coding. 
(Strauss: 1987, pg. 27). 
 
Choosing coding methods started with perusing available research on thematic 
analysis which was found to be limited despite TA’s wide usage (Boyatzis, 1998; 
Braun et al., 2006). In order to get a broader view of coding, the focus was changed 
to include all publications on coding in qualitative analysis. Coming from a post-
positivist / interpretivist stance the choice of coding methods was based on meeting 
both the needs for clarity in the process plus integration of interpretations and 
reflections in addressing the aims of the study. In addition demonstrating the cyclic 
nature of coding, the transcripts needed to be read and initial impressions noted in 
order to identify which coding methods were most appropriate. This process was 
repeated until the most suitable coding methods were identified (Patton, 2015; 
Saldana, 2016). 
Although there is no definitive method for coding, guidance was considered 
according to what methods met the needs of the study most appropriately (Blair, 
2015). Several approaches were found useful however a coding manual which 
provided a comprehensive and clear description of coding methods was chosen to 
be most appropriate (Saldana, 2016). This was most suitable to link in with the aims 
of the study and the underpinning theoretical stance of post-positivism and 
interpretivism (Boyatzis, 1998). Other coding models considered were found to be 
too restrictive as these were linked to a theoretical framework rather than a 







3.8.1 Coding methods 
The coding methods followed a heuristic, cyclical pathway used tend to overlap as 
they represent factors that are interrelated with regards to the research questions. 
The first wave of coding used all methods simultaneously, providing an overview 
from which initial impressions were noted highlighting key words or phrases (Fig. 4). 
The second analysis used each coding method to process specific information, 
however other areas were noted separately, as this process could not occur in 
complete isolation. Once a detailed picture started to emerge, codes were grouped 
into possible categories. Given the different phases of the study, using a number of 
coding methods ensured that the most amount of information could be drawn out of 
the body of data as possible. 
3.8.1a Elemental methods 
Elemental coding methods provide a basic overview of the entire body of data on 
which to build and include the researcher’s interpretations (Saldana, 2008).  
• Concept coding 
Concept coding represents suggested broader meanings or ideas stimulating 
reflection which is particularly relevant for the aims of this study (Saldana, 2016). 
There is an overlap with process coding as it also includes processes and uses 
gerunds (ing) words denoting action taking place on a number of levels from daily 
observable activities to more experiential processes such as coping or adapting 
(Charmaz et al., 2001). Processes also capture actions that occur over time thus it 
was a useful method to identify changes that patient participants described over the 
course of treatment (Saldana, 2003). 
3.8.1b Affective methods 
This method interprets the experiences of participants to convey the subjective 
qualities of the data such as emotions and values. In addition this method also 
considers the qualities of programs or policies and in this study this relates to 







• Evaluation coding 
This method was an obvious choice for an evaluation study and the method is 
closely linked to the aims of the study. Evaluation coding is used to make a 
judgement, about the use of policies, guidelines or programs which in this study 
relates to the NICE guidelines for OCD/BDD. It goes beyond this to consider how to 
make improvements and implications for future developments (Patton, 2015). 
• Emotion coding 
This coding process was especially useful to highlight experiences, feelings and 
perceived emotions whilst also taking the researcher’s perceptions into consideration 
(Smith, Flower, Larkin, 2009). Codes can be gleaned from language used but also 
interpretations of participants’ mood (Saldana, 2016; Goleman, 1995).  
• Values Coding 
Values coding conveys participant beliefs, principles, attitudes and perspectives from 
their experiences. This includes their view of themselves, others, objects as well as 
ideas. It is particularly valid for use in studies such as this concerning interpersonal 
and intrapersonal experiences using a case study approach (Gable, Wolf, 1993; 
LeCompte, Preissle, 1993). 
3.9 Categories 
Creating categories precedes the development of themes as the analytic process 
generates large amounts of codes which need to be classified. Categories organise 
findings from participants’ accounts by providing an explicit description of the 
content. The process of categorisation consists of three components: Origination, 
verification and nomination (Constas, 1992).  
Origination: This refers to the source of the categories which could be participants, 
the researcher or literature on similar works. In this study patient participants could 
not be involved in this process for reasons described elsewhere (3.17, pg.107) but 
clinician participants could contribute and through presentations disseminating the 
early findings to the team, possible categories were discussed and their feedback 





However as the study involves an interpretive element, the researcher’s analysis of 
the data was the main source of the categories. This introduces bias as the findings 
will be influenced by the views, perceptions and experiences of the researcher. 
Nevertheless, this is acknowledged as part of the process of analysing qualitative 
data (Smith et al., 2009; Vaismoradi, Jones, Turunen, et al., 2016).  
Verification: In order to support the categories developed this study used referential 
sources from studies that have similarities.  
Nomination: This is the process of assigning labels to categories which in this study 
uses the interpretive position as well as participants as a source. 
3.10 Themes 
Themes are constructs or concepts which capture key elements in the dataset, not 
necessarily the number of times it has been identified but how significant it is to the 
research question (Braun, et al, 2006). Themes are considered to be the underlying 
meanings interpreted from the data along with idiographic experiences of 
participants. Although generating themes is an essential part of qualitative research, 
there are limited studies that clarify the process of identifying themes (Ryan, 
Bernard, 2003; Braun, et al., 2006). This is possibly due to the diverse ways of 
generating themes in different qualitative studies particularly where the study is 
driven by a particular theoretical stance (Vaismoradi et al., 2016). 
There are different procedures to identify themes but for this study the approach 
illustrated in Figure 5, (pg. 95) was considered most useful to meet the aims of the 
study whilst tapping into the most relevant idiographic experiences of the participants 
to provide information in rich detail (Smith, Osborn, 2003; Smith et al., 2009; 










Figure 5: Idiographic experiential factors to identify themes  
 
 
Language use: Consider the potency of the words used regarding emotive content, 
delivery- hesitancy or difficulty in expressing themselves, stopping and starting 
responses. 
Frequency: Repetition of ideas, words or views. 
Cultural context: Identify the social context, perceptions according to age, gender, 
and ethnicity. 
Time: Critical events during the period investigated. 
Polarisation of experiences: Pros and cons of a situation, dichotomy expressed in 
perceptions of experiences. (Smith et al., 2009) 
Arriving at themes is an iterative process and requires reviewing codes then 
amending or accepting themes to reach the final selection (Fig. 4; Fig. 5). When 
describing the themes, using excerpts from participants’ interviews supports the 
















Two groups of individuals were invited to participate in this study based on prior 
working knowledge of the staff and the patient group under their care (Fig. 6). One  
group comprised qualified clinical staff (N= 10; psychiatrists, cognitive behavioural  
psychotherapists and occupational therapists) responsible for devising treatment 
programmes and providing treatment to patients. The other group were patients 
under care of the service who have a diagnosis of BDD (N=7). The total patient 
sample is illustrated in Table 6 (pg.118). 
 
Figure 6: Participant recruitment and sample  
 




Clinical staff       Patients  
 
7 Psychotherapists                                                        5 outpatients  
2 Psychiatrists                                                               2 inpatients 
1 Occupational therapist Diagnosis of BDD                                     
Under care of the service.                           
Minimum of 15 sessions or   
                                                                                      3 months inpatient stay. 
     
     Quantitative strand  
 
 
                     Database of local outpatients from 1st April 2006 (N=31) 








Staff were informed at the team meeting of the study and invited to participate. They 
were also asked to inform patients of the study and provide the patient information 
sheets to patients. Given the difficulty often experienced engaging patients who have 
BDD, it was deemed most appropriate for the clinician responsible for their care to 
invite them to participate. In this way the patient could consider participating without 
the potentially anxiety-provoking situation of meeting with a new person (i.e. the 
investigator) to discuss it. Also given the sometimes tenuous nature of their 
engagement, it was felt that being approached by someone new about the study 
could jeopardise their engagement. This is in keeping with the ethical principle of 
beneficence to protect patients’ well-being (United States, 1978).     
 
In addition the quantitative sample comprised a total of 48 referrals. A breakdown of 
the number of patients in different levels of the service is given in Table 5. These 
patients were accepted by the service as meeting the diagnostic criteria for BDD 
over a specific time period. Regional outpatients were included from 1st April 2006 
and national inpatients and national outpatients from 1st April 2007. These are the 
dates that the respective services were operationalised as models for implementing 
the NICE (2006) guidance for OCD/BDD. National outpatients are provided with 
treatment by the specialist service in their geographical area depending on their 
individual circumstances, although they fall within level 6 of the NICE guidelines 
(2006).  Patients are accepted from the age of 18; there is no upper age limit.  
 
Table 5: Number of patients referred on Level 5 and 6 of the stepped care 
model (NICE, 2006) 
 
Service Type                     NICE (2006) Level             N (48)            Percent  
  
Regional outpatients        5                    31     64.6   
National community          6            4       8.3   
National inpatients         6          13      27.1 








3.11a Inclusion criteria  
 
To ensure ethical recruitment in fulfilling the principle of non-maleficence only 
patients that were currently under care of the service were invited to participate in 
the qualitative strand of the study (Beauchamp, Childress, 2001). This included 
patients who completed treatment and were in follow up and those who completed 
an adequate trial of treatment, which is 15 sessions or 3 months inpatient stay. At 
that stage of treatment patients would have completed sufficient therapy to enable 
them to continue to practice the techniques and “be their own therapist” if they 
choose to discontinue formal sessions or if they wished to be discharged from the 
inpatient ward. 
 
For the quantitative data all the referrals of patients accepted for treatment were 
included in analysis. Dropouts and missing data was included as intention to treat 
analysis with the last known score on measures carried forward.  
 
3.11b Exclusion criteria 
 
For the semi-structured interviews, patients were excluded if they were actively 
suicidal, psychotic or regularly abusing drugs or alcohol. This suitability was 
determined by the patient’s responsible clinician in inviting patients to participate in 
the study. The sample of clinicians excludes staff, students and ancillary staff not 








Bringing together quantitative and qualitative methods in this study has its own 
challenges especially in determining the process of sample selection. The patient 
samples for both the quantitative and qualitative strands of analysis were obtained 
from the same database. In addition a sample of clinicians was used in the third 
phase of the study to provide additional qualitative data. The samples were not equal 
in size (Fig. 6). Sample sizes in qualitative methods tend to be smaller than 
quantitative samples as the emphasis is on the deeper understanding of the 
experiences of a particular group rather than generalising findings to the population 
(Patton, 2002). The analysis in the three phases, generated data which was then 
merged and compared using a convergent mixed methods parallel design (Appendix 
H). The findings were then discussed in relation to the aims of the study (Chpt. 7). 
 
3.12a Quantitative sample Phase 1 
 
Quantitative studies emphasise the generalisability of findings requiring large 
samples of a given population (Palinkas, Horwitz, Green, et al., 2015).  Non-random 
sampling was used in the collection of quantitative data to ensure the largest sample 
of patients relevant for the study could be obtained (3.11a, b).  
 
• Power considerations 
 
The general guidance for sampling is to obtain the largest sample possible to be able 
to detect small but significant changes which could be generalised to the population 
(Moher, Dulberg, Wells, 1994). However there is call for less focus on sample size 
as this may mean important trials are unpublished and knowledge lost especially in 
subjects with a dearth of information, which is the case with BDD (Schulz, Grimes, 
2005). Furthermore in retrospective studies such as this a power calculation is not 
relevant as all cases meeting the inclusion criteria in the database will be used. 
Instead the confidence intervals from the statistical tests should prove more useful 
as well as transparency in describing the process leading to the sample selection 
(Schulz, Grimes, 2005; Dancey, Reidy, 2004).   






Qualitative methods focus on the depth of understanding of the data which in 
contrast to quantitative methods can be generated by a smaller sample (Patton, 
2002). Purposeful sampling was used to identify the participants for the qualitative 
component of this study (Fig. 6; Table 6). This is a technique used to select a sample 
that will provide the most relevant information in a short timespan when there are 
limited resources at one’s disposal (Patton, 2002). The samples identified and 
selected have a particular experience relating to the subject of study i.e. either as a 
patient or as a clinician providing treatment (Cresswell, Plano Clark, 2011). It is also 
important that the individuals included in the sample are willing to participate and 
provide a reflective account of their experiences (Bernard, 2002; Spradley, 1979). 
 
Recognising that patients and therapists have a different experience of the 
therapeutic dynamic, meant that it was necessary to obtain data from both groups to 
fully explore the treatment experience (Wright, Davis Vanderbilt, 1994). The 
therapeutic relationship, especially in CBT is geared towards the patient achieving 
behaviour changes therefore although the therapy is collaborative in nature, there is 
a power difference with the therapist in the position of greater control (Wright, Davis, 
1994; Beck, Rush, Shaw,  Emery, 1979; Orlinsky et al., 1994). Therefore obtaining 
views from patient and therapist allowed for aspects of therapy, such as the 
therapeutic relationship to be explored from both perspectives and is linked to the 
study’s aims (Frank, 1985; Strupp, 1988).  
 
3.13 Data collection 
 
Clinical information regarding severity and outcome was extracted from databases. 
Clinical and demographic data was collated; analysed and interpreted using 
validated scales which are administered routinely at assessments and reviews. In 
addition the patients’ level of functioning is also rated to provide a comprehensive 
view of the impact of the psychopathology on the patient’s life and to establish 
whether there were any changes in their functioning following treatment. Data 
collected was analysed to determine changes in clinical symptoms of BDD. 
 






Semi-structured interviews are often used in qualitative research to aid in exploring 
views and experiences of the participants regarding a particular topic (Edwards, 
Holland, 2013). Using semi-structured interviews in this study fits in with the nature 
of the data needed- as it is a service evaluation, the interview schedule was aimed at 
obtaining the most relevant data to address the research questions (Appendices O, 
P). 
 
Patients with BDD are often hesitant to meet others even those with BDD for fear of 
being judged therefore semi-structured interviews appeared the most sensitive way 
to engage them in the study (Phillips, 1991). The benefit is that it provided a clear 
format and direction to ensure relevant data was obtained but also allowed for 
respondents to elaborate on their lived experience. Given it allows greater flexibility; 
it also aids in building rapport and supports the exploration of the participant’s views 
beyond the constructed questions (Smith, 2008). Even so it was difficult to persuade 
some patients to have a face to face meeting and they would only agree to 
telephone participation. In accordance with the principles of beneficence and justice, 
these participants’ requests were respected (United States, 1978; Beauchamp and 
Childress, 2001). Research comparing telephone and face to face interviewing found 
that there was no significant difference between data obtained (Herzog, Rodgers, 
1988; Sweet, 2002). Telephone interviews are mainly used in qualitative studies 
using small samples and TA in particular allows for flexibility in methods of data 
collection (Carr, Worth, 2001; Reid, Flowers, Larkin, 2005). In addition as the service 
is both regional and national, interviewing patients face to face was not always 
practical.  
 
The investigator allowed 30 to 40 minutes for the interviews as denoted on the 
information sheets. However this required flexibility with regards to the needs of the 
participant. The majority of interviews took 20-30 minutes, but some took 15 minutes 
and others needed more time; taking more than an hour. Some of the difficulties with 
using semi-structured interviews are that the investigator’s control over the interview 
can be reduced (Smith, 2008).  This meant that interviews had to be ended when the 





some interviews took longer as responses had to be explored further and 
participants needed prompting or support to express their views.  
 
Patient semi-structured interviews:  Interviews were conducted on the hospital site 
in the team’s interview rooms or by telephone. The interviews included checks for 
signs of distress when considered necessary from the patient’s response or non-
verbal cues such as silence or change in tone of voice or expression. The patient’s 
responsible clinician was informed of the interview. Two face to face interviews were 
conducted and five were by telephone. 
 
Clinician semi-structured interviews:  The clinicians working in the Community 
OCD/BDD Service are based in community sites in boroughs across the Trust. 
Therefore for practicality reasons interviews were conducted either by telephone or 
on the hospital site in the team’s interview rooms. Three interviews were conducted 
face to face and seven by telephone. 
 
Transcribing: Digital audio recordings were made of the interviews and to ensure 
accuracy, transcripts were compared to the recordings and amendments made 
where needed. All interviews were transcribed by the investigator and follow the 





These questionnaires are routinely administered from assessment through to the 
end of treatment and are collated and stored on the Trust’s database.  
 
There are two self-reporting measures:  
 
Beck’s Depression Inventory (BDI) (Beck, Ward, Mendelson et al., 1961) is a 21-
question multiple-choice instrument for measuring the severity of depression. The 
questions are scored from 0 to 3 with a total scoring range of 0 to 63. The BDI is 
reported to have been structured into groups of symptoms from clinical observations 






The BDI has been extensively used since its development and has been established 
as a reliable measure in both clinical and non-clinical studies (Richter, Werner, 
Heerlein et al., 1998; Blumberry, Oliver, McClure, 1978; Beck, Steer, 1984). Reviews 
of the BDI describe variability of scores, even over the course of a day, however this 
would be in keeping with symptoms of depression and it is acknowledged that the 
BDI is highly sensitive to changes in symptoms (APA, 2013; WHO, 2018; Richter et 
al., 1998).  
 
A weakness of the BDI lies in its inception, when it was tested on predominantly 
Caucasian samples in the United States (Dozois, Covin, 2004; Richter et al. 1998).  
Therefore it falls short in representing other population groups and considering 
cultural differences which have a bearing on how depression is perceived  (Dozois et 
al., 2004; Falicov, 2003). It is also plausible that some patients may not be candid in 
rating their symptoms which could reduce its reliability (Stehouwer, 1987). There is 
also criticism in the literature that some of the items such as “crying” may have 
different connotations for males which could lead to gender bias (Barroso, 
Sandelowski, 2001). Bearing in mind its limitations, the BDI is still an appropriate 
choice of measure, particularly as it reflects changes in symptoms with 
psychotherapeutic treatment (Demyttenaere, De Fruyt, 2003). Overall it is simple in 
its structure, easy to score, gives a comprehensive rating of symptoms and can be 
completed in a short amount of time which makes it more user-friendly for patients 
(Dozois et al., 2004). Therefore it was considered the most appropriate measure for 
patients in the care of this service.  
 
Sheehan’s Disability Scale (SDS) (Sheehan, 1983), is a five item measure used to 
assess the extent that symptoms result in functional impairment in three interrelated 
domains: work/school; social/leisure; family life. The first three items are rated on a 
visual analog scale ranging from 0 to 10 with a high score indicating severe 
impairment. The last two items ask about how many days the respondent missed 
work or study and how many days were unproductive due to their symptoms (Rush, 
First, Blacker, 2008). Scores over 5 on each item are considered to indicate 






The SDS is a simple plus basic scale but it is the simplicity and ease of use that 
make it an appealing patient-rated measure. It also enables clinicians to have a clear 
indication of the level of functioning in the most significant areas of a patient’s life. In 
addition the reliability and validity of the SDS has been positively evaluated in 
different populations (Arbuckle, Frye, Brecher et al., 2007; Coles, Coon, DeMuro et 
al., 2014). 
 
There are two scales administered by therapists:  
 
Yale Brown Obsessive Compulsive Scale Modified for Body Dysmorphic Disorder 
(BDD-YBOCS) (Phillips, Hollander, 1997). This is a 12-item semi-structured 
instrument designed to rate severity of body dysmorphic disorder symptoms in the 
week prior to the assessment. It has been modified from the extensively used Yale 
Brown Obsessive-Compulsive Scale (YBOCS) for measuring OCD symptoms due to 
similarities shared between these disorders (Goodman et al., 1989a, b; Phillips et al., 
2010). 
 
The BDD-YBOCS has been widely used in studies on BDD (Wilhelm et al., 1999; 
Phillips et al., 2002; Phillips et al., 2003; Wilhelm et al., 2011). From the 43 studies 
reviewed 31 studies used the BDD-YBOCS across three different types of modalities 
(Appendices E, F, and G). The first five questions assess the preoccupation with 
appearance–related concerns and the second five items measure involvement in 
behaviours linked to appearance concerns. There are two additional questions on 
the BDD-YBOCS; one which is designed to give an indication of insight and the other 
of avoidance due to BDD symptoms.  A cut off score of 20 is used to indicate the 
presence of BDD (Phillips, 2006).  
 
Validity and reliability reviews of the BDD-YBOCS are very limited with the main 
study evaluating the scale conducted by one of its designers which could indicate 
bias (Phillips et al., 1997; Phillips et al., 2014). However it has also been found to 
maintain validity and accuracy across different languages and cultures (de Brito, 
Sabino Neto, de Oliveira et al., 2015). One of the areas it falls short on is rating 
overvalued ideation which has been found to be a leading factor in treatment failure 





Scale (BABS) is used to assess insight and overvalued ideation (Eisen, Rasmussen 
Phillips, et al., 2001). This makes it more cumbersome as it involves having to use 
two scales which clinicians have to be trained to do. In addition, there is training for 
clinicians to use the YBOCS but none for the BDD-YBOCS which calls reliability into 
question (Eisen, et al., 2001; Goodman et al., 1989a, b).  
 
Montgomery-Asberg Depression Rating Scale (MADRS) (Montgomery, Asberg, 
1979). A 10-item measurement tool conducted as a semi-structured interview, to 
assess the range and severity of symptoms of depression on a scale from 0 to 6 with 
higher rating indicating greater severity in symptoms. 
 
Originally developed to assess the effect of antidepressant medication on symptoms 
of depression, the scale is a useful adjunct to the BDI given the treatment focus of 
CBT and medication for BDD in the service (Demyttenaere et al., 2003; Bech, 2006). 
Studies on sensitivity of the MADRS indicate good performance in differentiating 
between patients who did or did not respond to treatment and between levels of 
severity (Montgomery et al., 1979; Kearns, Cruickshank, McGuigan et al., 1982, 
Bowling, 2005). Good inter-rater reliability and validity has been shown in a number 
of studies (Montgomery et al., 1979; Davidson, Turnbull, Strickland, et al., 2006; 
Takahashi, Tomita, Higuchi et al., 2004).  
 
Although developed as a semi-structured interview tool, the rating relies on the 
clinician’s assessment of the patient’s reported symptoms. Hence it could be 
considered that the scale is not unbiased. Further research has suggested that 
development of a structured interview guide will improve inter-rater reliability thus 
making the scale’s reliability and validity more robust even across different language 
domains (Williams, Kobak, 2008) Takahashi, et al., 2004).    
 
 3.16 Challenges in using mixed methods 
 
As previously discussed both TA and quantitative methods have strengths and 
limitations but combining them reveals another level of understanding of the data. 
This study will build on gaps in the literature by using a mixed methods approach 





for large amounts of data to be collected and analysed and results to be generalised 
to the larger population (Cresswell, 2015). However quantitative methods do not 
explore the experience of participants which is better served by using qualitative 
methods (Creswell, 2015).  
 
A difficulty with mixed methods design is that it requires more time commitment due 
to the multiple strategies used to analyse and integrate data (Bazeley, 2004). 
Conducting individual interviews were also more time consuming although using 
telephone interviews reduced travel time. Using semi-structured interviews, gave 
voice to the participants in the study which will provide a more vibrant context for the 
numerical results of the quantitative analysis (Smith, 2008). Personal accounts are 
also more appealing to readers (Cresswell, 2015).  Similarly using semi-structured 
interviews with clinicians enabled them to express their views more openly whilst 
reducing bias as responses were not influenced by the presence of other team 
members. 
 
In addition this is the first known study written in English to give a detailed account of 
clinicians’ perspectives of treating BDD within a psychological and pharmacological 
model. This will add to the knowledge of the treatment aspects especially with 
regards to areas clinicians feel are lacking and require further development. Bringing 
together both the methods will make the information more accessible to both 
clinicians and the general public. 
 
3.17 Quality assurance of the research  
 
This study incorporates the four main principles for establishing the quality of 
qualitative research (Yardley, 2000; Smith et al., 2009). In order to ensure sensitivity 
to the context a clear understanding of the existing literature on BDD and its 
treatment was required along with in-depth exploration of the meanings of their views 
and experiences from the data gathered from respondents (Yardley, 2000). The 
principle of sensitivity was vital in conducting the interviews which required engaging 
the participant, building rapport and recognising any distress or unease which also 






Principles of commitment and fidelity were displayed by care and attention to the 
participants during data collection and with the analysis of the data (Yardley, 2000; 
Smith et al., 2009). The fidelity of the data can sometimes be difficult to ensure if 
participants do not wish to have further involvement. Therefore the interviews in this 
study are transcribed from audio recordings and the (HCP) respondents who agreed, 
were sent copies to verify the content whilst most did not feel it necessary. It was 
also considered to not be beneficial to the patient participants to share the 
interpretation of the transcripts with them as this could impact on their relationship 
with their therapist and/ or cause disturbance in the therapeutic process. This is in 
accordance with the ethical principle of non-maleficence to ensure the participants’ 
well-being. 
 
Transparency and coherence is the third principle involving the clear description of 
the processes involved, from design through to analysis, in conducting the study 
both for participants and for future research (Smith et al., 2009). Quotes in 
participants’ own words are included to provide a context for the emerging themes 
and to support findings and interpretations. The researcher provides clear 
explanations of the transcribing process and the style of interpretation used to 
ensure findings are considered within this framework and also to ensure the fidelity 
of the data   (3.7.1, pg. 91; 5.2.1, pg.130). 
 
The fourth principle regarding impact and importance highlights the purpose of the 
study which is to be beneficial to patients with BDD and clinical staff treating the 
disorder (Yardley, 2000; Smith et al., 2009). The study was conducted with these 
principles as guidance; bearing in mind that the needs of the participants are the 




A service evaluation is described as “designed and conducted solely to define or 
judge current care” (Health Research Authority, 2017). In this type of project the 
standards of care provided are considered but it does not involve undertaking any 
treatment or intervention. Existing data is collated and analysed; although input from 





semi-structured interviews to provide their experience of the treatment and help 
determine what interventions were most effective. 
 
As this study was deemed a service evaluation, NHS Research Ethics Committee 
review was not required. 
However ethics approval was sought and obtained from: 
• The College of Health and Social Care Research Ethics Committee at the 
University of Derby (Appendix I). 
• Approval and registration was obtained from the South West London & St 
George’s NHS Mental Health Trust Quality Governance department. The 
department approves and registers audits but there is no separate department 
for service evaluations so these are registered alongside audits. Hence the 
wording in the standard approval correspondence received (Appendix J). 
 
The ethical considerations significant to this study require an adherence to the British 
Association of Behavioural and Cognitive Psychotherapy (BABCP, 2010) 
professional code of conduct as well as the South West London and St George’s 
NHS Mental Health Trust’s policies on consent, confidentiality and clinical 
governance.  
 
The principles that form the foundations of biomedical ethics have been widely 
discussed in the literature (International Council of Nurses, 1996; Beauchamp, 
Childress, 2001; Polit, et al. 2004). There is a consensus as to the main principles 
which should guide research, including beneficence, non-maleficence, justice and 
autonomy. These principles underpin the non-consequentialist ethical theory of 
deontology which is embraced from a patient-centred position in this study (Pieper, 
2008). The description of patient-centred deontology stipulates that individuals are 
not to be treated as a means to an end (Kant, 1785). As observed in the literature, 
deontologists tend to be more considerate of the costs to participants (Schlenker, 
Forsyth, 1977).     
 
The principle of beneficence requires that any research that is carried out ensures 
that participants’ decisions are respected and they are protected from harm and their 





concerned with building trust between the researcher and the participant is most 
important to enable participants to feel comfortable in discussing their views and 
experiences (Parahoo, 1997). This also involved using the principles of CBT in 
engaging the participants and being sensitive to their concerns and needs. 
 
In accordance with these principles, the ethical basis in conducting this study 
focused on ensuring the appropriate procedure was followed for participant 
interviews. The purpose was not just to obtain information from participants but to 
safeguard them with regards to their informed consent, voluntary participation and 
confidentiality. This responsibility to ensure the wellbeing of participants during the 
study is required by the principles of non-maleficence and beneficence. The 
investigator’s independent position is clearly explained to participants as duty bound 
to protect the interests of the participants and having no influence on treatment 
provided or on staff management.  
 
3.18.1 Consent  
 
To fulfil the principles of non-maleficence and autonomy all participants in this study 
were fully informed in writing and verbally about the purpose, methods and how the 
research findings will be used. No incentives were offered for participation. 
Participation was subject to consent for any data and information they provided to be 
used. Participants were provided with written information on what their contribution 
will involve (Appendices M, N). Further information or clarification was provided to 
participants if requested as was explained in the participant information sheet. This 
enabled participants to make an informed choice based on all the information being 
provided thus ensuring an autonomous decision and no harm from any omission or 
commission (Appelbaum, 2007). As detailed in the information sheets, participation 
was voluntary and they were also able to withdraw their consent at any time prior to 
the data being analysed without the need for any explanation and without prejudice.  
 
The principle of non-maleficence requires a commitment to protect participants from 
harm. In this type of study it is important to ensure participant’s needs and well-being 
are the first priority. Therefore patients were identified and invited by their 





patient’s mental state and risk status. The responsible clinician gave their patients 
the information sheets and consent forms.  
 
For the clinicians’ feedback, information sheets and consent forms were provided by 
the study investigator to participate in the service evaluation. All data was 
anonymised or pseudonyms used and none of the patients or clinicians will be 
identifiable in the report of the findings. Participants were informed that they can 
refuse to answer any question and can request that the recording of interviews be 
stopped and the interview terminated at any time. Permission for recording was 




In accordance with the principle of non-maleficence, anonymity of respondents is 
respected (Beauchamp et al., 2001). No identifying details of patients and clinicians 
were used in the research study. Participants were informed of the confidentiality of 
information they supply in writing and verbally. The participant was also made aware 
of exceptions to this. The exceptions are if the participant provides information 
regarding issues of risk either to them or to others. This information would have to be 
relayed to the necessary parties to manage appropriately. Patients are provided with 
details of the Trust’s confidentiality policy as standard procedure for all patients 
offered assessment or screening by the service.  
 
Data provided by clinicians was anonymised and stored on a separate Trust 
database developed specifically for the purpose of this study and only accessible to 
the investigator. This data will be stored for two years and then destroyed securely 
according to Trust policy following the conclusion of the study. This is also in keeping 
with the principles of the Data Protection Act (1998). 
 
3.18.3 First do no harm 
 
In clinical research non-maleficence requires disclosure to subjects any possible 
risks that participation may involve (Lawrence, 2007). In addition the principle of 





1978). To uphold this principle in the course of the semi- structured interview, if the 
participant became distressed or wanted the recording stopped for any reason, the 
interview was stopped and the participant was given time to discuss their concerns 
or upset.  
 
As agreed with the specialist service, for patient participants, their therapist was 
available if they wished to discuss any concerns with them. Interviews as far as 
practicable were arranged for when their therapist was available for face to face or 
telephone consultation. The participant was asked if they wished for their GP or 
other health care professional to be contacted following the interview. In debriefing 
following the interview, it was clarified whether they still agreed to have their 
responses included in the study or if there was any information they did not want to 
be used.  
 
As it is a national service, for practical reasons some participants were not able to 
travel to the hospital. In conjunction with the principle of justice, it was unfair to 
exclude them on geographical grounds; therefore their interviews were conducted by 
telephone.  
 
 In clinical research non-maleficence requires disclosure to subjects any possible 
risks that participation may involve (Lawrence, 2007). In addition the principle of 
beneficence requires making an effort to secure their well-being (United States, 
1978). For patient participants, prior to the interview their responsible clinician was 
asked about any current concerns about the patient being interviewed. If there were 
any concerns from the clinician, the plan was for their clinician to inform the patient 
that the interview will be postponed or cancelled as appropriate and for the clinician 
to explain their concerns.  
 
If the responsible clinician did not have any concerns, the investigator also clarified 
with the patient when contacted if they wished to go ahead with the interview at that 
time. If the patient voiced any concerns they had the option to rearrange the 
interview or withdraw their participation. Similarly if the clinician participant was upset 
in any way by the interview they had the option to discuss their concerns with their 





Following the interviews the participating patients and clinicians were offered a 
debriefing session. This was to identify if any emotional distress was caused by the 
interview process; to answer any questions; to ensure the participant was 
emotionally settled before ending the session. If any distress was noted, an action 
plan was to be established to ensure the appropriate support was available for the 
participant. They were given a debriefing sheet with the investigator’s contact details 
if they wished to discuss any aspect of the interview at a later date (Appendix Q). 
 
Patients were advised that if they had any queries regarding their treatment, they 
could contact the professionals involved in their care. With regard to identifying risks 
in the patient group, the plan was to alert the professionals responsible for their care. 
Clinicians with any queries outside of the study remit would have been directed to 
their line manager or supervisor. The participant information sheets include these 
provisions (Appendices K, L). 
 
The study was conducted in a non-discriminatory manner in conjunction with the 
ethical principle of justice, in particular the response to each participant’s needs. 
Translated information was available for patients if needed and a translator would 
have been provided if required for patient interviews. The team base is equipped for 
people with physical disabilities to ensure accessibility. This is also in keeping with 
the BABCP standards of conduct, performance and ethics (BABCP, 2010).  
 
3.18.4 Benefits of the study 
 
The second principle of beneficence refers to the benefit of research to the 
participants as well as to society (United States, 1978). In this study participants had 
the opportunity to voice their opinion on treatment received and treatment provided– 
what they felt worked best and aspects they felt were less helpful. Although there 
may not be any specific benefit for each individual, the information they provided 
could offer some direction as to the best ways of engaging patients in treatment and 
highlighting interventions that will enable them to continue to progress at the 






Findings from the study once published will add to the body of knowledge regarding 
BDD. This will be helpful in developing a general awareness of the disorder in 
society and promoting treatment methods for BDD that have been found to be most 
beneficial. This satisfies the principle of beneficence where the study findings may 
lead to improving knowledge and interventions to have longer term benefits for larger 
society (United States, 1978). In addition this upholds the principle of fidelity in 
maintaining the highest standards of care and professional conduct acting in the best 
interests of the patient (BABCP, 2010).  
 
3.18.5 Dissemination of findings 
 
A continuation of the second principle of beneficence was to ensure the aims and 
objectives of the study, in addition to being beneficial, will also make a valuable 
contribution to both the body of knowledge and the service (United States, 1978). 
The researcher has an ethical responsibility to ensure findings from the study are 
available to other health care professionals to increase the development of 
knowledge in this field (Singh and Singh, 2007; Fernandez, Kodish, Weijer, 2003). 
This is especially relevant regarding BDD considering the dearth of research 
available. In addition there is the responsibility to the participants who provided the 
information to offer them the opportunity to view the findings (United States, 1978; 
Fernandez, et al., 2003). In this study, the aim is to disseminate the results of the 
study through presentations and publications and to make copies of the findings 




The small sample size of the quantitative data may be considered to limit 
generalisability as does the focus on just one service. Nevertheless from studies 
reviewed the average sample size for pharmacotherapy studies was M=32.6 and for 
psychological therapies M= 16.12.   
 
There is also growing support for the use of smaller samples in qualitative studies 
(Smith et al., 2003; Reid et al., 2005).  Although findings appear to be less 





greater depth without the detail becoming lost in vast quantities of information (Smith 
et al., 2009). In addition as treatment resources for BDD are very limited this study 
will produce preliminary findings to add to the research base and provide the 
opportunity to develop further research projects. 
 
Although there may appear to be a selection bias in using both inpatient and 
outpatient groups as they differ in factors which could influence outcome, these 
groups are not being compared as they received treatment on different levels of the 




TA provides an experiential aspect to the study and in so doing also brings a greater 
understanding of the quantitative data. This can be used to inform how to refine the 
application of the NICE (2006) guidelines to address concerns, needs and 
shortcomings as well as to reinforce areas of strength and excellence revealed 
through the analysis of the data. In addition providing a clear and transparent 
process of thematic analysis also adds to the knowledge base for qualitative 
research as literature on TA is also limited (Braun et al., 2006; Ryan et al., 2003; 
Vaismoradi et al., 2016).  
 
Findings from the study are presented in the subsequent chapters. These are 
separated into quantitative results (Phase 1) and qualitative findings (Phase 2 and 3) 
using TA. The chapters flow from descriptive statistical data into a deeper 
interpretation of the patients’ and health care professionals’ (HCPs’) views which are 







Chapter 4:  
Phase 1 









This chapter is presented in two parts. The first provides a description of the total 
patient participants. The second reports the results from analysis of patients’ 
measures pre- and post- treatment.  
  
4.2 Patient participant characteristics 
 
Patient participants are divided into three groups from the quantitative data collected: 
Outpatients treated at level 5 of the NICE guidelines (2006); national service 
inpatients and national service outpatients treated at level 6 of the NICE guidelines 
(2006). Table 6 describes the patient participants. 
 
Outpatients in the national service treated at level 6 (L6 national outpatients) may 
have symptoms of similar severity as the inpatients however usually differ with 
regards to need for 24-hour nursing care. They were provided with intensive 
treatment, often in their own homes comprising several consecutive days of therapy 
which included supporting their local service to manage their care. However some 
patients have been treated as “outpatients” who were actually admitted to an acute 
inpatient setting elsewhere and it was deemed more beneficial for therapists to treat 
the patient there rather than admit them to this unit. This may be due to their level of 
risk, their distress at being moved from a familiar environment or being far from their 
support network. 
 
The sample of patients who participated in the semi-structured interviews is included 
in the quantitative data analysis but will also be described separately  to provide a 












Table 6: Sociodemographic characteristics of patient participants by group 
and combined 
 
 Outpatients  
    (N=31) 
 
Inpatients  
   (N=13) 
 
L6 National 
outpatients          
(N=4) 
 
      Total Sample 
            (N=48) 
 Mean      SD Mean       SD    Mean          SD       Mean          SD 




    39.7         20.8 
    R= 24-70 
     35.13         12.30 




    14.0           4.32      15.90           5.930 










 11        35.5 
 20        64.5 
 
 14        45.2 
 12  38.7 
   4  12.9 
   1    3.2 
 
   7         53.8 
   6         46.2 
 
 10         76.9 
   1           7.7 
   2         15.4 
   0           0.0 
 
      2              50.0 
      2              50.0 
 
      3              75.0                   
      0                0.0 
      0                0.0 
      1              25.0 
 
      20          41.7 
      28          58.3 
 
29          60.4 
      13          27.1 
        4            8.3 





Other incl. Chinese 
Mixed 
 
 26 83.9 
   1   3.2 
   2   6.5 
   1   3.2 
   1   3.2 
 
  12 92.3 
   0            0.0 
   1            7.7 
   0            0.0 
   0            0.0 
 
      4             100.0          
      0                0.0 
      0                0.0 
      0                0.0 
      0                0.0  
 
    42          87.5 
        1            2.1 
        3            6.3 
        1            2.1 
        1            2.1 
Accommodation  





 13 41.9 
 14 45.2 
   0           0.0 
   4         12.9 
 
   3 23.1 
   8 61.5 
   0            0.0 
   2  15.4 
 
      1               25.0        
      1               25.0 
      1               25.0 
      1               25.0 
 
       17           35.4 
       23           47.9 
         1             2.1 








 25 80.6 
   2   6.5 
   2   6.5 
   1   3.2 
   1   3.2 
 
 11  84.6 
   1    7.7 
   1    7.7      
   0            0.0  
   0            0.0          
 
      3               75.0 
      1               25.0 
      0                 0.0 
      0                 0.0 
  0                 0.0 
 
       39           81.3 
         4             8.3 
         3             6.3 
         1             2.1 
         1             2.1 
Children       
None               27         87.1          12 92.3     4      100.0                43     89.6 
Parent    2          6.5   1   7.7     0                 0.0                  3       6.3 






4.2.1 Sociodemographic findings 
A total of 48 participants were included in the study. The data indicated a larger 
percentage of females than males presenting with BDD in the service (Table 6). The 
participants were predominantly Caucasian, ranging in age from 18-70 years old with 
an average onset age of 15 and range of 10- 45 years. The average duration of BDD 
was 19.23 years in keeping with studies indicating long duration before seeking 
treatment ((Veale et al., 1996; Phillips, et al., 1997). English was the first language 
for all patients. 
Areas of note were the high rate of unemployed participants; single status and no 
children. There was also a majority of participants living with their parents. These 
findings are consistent with the literature indicating the disabling impact of BDD on 
the individual’s functioning (Phillips, et al., 2005; Phillips et al., 2008).  
4.3 Clinical factors  
At assessment patients provided detailed descriptions of the features they are 
concerned about by completing the Body Dissatisfaction Checklist (Appendix Z.v).  
Table 7: Most common areas of preoccupation  
Feature Incidence in total sample  
(N= 48) 
Skin  20 
Whole face 15 
Nose 14 
Eyes 9 
Whole body 8 
Hair on head/baldness 8 
Breasts 7 
 
Features that were more noticeable tended to be areas of preoccupation (Table 7).  
These results shared similarities with findings in research studies (1.2.4 pg. 20; 





one area of preoccupation and this could sometimes change in the course of 
treatment with additional areas becoming the focus. The data also revealed that five 
patients had previous cosmetic surgery and four performed self-inflicted surgery 
which is an indication of the extreme measures patients with BDD will go to alleviate 
their distress (Veale, 2000; Phillips et al., 2005; Phillips, et al., 2006). 
Findings of note were the high risk profiles with 30 patients indicating suicide risk 
with suicidal ideation or previous suicide attempts (Appendix U). Alongside this were 
29 instances of misuse of alcohol and illicit substances (Appendix U). There was 
also a high comorbidity rate (Graph 4). These findings are in keeping with the 
literature reports on clinical features of BDD (Conrado et al., 2010; Phillips et al., 
2006; Grant et al., 2001).   
Graph 4: Incidence of comorbid disorders in the sample 
 
Comorbid depression was present in 85% of the sample followed by 54% with OCD. 
There were also 33% of patients with more than 2 comorbid disorders in the sample. 
Additional disorders occurring singly in the sample were: hoarding; personality 
disorder (unspecified); Asperger’s Syndrome; schizophrenia and bipolar disorder.  
The medication regime usually consisted of a SSRI and augmentation with a 
dopamine blockade. From the available data collated, the most common medication 
















prescribed (Appendix V). Given the limited research studies into pharmacological 
treatment for BDD, the guidelines concluded that there is no evidence for either 
SSRIs or augmentation with dopamine blockades in BDD however they suggest the 
similarities between BDD and OCD warrant trials with this medication as they have 
been shown to be effective in OCD (NICE, 2006: 6.13.7, pg.173). This is concerning 
as pharmacological treatments for BDD seem to be a trial and error exercise. Indeed 
following the trial of Pimozide this medication was found to have concerning health 
effects (Phillips, 2005a). Given the lack of clear direction in the NICE guidelines 
(2006) for pharmacological treatments, evidence was sourced from any available 
research studies to support prescribing practices in the service (Appendix F, 
Appendix V).  
One of the shortcomings identified in the literature was that patients do not always 
engage in treatment and there is a relatively high dropout rate. From the total of 48 
participants, 10 (20.8%) dropped out of treatment before the 15 sessions or three 
months admission. Four of the non-completers were outpatients, three were 
inpatients and three were L6 national outpatients. Reasons for dropout were 
obtained where possible which could help in reviewing strategies for engagement 
(Table 8).  
Table 8: Reasons for dropout where provided: 
Outpatients  2 disengaged as felt therapy too difficult  
   1 relapsed into use of illicit substances 
Inpatients  1 requested discharge as felt was coping better after 2 month 
   admission 
   1 relapsed into alcohol abuse 
L6 national   1 disengaged as felt therapy too difficult 
outpatients  1 relapsed into use of illicit substances 







4.4 Analysis of interventions provided 
The expectation of the service as per referral criteria and in accordance with the 
stepped care model is that patients are provided with CBT prior to being referred to 
the specialist service (Fig. 1; NICE, 2006). However the recognition and expertise to 
treat BDD is still lacking amongst healthcare professionals and patients are accepted 




Treatment with an SSRI was accepted by 81.3% (N=39) of patient participants 
which was offered in line with the NICE guidelines (2006).  A further 12.5% of 
patients were not offered SSRIs (N=6) and 6.3% (N=3) refused to be prescribed 
SSRIs (Graph 5). The reasons for refusal where available were: concerns about 
physical effects of medication on skin; concerns about side-effects. As previously 
stated, there are no medications currently licenced for treatment of BDD (FDA, 
















Augmentation studies are even more limited and success rates are variable 
(Appendix F). Augmentation with dopamine blockades were provided in lower doses 
than for psychotic disorders and were taken by 31.3% (N=15) of patients and 4.2% 
(N=2) refused (Graph 6). The majority of patients (64.6%, N=31) were not given 
augmentation as the team did not think it would be clinically beneficial. The team 
usually opt for trials with other SSRIs and psychological interventions instead. Once 
again the question arises, where is the evidence base to suggest the use of 
augmentation is warranted for treatment of BDD? Out of four studies two studies 
showed some responders (Rashid et al. 2015; Phillips et al., 1996a). However 
findings in these studies were inconsistent as the same augmentation used in two 
different studies showed no response in one and possible response in the other 
(Phillips, 2005b; Rashid et al., 2015). Clarity was lacking in the study regarding 

















 Table 9: Treatment outcomes for level 5 and level 6 inpatients and national          
outpatients 
Patient group    Treatment 
phase 
 BDD-YBOCS  
Mean       SD 
        BDI     
Mean       SD           
     MADRS 
Mean      SD           
      SDS                 








treatment            
 
20.84       10.41   
p=0.001 
 19.45      12.09 
p=0.001 
14.39   9.69 
p=0.001 




Baseline 36.08    3.12 33.85       12.53 
 
29.15      10.09 
 







23.23       10.02 
p=0.001 
19.69       12.14 
p=0.016 
18.00      10.80 
p=0.005 










23.25    13.3 
p=0.362 
25.75   11.44 
p= 0.391 
19.00   6.16 
p=0.391 










31.60    6.02 
21.38    10.3 
p=0.001 
29.38       12.45 
20.04       11.93 
p=0.001 
23.85   9.64 
15.75   9.78 
p=0.002 
22.31   7.45 
15.15      10.31 
p=0.001 
 
4.5 Treatment outcomes 
Patients in the L5 outpatient group showed significant improvements from baseline 








Graph 7: Level 5 Outpatients pre- and post- treatment scores  
 
The outpatient group improved by 31% on the BDD symptom measure; 30% on BDI; 
34% on MADRS; 36.5% on SDS.   
L6 inpatients showed significant improvement in BDD symptoms from baseline and a 
trend towards significant improvements in depression and functioning (Graph 8).  
Graph 8: Level 6 Inpatients pre- and post- treatment scores  
 
The inpatient group showed a response rate of 35% on BDD symptom measures; 

































Despite the improvements, BDD symptoms for all groups remained within the 
moderate level of severity with depression ranging between mild and moderate and 
functioning from mild to moderate impairment. However given this is a specialist 
service and patients referred are at the more severe end of the spectrum, this result 
is in keeping with their levels of severity. Still the qualitative data may provide 
additional insights into the outcomes on measures of severity. 
A finding of particular note was L6 national outpatients only showed a 5 point 
improvement on BDD symptom measures overall and between 1.25 and 2.75 points 
on measures of depression and functioning (Graph 9).  
Graph 9: Level 6 National outpatients’ pre- and post- treatment scores  
 
 
The L6 national outpatient group showed minimal improvements on all measures. 
The BDD-YBOCS indicated 16% improvement on the BDD symptom measure; 4.6% 
on BDI; 12% on MADRS; 7% on SDS. 
This finding may have implications for treatment in this service category as the 
outcomes for patients in this level did not reach significance on any measures of 
symptoms. In addition three patients in this service category dropped out of 
treatment (Table 8, pg.121). The reasons for the lack of responders in this group are 
not clear and there were no participants from this service level in the qualitative 
phase of the study. However given it is a small number of patients, examining the 
individual demographics and scores on measures may shed some light on this 


















All patients in this group indicated high risk behaviour: one had suicidal ideation, 
three had previous suicidal attempts. All had more than two additional comorbid 
disorders (Appendix W). They had all been prescribed SSRI medication although 
one was non-compliant with medication. None had augmentation to their medication 
regime. Three showed marked levels of impairments in social, work, home 
management spheres. These factors combined with symptom severity may have 
contributed to difficulty gaining benefit from the outpatient national treatment (Table 
9, pg.126; Graph 9).  
The nature of treatment for this group tends to be: 
• Providing an intensive series of treatment days in collaboration with local 
services. 
• The patient is expected to continue to practice skills and techniques learnt 
with support from their local mental health service. 
• Follow up from specialist service. 
These patients may be falling in the gap where the specialist service does not have 
the resources to provide ongoing treatment on a national level to patients who do 
not meet the inpatient criteria for admission. Nevertheless they have developed a 
system of disseminating skills and collaborating with local mental health services to 
provide treatment in areas nationally where there is no access to specialist BDD 
services. However this group needs further investigation to evaluate effectiveness of 
the service provision in its current form. 
Level 6 inpatients had a greater baseline severity than L5 outpatients as was 
expected (4.2, pg. 121). However the inpatient group showed greater improvements 
on all measures compared to outpatients apart from measures of functioning which 
may be attributed to greater impairments in functioning at baseline for the inpatient 
group (Table 9). The qualitative data may give an indication of the reasons for the 









This chapter provides an interesting insight into the population of patients with BDD 
who present to specialist services. Several points emerged from the 
sociodemographic breakdown. The ethnicity of patients with BDD is an area with 
very limited research. Patients were predominantly Caucasian despite being based 
in a locality with ethnic diversity and also having a national component to the service. 
Questions arising from this are whether people from minority ethnic groups do not 
have access to services; are they more reluctant to use mental health services or are 
methods of engagement used not effective? Furthermore, without people being 
aware of the disorder, including within health care services, it is less likely to be 
recognised or have treatment offered.  
The findings are consistent with literature descriptions of the young onset age of 
BDD with long duration of the condition (Phillips, et al., 2006; Veale et al., 1996). 
This also highlights the need for developing the awareness of BDD so that it is not a 
hidden disorder. One of the findings of concern is the high risk profiles of the patients 
in the sample (Appendix U). This shows similarities to reports on risk behaviour in 
BDD (1.2.6, pg. 21; Phillips et al., 2005; Phillips, 2007; Cotterill, et al., 1997). Given 
BDD is not easily recognised, risk prevalence may be greater than reported and is 
another area needing further investigation.   
 
In addition findings indicated 40% of patients had a history of misusing alcohol or 
illicit substances (Appendix U). Interestingly when examining reasons for dropout 
three of the eight patients who responded indicated relapse into alcohol or drug use 
(Table 8, pg.121). Self-medicating with alcohol and illicit substances may have 
developed to cope with the anxieties generated by BDD (Grant, Menard, Pagano, et 
al., 2005). This again points to the need for earlier intervention as long term sufferers 
of BDD tend to have comorbid disorders and be more impaired with their functioning 
(Phillips, et al., 2008). Examining the experiences from patients’ interviews in Phase 










Phase 2: Thematic analysis  
 
How patients with BDD respond to and experience 
treatment that has been recommended by the NICE 









This chapter unfolds with a description of the data management plus the process 
and method of analysis including coding followed by a depiction of the patient 
participants (Appendix R). For clarity and transparency the coding process is 
demonstrated in Table 11 (pg.135) and an excerpt from a patient’s transcript 
demonstrates the coding process (Appendix S). For clarity a list of the superordinate 
and subordinate themes extracted from the patients’ interviews is illustrated in Figure 
7. The focal point of this chapter is the exploration of each superordinate and 
subordinate theme supported by patients’ quotes with further interpretation by the 
author. The data in this study was reported in keeping with the critical realist 
framework analysing both manifest and latent content. The manner in which the 
findings were reported was chosen to demonstrate authenticity in the interpretation 
of the data (3.7.1, pg. 91). Using TA from a critical realist approach enables the 
interpretation of experiences and meaning whilst acknowledging the researcher’s 
bias (Vaismoradi et al., 2016). The chapter concludes with a discussion of the 
findings in relation to literature.  
  
5.2 Data Management  
5.2.1 Transcription 
The way that data is transcribed can strongly influence how participants are 
portrayed and perceived (Oliver, Serovich, Mason, 2005). Audio recordings of the 
interviews were transcribed using a more denaturalised approach which aims to be a 
verbatim portrayal of the interview contents (MacLean, 2004). However the precision 
of reporting is focused on meanings, views and experiences expressed rather than 
filler words (i.e. “um, er”) (Oliver, et al., 2005). Nevertheless given that supporters of 
naturalised transcribing argue these could be useful to provide additional information 
about the participant’s affect, filler words were excluded unless they illustrated 
meaning or the tone of the response (Schegloff, 1997). By focusing on content of 
dialogue, it can limit misunderstanding or misrepresentation of the participant’s 
response (Billig, 1999a). 
Choosing this method of transcribing is linked to the nature of the research question 





interventions recommended and to contribute to the body of knowledge. Also this 
method is more allied with the underpinning theoretical framework and the use of TA 
which requires richness and depth in analysis but not to the extent of interpreting 
every mannerism or involuntary vocalisation.  
Transcripts were prepared for analysis by numbering each line to allow for cross-
referencing. Where any comments could possibly identify an individual or third party, 
these were removed and denoted by closed brackets ([  ]). Initial analysis involved 
an overview of each transcript with notes made in the margins about salient 
comments or words used. The transcripts were then re-read and specific information 
was identified by using coding strategies (3.8, pg. 94) that address the research 
questions (Saldana, 2016).  
5.2.2 Data Analysis  
Data gleaned from participants’ accounts called for organisation and structure. This 
was found in a heuristic approach which helped to assimilate the data into a more 
coherent format (Smith, et al., 2009). The notes were used to develop lists of the 
information. The lists were then interpreted for each case to propose an impression 
of how the participant made sense of their experience. A search was made across all 
the transcripts for common words or ways of describing an experience (Fig. 8, 9). 
Notes from each transcript were then compared and codes were assigned. This 
process was repeated until codes were exhausted. The codes were then categorised 
and emergent themes identified.  
• Superordinate themes  
Superordinate themes indicate the prevalence of dominant ideas or patterns 
across the dataset following analysis to refine themes (Smith, et al, 2009).  
• Subordinate themes 
Subordinate themes refer to recurrent patterns identified in more than half the 
sample that give structure to the more complex overarching superordinate 
theme by providing patterns of meaning (Braun, et al, 2006). 
The process of arriving at the final themes was a journey in itself. Thematic analysis 
also provides an interpretive view of the data rather than being purely descriptive 





actual feelings and experiences reported and used “therapist- language” which was 
a familiar medium for the researcher. Putting this aside, transcripts were re-read and 
notes made for each case again. Themes were identified and evidence sought in 
quotes. Themes were discarded several times before arriving at the core themes. 
Although the process is a search for patterns, it is also seeking to identify deviations 
and idiosyncrasies which may give added insights. Once this was clear, the 
superordinate and subordinate themes all seemed to flow together in a coherent 
structure.  
Where themes existed in more than half the sample, these were taken further with 
lesser themes discarded or considered for subordinate themes. In addition themes 
were identified that highlighted a significant experience for participants that related to 
the research question. 
Although for the purpose of transparency and accuracy it would have been ideal to 
involve patients in the analysis, following discussion with the clinicians responsible 
for the patient participants, it was not deemed appropriate to present the transcripts 
to the patients. Patients generally found it anxiety-provoking being interviewed in the 
first instance with most opting for telephone rather than face-to-face interviews. It 
was considered that for some patients, the fragility of their engagement may be 
jeopardised. This is an area that can be explored in future studies. 
 
5.3 Patient characteristics 
 
Sociodemographic and clinical characteristics of the patient sample are shown in 
Appendix R. Using pseudonyms felt more personalised rather than assigning a value 
to each participant. It helps to maintain the essence of the analysis in focusing on 
their idiographic experiences. The researcher is denoted by ‘R’. 
 
The sample was predominantly female and all were Caucasian. The mean age was 
31 (R=18-49) with mean onset age of 14 (R=12-16). The average duration of BDD 
symptoms was 17 years. The impact on functioning is striking with the majority of the 
patients in the sample unemployed, living with their parents and single. In addition 
five patients had more than two comorbid disorders; three used substances; five 





All patients received SSRI medication with two receiving more than two trials of 
SSRIs and two received augmentation. 
The individual pre- and post- treatment scores of participants on clinical measures of 
symptom severity are presented in Table 10.   






        BDI     
 
     MADRS 
 
      SDS                
 
 Comment 




       37 






  9 
BDD symptoms reduced 
by 52.5%. Overall 
functioning shows mild 
impairment. 


















BDD symptoms reduced 
by 45%. Overall 
functioning shows mild 
impairment. 
 










  4 
20 
 
  8 
30 
 
  0 
BDD symptoms reduced 
by 60%. Overall 
functioning shows no 
impairment. 
 







  1 
20 
 
  2 
24 
 
  4 
13 
 
  0 
Reduction of BDD and 
depression symptoms to 
non-clinical range. 
Overall functioning 
shows no impairment. 
 







  8 
17 
 
  9 
12 
 
  6 
17 
 
  5 
BDD symptoms reduced 






















A 7.5% reduction in BDD 
symptoms, still within 




















A reduction of 22.5% in 





From the seven patients in the sample, one made complete recovery, three had mild 





range. A >40% decrease in BDD-YBOCS scores corresponded to significant 
improvements in functioning measured by the SDS. Most of the patients had 










Emergent themes  
Feeling listened to 
Trusting 




Feeling understood  
Socialising  





Negative views of self 










Connecting with others 
 




Too much to tolerate 
Feeling pushed 
Overwhelmed 
Loss of independence 
Not taking responsibility 
Barriers 
Not buying it 
Feeling put upon 
It’s not working 
Learning 
Can’t cope  











Not giving up  
Building resilience 
























5.4 Themes  
 
Three superordinate themes were identified and are listed in Figure 7 with their 
associated subordinate themes. The themes identified indicated patterns of 
experiences from engagement through to the end of therapy.  
 





Superordinate theme 1 
 
5.5. Connecting  
 
One of the difficulties described by participants is feeling alienated from the rest of 
society. This is usually linked with fear of rejection and avoidance. Not only does this 
impact on social relationships but also engaging with healthcare professionals 
(Veale, 1996; Phillips et al, 2008). Patterns identified in the subordinate themes 
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For patients the process of engaging in treatment meant developing trust in the 
therapist as well as themselves and others (Ryan and Deci, 2000). The therapeutic 
relationship forms a vital part of treatment (Strupp, 1988; Greenhalgh, Heath, 2010). 
The initial stage of engagement in treatment is critical, in particular for patients with 
BDD who find it difficult due to the nature of the disorder (Wilhelm, et al., 2013; 
Crerand, et al., 2006; Marquesa, et al., 2011). A common theme running through the 
patients’ accounts is of their interactions with their therapist and the bearing this had 
on their experience. 
Alice’s account illustrates her experience of building trust in the therapist which 
enables her to trust herself and finally extends to other people.  
Alice: “My therapist was very supportive but did not let me get away with not doing 
my homework.  
The aim was to help me move away from coping strategies I had developed to deal 
with my feelings of shame and disgust. For e.g. I always showered in the dark. The 
coping strategies served as a constant reminder that I thought my body was 
disgusting and never gave me or others the chance to challenge these thoughts.  
It is hard to express the gratitude I feel to my therapist and the BDD service. 
 
 
The therapeutic relationship features highly in her account and appears to set a 
foundation for the progress that follows. She describes feeling supported but also 
being reminded of taking responsibility in her treatment. Support seems instrumental 
in helping her to follow through into the most difficult part of the process, to trust 
herself to overcome the fears.  
In Fred’s response however, there appears a dichotomy in his views of the therapy 
and the therapeutic relationship.  
R: “Would you recommend others to have this type of treatment if they had BDD? 





helps someone like me who's thoughts are mixed and unsure to then be put on the 
correct pathway for recovery.  
R: “Are there any other aspects about your treatment that you would like to tell me 
about?” 
Fred: “None in particular except that my therapist shown real and genuine desire to 
see me improve and live a more fulfilled life.”  
 
Fred’s account gives an impression of unrealistic expectations “miraculous”; a 
solution for “all” problems. Although he goes on to deny that to be the case (“what 
does?”) it seems he is saying what he thinks the researcher (R) wants to hear. Fred 
expresses uncertainty about the treatment and although he describes it being 
helpful, his use of language indicates he felt he was not really making a choice. He 
appears to believe that his therapist is working in his best interests but he does not 
seem to have fully bought into the treatment.  
On the other hand Eve’s responses in the interview were limited but she became 
more animated when talking about working with her therapist.  
R: “What do you think was the most helpful part of the treatment?” 
Eve: “Face-to-face sessions with [therapist] gave me the opportunity to talk through 
things that I have always been unable to talk about and to explore new ways of 
thinking and controlling my anxieties.”  
Here Eve expresses how trusting her therapist enables her to reveal more about 
herself. This is especially significant to Eve as she has not felt able to do so before. 
More importantly by making a choice to take this step, she is asserting her autonomy 
in bringing about change.  
There is a similar strand in this excerpt from Gail which gives an impression of 
enduring a painful experience over most of her life. 
Gail: “I know, I have had BDD since I was a child and suffered all my life with 
negative thoughts and had many forms of counselling and cognitive therapy to try to 
support me but sadly the treatment didn't work and wish I had of been offered this 





Gail’s experience of how others responded to her made her own struggle with BDD 
more difficult. There is a sense of regret and loss for all the years when her 
difficulties were not understood. Her account is tinged with relief that she has finally 
found people who recognise what her needs are and provide treatment that works 
for her.  
5.5.2 Building tolerance  
 
Being exposed to social situations was part of the interventions used in treatment. 
Four patients expressed their discomfort and distress of being in public and with 
other people, particularly fearing negative evaluation. However they also describe 
the experience of growing tolerance to the situation and what that came to mean to 
them. 
 
Betty’s account resonates with conflicting emotions. On one hand she feels 
vulnerable being forced to endure closeness to others. On the other hand she also 
awakens to her need to be part of the group. There is a sense of resentment of being 
in a situation out of her control but this gives way to feeling more relaxed as part of 
the community, no longer needing to hide away. 
 
Betty: “Just being in the inpatient environment was a good exposure for 
 my BDD as being around people was a difficulty at the time.”  
R:     “What was the difficulty for you?” 
Betty: “Just having to leave my room and people seeing me.” 
R: “What do you think was the most helpful part of the treatment? 
 “I think the most helpful part of treatment was the communal environment…”   
R: “Which aspects did you feel were not helpful?  
Betty: “I suppose the time limit on inpatienting but I understand why it is what it is, 
 but given the chance I would have stayed a little longer to try and complete 
 my final exposure tasks.” 
  
Betty’s initial distress has been overtaken by the greater need for creating bonds 
with others showing a direct link between learning to tolerate and establishing a 
connection. At the end of treatment the conflicting feelings arise again but from a 





ward community and having to face the world outside. There is a reversal from 
resenting the intrusion of others to wanting to cling onto the familiarity of the 
community she has come to feel accepted by. Betty also appears uncertain of being 
fully prepared to face the outside world. Treatment has become the safety net but 
she also recognises part of the recovery process is learning to trust herself to be 
able to put this into practice outside of the ward. 
 
There is a similar conflict displayed in Cathy’s responses which indicated intense 
feelings of fear and alienation around other people. 
 
R:         “Which aspects did you feel were not helpful?” 
Cathy: “It was difficult being on the ward.”  
R:    “What was difficult?”  
Cathy: “Being around other people when I hadn’t even been going out… but I guess 
it also helped with the exposure.” 
 
Similar to Betty, there is a sense of resentment of being “forced” into being in close 
proximity to other people. However this was in a more controlled environment than 
being in public places, which she seems to reflect on. Cathy is able to consider the 
benefits of the situation and used it to help her being around people. 
 
Alice also found therapy tasks difficult initially and the language she uses signifies 
the intensity of her experience. 
 
Alice: “Sometimes I found the homework exercises very upsetting but gradually I 
have become less fearful and the disgust with my appearance has decreased. It also 
felt good to learn to do things in a more “normal” way and I had a chance to discover 
that the earth would not swallow me up and others would not run screaming if they 
saw my body.” 
 
As a social being with a need to share a bond with others, Alice felt that she would 
be rejected. However in her description of tolerating the anxiety and recognising the 
deprecating views of herself are her own, she is taking the next step of allowing 





in keeping with the average person (“normal”). She takes enjoyment from re-
connecting with the outside world and starting to trust that others will not always 
reject her which is described as a monumental step. Her account sounds 
exaggerated but for Alice this is based on her own extreme reaction to her 
appearance.  
This strength of response is a common pattern in patients’ experiences as seen in 
the following extract: 
 
R: “What do you think was the most helpful part of the treatment?”  
Dan: “Think about something else instead of being absorbed by this idea that people 
are staring at you and the fact that we just talked about other people, their lives. You 
know, they’re not necessarily concerned with you. They’ve got their own lives to deal 
with. It helps to shift the perspective.”  
 
Part of treatment was going out to public places which highlighted anxiety Dan’s 
experience of being negatively evaluated by others. His use of the word “absorbed” 
describes the intensity of feeling and gives an impression that the anxiety takes over 
completely. He goes on to explain how he experienced the process of change. This 
happens with beginning to see others as individuals as well, rather than merely 
agents of negativity towards him. Dan has moved beyond tolerating the anxiety of 
being with others and is immersed into the world around him.   
 
Superordinate theme 2 
5.6 Taking a stand 
The themes previously described flow into the next phase of treatment: developing a 
stronger sense of self. Self-determination theory (Deci and Ryan, 1985) explores 
how people develop, what motivates them and how they maintain a healthy state. 
The theory also considers the intrinsic and extrinsic factors that play a role in this 
process (Ryan et al., 2000). The treatment offered by this service is focused on 







The concept of personal self is of having a clear, unitary awareness of who one is 
(Baumeister, 1998). One develops a sense of self through interactions with 
significant people in one’s life as well as experiences of the world. These 
experiences influence the perceptions of oneself and the development of a sense of 
self that guides one’s behaviour and views (Harter, 1999).  
Patients expressed their sense of self in a number of ways which also gave an 
indication of how they viewed and engaged with therapy. 
Fred’s account shows a stance being taken. 
Fred: “I felt many methods of targeting my BDD were attempted to see which one 
would be most effective for me.” 
The reference to BDD as “my” denotes BDD is seen as a part of the self. Treatment 
on the other hand is described from a passive stance rather than a collaborator. 
Treatment is expressed as something that was done to the patient which gives an 
impression of resistance to letting go of this “part” of the self despite the difficulties 
the disorder causes. 
Cathy also expresses having doubts when she started treatment. It is evident how 
intensely Cathy felt about her face and detached from accepting her face as part of 
herself. 
R: “How do you feel about the treatment you received for BDD?” 
Cathy: “I was not sure treatment could ever change the way I feel about my face. I 
felt that I didn’t want this face. But things have changed for me with the treatment.”  
R: “In what way?” 
Cathy: “I could still see things I wanted to change but I have moved away from the 
idea of not looking like me, which is a positive thing.”  
However in contrast to Fred’s account, Cathy uses the word (“my”) in a different 
context expressing an ownership of the treatment. The outcome is more progressive 





She admits to still having thoughts about changing her appearance but the intensity 
and meaning has altered. Her experience of progress is reflected in her acceptance 
of herself and being able to assimilate her physical appearance as part of herself. 
There is a sense of becoming a “whole” person with a merging of mind and body. 
The result is an altered perception of herself along with a sense of accepting and 
being more comfortable with who she is. 
At the other end of the scale, Dan epitomises the superordinate theme of taking a 
stand especially in his view of how appearance is portrayed generally in the media 
and what he believes is best for him. 
Dan: “When I came into the sessions, I came with the idea that looks are everything.  
I believe aesthetics have become very important in the magazines and TV. You just 
have to see TV, now we getting a bit like America, we have to get the really good-
looking people on TV, who get the majority of jobs, so I think it is putting pressure on 
people to conform to this sort of beautiful image. For me because of the sessions, 
whether other people think it’s right or wrong. I believe I have got my idea of what I 
want to have done under control. This is where it stops for me and that’s it really.”  
 
He has revised his sense of what he identifies with and has a new outlook on his 
previous view of wanting more plastic surgery (“what I want to have done…)”. Dan’s 
sense of confidence is palpable in dismissing what other people may think about his 
appearance. He clearly and strongly defines his stance. 
The patient’s accounts indicate positions along a continuum- from Fred who is 
ambivalent and resistant to change, Cathy who is initially struggling to engage but 
has progressed and Dan who is using therapy as effectively as he can. This leads on 
to the next aspect of the therapy process – to consider how patterns of engagement 
could impact on outcome. 
5.6.2 Owning treatment 
 
Delivering CBT is based on collaborative working with patients (BABCP, 2010). 
Patients need to be committed and willing to take responsibility for their treatment; 
however this is the best or ideal case scenario because patients may experience a 
variety of complicating factors which make it difficult for them to engage as 





those patients who take responsibility for their progress rather than expecting their 
therapist to do so are more likely to make improvements and carry this forward to 
longer-term benefit (Delsignore, 2008). 
   
The patients participating in this study describe varying degrees of ownership for 
their treatment. In keeping with findings in the literature, the accounts of patients who 
took more responsibility show a greater sense of achievement and a more positive 
outlook for their future. 
 
Betty’s remarks indicate ownership and involvement in her therapy.   
 
Betty: “I think the most helpful part of treatment was the communal environment, 
and also the emotional support from therapists and their help in creating set  
exposure tasks useful to me.” 
 
Betty used professional support provided but also took the initiative to consider 
aspects which can help her, such as the setting in which therapy was provided. The 
communal environment signifies an ongoing exposure exercise for someone with 
BDD but Betty views this as an opportunity to help herself.  
 
Similarly Eve takes the initiative to seek out self-help and from the use of words “I” 
and “my”, the emphasis in this extract is on her responsibility to progress. 
 
Eve: “The books I bought were also very helpful, following advice, on BDD and on 
assertiveness. My own notes are also helpful.” 
 
Her notes help her reflect on the process of therapy which is from her own 
perspective rather than the clinicians involved in her care.   
 
This theme follows on in Dan’s account where he demonstrates responsibility for his 
improvement whilst using support effectively.  
 
Dan: There are things that I found worked better for me. Simple things, you know, 
where you try to listen, listen to the things that are happening around you…. It also 






Dan took an active role in trying different interventions and deciding what he felt was 
most beneficial. Repetition of the word “listen” emphasises the focus on this skill that 
he has developed. Being actively involved in the process of reflection helped Dan to 
consolidate his learning experience. 
 
Taking ownership of the treatment feeds into the next subordinate theme which 




A central principle of CBT as described in 5.5.2 is to help patients become more 
autonomous which is shown to be most beneficial in aiding and maintaining progress 
(Ryan, Deci, 2008). Patients demonstrate a greater sense of achievement. Their 
comments invoke strong images of their struggle and their triumph.  
 
Alice offers a powerful depiction of how she sees herself taking control of her life and 
overcoming the disorder.   
 
Alice: “I can push aside the bullying thoughts of BDD. For the first time in years I  
also feel hopeful. BDD is a bully and a prison and now I am breaking away.” 
 
Therapy was a catalyst in making change happen. Alice acknowledges her own 
effort in creating a happier and healthier state of being. There is a sense of freedom 
and release with new purpose and an optimistic view of life.  
In a similar way Dan talks about how he used therapy to help himself.  
 
R: “Which aspects did you feel were not helpful?” 
Dan: “I don’t think there’s anything I didn’t find helpful, because, you know, just 
talking about things obviously helped but when you came up with ideas of what I 
could try and do, you try and try them and you know if it works for you or not. In the 






Dan places emphasis on the guided aspect of the therapy and the efforts he made 
as can be seen in the repetitive use of the word “try”.  He has used the treatment as 
intended; to develop his own coping skills and find his own way forward.  
Likewise Gail describes moving away from BDD and the benefits of making these 
changes. 
 
Gail: “When you have something like BDD you live in a bubble and get so caught up  
in rituals and checking, thinking you are helping yourself by carrying out these rituals  
but for only short term relief and then it comes back more intense, but in fact carrying  
out the different programmes makes you see things differently and working through  
and facing things does make things in the long term more manageable.”  
 
From Gail’s account, one gets the sense of being isolated and consumed by the 
disorder. She describes the distorted view of people with BDD who are caught up in 
destructive patterns. She sees this from another perspective now and despite how 
difficult it can be, she sees that dealing with the problem is the only way for 
sustained improvement. She gives the impression of determination and a strong 
sense of commitment to overcome her difficulties. 
 
Cathy’s words “feel safer” signifies how dangerous she saw the world. Feeling safe 
has meant avoiding being outside of her comfort zone and especially strangers, 
finding it difficult to trust that others will not harm her. 
 
R: What was the most helpful part of treatment? 
Cathy: “Doing the exposure programme with my therapist. Going out, to shops and 
public places I would have avoided before.” 
“I can go out, feel safer.”   
 
Cathy shows a drive to triumph over the fear and take back control: “I can go out”. 
This brings her underlying resilience to the fore. She will not be defined by her fear 








Superordinate theme 3 
5.7 A meaningful experience 
This set of themes relates to the experience of the journey through therapy. For most 
patients therapy is a significant experience in their lives. The decision to seek 
therapy is often filled with anxieties and preconceptions until they have a clearer idea 
of the therapy process. Therapy often involves challenging their behaviour and 
exploring aspects of themselves which can evoke intense emotions (Beck, 2011).  
5.7.1 An emotional experience 
The process of engaging with a therapist itself can evoke intense emotions. 
Alongside this is then working on the most difficult and fear provoking situations they 
can imagine. This demands a great deal of belief in themselves as well as the 
therapy (Beck, 2011). 
The following excerpt demonstrates the overwhelming emotion experienced by the 
patient recounting her journey from addressing her problems through to achieving 
change. 
Alice: “The coping strategies served as a constant reminder that I thought my body 
was disgusting and never gave me or others the chance to challenge these 
thoughts.” (Pause) R: Are you okay?  
Alice: “Yeah…Sorry.” R: That’s ok, take your time. (Participant pauses.) 
R: Are you ok to continue or do you want to stop here? 
Alice: “I’m ok, sorry. …I have become less fearful and the disgust with my 
appearance has decreased.” 
“The therapy has saved my life and remade it.” 
 
The intensity of negative feeling Alice experienced towards herself seems to 
overwhelm her when she recalls views of herself. The language used is intense: 
“disgusting” illustrating how extreme her self-view was. There is a lack of assimilation 
of her appearance into her identity. This lack of connection means her physical self 
is almost alien to her yet she is unable to get away from it which led to a sense of 
desolation and despair. Yet she describes a transformation through the course of 





Fred’s experience was overwhelming as well but related to his experience of the 
therapy techniques. 
 
Fred: “I felt that at times the treatment felt too much, especially with the regular 
exposures. Although it was very beneficial to my treatment and helped a lot, maybe if 
there were other less intense ways to introduce me into regular exposures it would 
have helped me gradually adjust more to the exposures. 
… to fully change one’s mindset is a challenging and daunting task. It became a bit 
off putting on occasion but I wanted to improve.” 
Fred’s experience of the interventions being too difficult is one expressed in the 
literature by patients who disengage from treatment (Folke, et al, 2012). There is no 
question that therapy is arduous especially when the problem has been ongoing for 
several years with severe impact on functioning. Fred finds addressing dysfunctional 
patterns of behaviour very difficult as these have been developed over the course of 
years as a strategy of “coping,” although it keeps him within the boundaries of the 
disorder. Fred expresses a dichotomy in his feelings about therapy whilst his 
expectations or possibly his view of the therapist’s expectations are unrealistic- “fully 
change one’s mindset…” which sets the scene for a lack of full commitment to the 
treatment. This pattern runs through most of Fred’s responses. 
Betty expresses her frustration at the loss of independence and a feeling of lack of 
control.  
R: Which aspects did you feel were not helpful?  
 
Betty: “I also found being given my medication by staff instead of self-administering 
frustrating, but then again I do understand why they might have to do it this way.”  
R: What would you have liked to be different in the treatment?   
Betty: “I can’t really think of anything but if really nitpick I would have liked less focus 
on drug treatments.”  
R: Why do you feel that way?  
Betty: “I went through a lot of changes of medication and side effects during my 






There is also a sense of resistance to medication as a treatment option as she 
continues to discuss her feelings about this. The feeling of loss of control continues 
into her further comments.  
5.7.2 Moving on  
The ending of treatment is a very meaningful experience in the patient’s care. This is 
the culmination of all that has happened throughout treatment whether progress is 
made or not (Weddington & Cavenar, 1979). The process of ending therapy in CBT 
is introduced from the initial meeting with ongoing encouragement to take 
responsibility for their treatment. This is in keeping with preparing the patient to 
become their own therapist (Beck, 1995).  
This excerpt from Gail is indicative of her embracing the approach and putting it into 
practice for a positive outcome.  
Gail: It was hard at times but worth persevering. I have managed to do things I 
thought would never be possible for me, like going on holiday and sitting on a beach. 
R: Are there any other aspects I have not asked about regarding your treatment that 
you would like to tell me about? 
Gail: “All I would say is I still have moments and things that l find difficult to face but I 
have the tools now to help myself and will do so if I am in the right place mentally, 
and as my therapist said you will have a blip now and then and that's normal refocus 
and carry on.” 
Gail’s experience is filled with evidence of her growth and progress. Her account 
shows a sense of achievement enabling her to have a better quality of life. Still she 
remains realistic about the course of the disorder and recognises there may be 
challenges ahead but she is better equipped to deal with that. Her outlook shows the 
potential for the improvements to be sustained beyond therapy.  
The patient’s views of their lives post-treatment is testament to how they see their 
development and learning as part of their way forward. In Dan’s view he sees himself 








Dan: “It’s also helped me with socialising, in social and work situations. 
I used to get stuck at mirrors, shop windows, it was always detrimental to me, it 
never helped. I don’t have that anymore. I probably look at mirrors like everyone 
else, probably less, look at my appearance, I’m a bit scruffy (laughs). I probably don’t 
look in the mirror as much as I should now!” 
 
Dan is able to laugh at himself now rather than having self-deprecating thoughts. His 
sense of self is more solid as someone who has grown and is instrumental in 
determining his own way forward seen in repetitive use of “I”. 
 
In reflecting on their experience, patients illustrated the contrast between their initial 
and end of treatment perspectives.  
 
Alice: “Before starting therapy I was filled with disgust and shame about the way I 
looked. …I feel like a different person and am happy for the first time in a long time… 
For the first time in years I also feel hopeful.”  
This contrast is vividly described by Alice giving an image of movement along a 
continuum from extreme self-loathing to acceptance of herself. The repetition of “first 






An exploration of the content of the patients’ interviews highlighted key interventions 
which may have influenced their experiences of treatment and is described in Table 
12.  
Table 12: Experience of specific interventions 
Interventions that were experienced as 
helpful  
Number who expressed this (N) 
Aspects of treatment experienced 
as unhelpful  
Number who expressed this (N) 
Exposure, eliminating safety  
behaviours (N= 6) 
Particular theoretical concepts (N=1) 
Attentional refocusing 
(N=2) 

















Out of seven patients, five stated that they did not find any aspect of treatment to be 
unhelpful. Two described what they felt was not beneficial.  
These factors were theoretical concepts of CBT for BDD; time limit to in-patient 
admission; medication and cognitive strategies. Interestingly the two patients who 
described aspects they felt were unhelpful showed the least amount of improvement 





functioning. From the analysis of these cases (Fred, Gail) detailed previously in this 
chapter their limited improvement raises further questions for investigation.  
The patients expressed how they used different interventions to help them make 
changes which they felt led to their improvement.  Despite behavioural tasks being 
described as difficult, it was clearly considered most instrumental in assisting change 
and also leading to altered perspectives supported by cognitive interventions. 
Activities of daily living skills were also considered an important factor in improving 
quality of life.  
Both respondents, who received inpatient treatment, expressed finding the ward 
environment difficult but again the exposure aspect of being in a communal setting 
was considered helpful.  
5.8 Discussion of Findings 
 
This was a fascinating exploration of patients’ experiences in their journey from 
starting treatment to beyond. One of the vital elements identified was developing 
trust. Patients acknowledged the importance of trusting in their therapist but also in 
themselves. Particularly when interventions are difficult to tolerate, trusting that the 
therapist will support them through it is an important part of maintaining engagement 
and could play a part in positive outcome (Bohart, Elliott, Greenberg and Watson, 
2002). The literature also suggests that patients who feel understanding and 
empathy from their therapist are more likely to engage fully in the treatment 
(Lambert, Barley, 2002).  
 
BDD sufferers endure an extremely disabling impact on their lives so treatment is 
geared to improving symptoms of BDD as well as overall functioning. The emotions 
flowing across these accounts range from intense fears, dread and anguish to joy 
and strength but also resistance and feeling overwhelmed. The majority of patients 
described improvements and benefits from treatment. However there were patients 
who made limited progress and found treatment difficult. Patterns found in their 
accounts mainly indicated less collaboration resulting in limited responsibility 
accepted for treatment; difficulty tolerating the interventions and not being fully 
committed to treatment. Although this sounds as though all the responsibility for 





whilst preparing the patient to become more accountable to themselves through 
learning the skills they need to become their own therapist (BABCP, 2010). However 
for some patients this process did not fully occur which indicates that other 
approaches could be useful where CBT and medication have not enabled progress 
(RCPSYCH, 2018). Further research is required into alternatives when patients find 
it difficult to engage in CBT e.g. motivational interviewing techniques (Miller, Rollnick, 
2002; Wilhelm, et al., 2013). 
However BDD treatment options are still limited as there is both a lack of research 
and knowledge about BDD (Phillips, 2000). This is further illustrated by patients’ 
reporting their experience of BDD not being understood and difficulty accessing 
appropriate treatment. Patients express their frustration and sense of loss for years 
spent trying to find treatment but also gratitude for finally receiving treatment that 
addresses the BDD. Gratitude has two strands – the first is recognising the positive 
interactions of others to benefit oneself and the other is of a more general nature 
regarding what is meaningful in one’s life (Armenta, Fritz, Lyubomirsky, 2016). 
Patients were grateful for treatment they received but they could also recognise the 
part they played in making change happen. Gratitude can play a role in encouraging 
people to make constructive changes by motivating them to behave more 
benevolently and reduce destructive behaviour patterns (Emmons, Mishra, 2011; 
Bono, Emmons, Mccullough, 2012). It is linked with experiencing “positive 
psychological states, much like contentment, pride, and hope” (Giacomo, et al., 
2012: Chpt. 33: pg. 560.) 
 
 A number of positive emotional and social outcomes, such as increased feelings of 
connectedness and greater perceived social support can arise from the feelings of 
appreciation (Wood, Maltby, Gillett, et al., 2008; Giacomo, et al., 2012). Developing a 
connection with others was a key part of patients’ experiences of progress. Gratitude 
served as a key indicator of the change in perception of patients’ relationships with 
others where they regarded their therapists as the source of helping to improve their 
quality of life which then extended to others in their network for example, fellow 
patients on the inpatient ward and recognising the value of connecting with others. 
A thought-provoking exploration of identity shows patients experiencing significant 





strength and confidence in how they see themselves. This seems to be a critical 
factor in their progress. Those patients who experienced significant improvements 
described a greater level of self-esteem and confidence than those who expressed 
difficulty engaging in the treatment. The development of a sense of self appears as a 
product of the therapeutic process rather than an aspect specifically targeted in 
treatment. 
It was important to minimise misinterpretation of data, therefore significant 
statements were identified in context of the entire interview and coded according to 
what the patient appeared to emphasise. The aim was to avoid interpreting data to fit 
categories or coding types. Instead larger extracts were quoted as examples to 
provide a context for statements coded so that patients’ experiences were not 
misinterpreted e.g. where they used humour or irony. The analysis was an iterative 
process through which codes and themes were considered several times and either 
kept or discarded before finally being written up.  
The overall conclusion is that treatment was largely well-received and although 
patients found the techniques difficult, in some cases they were able to use these to 
extremely good effect. From their accounts it also appears that these improvements 
are sustainable as they have the tools to continue to address difficult events in their 
lives post–treatment. However it also highlighted areas for development in the 
current treatment recommendations particularly for patients who find the techniques 
too difficult or are unable to use the treatment when there may be complicating 








Phase 3: Thematic analysis 
How clinicians treating patients with BDD experience the 
application of the NICE (2006) guidelines for OCD/BDD 







This chapter is the third phase of analysis focusing on findings from clinician’s 
experiences of providing treatment for BDD. The analysis process has been 
described in the previous chapter (5.2) but additional information will be explained 
concerning this sample. As the team is small, the description of the clinical staff who 
participated in the study will be brief to maintain anonymity. To promote 
transparency, the process of coding and arriving at themes is displayed in Table 14. 
Superordinate and subordinate themes extracted from the interviews are illustrated 
in Figure 8. An excerpt from a HCP’s transcript providing an example of the process 
involved in coding is included in Appendix T. As in chapter 5, each superordinate 
and subordinate theme is described and interpreted supported by quotes from 
participants.  
Language is the participants medium to express meaning and experience 
(Widdicombe, Wooffitt, 1995). It is argued that how language is interpreted cannot be 
separated from the researcher’s perceptions and own experiences in the process of 
analysis (Trochim, 2006). Therefore as previously explained the approach taken to 
report data reflects the researcher’s interpretation (3.7.1., pg. 91).  
 
6.2 Data analysis 
 
As in patients’ interviews, audio recordings were made to ensure accuracy. The 
difference with the samples was that clinicians could be approached to verify 
transcripts. Early on in the interview process, it was deemed necessary to provide an 
additional reassurance to clinicians to address any concerns that their knowledge of 
the NICE guidelines was being evaluated. This was noted following the first 
participant’s comments about not having read the guidelines lately. A standard 
statement was therefore relayed at the start of each interview: 
“This interview is designed to gather your experiences and views as clinicians in 
treating patients with BDD using the NICE guidelines. This is not a test of your 
knowledge or expertise”.  
 
6.3 Clinician participants 
The sample of clinical staff (N=10) responsible for treatment were interviewed for the 





of the staff members but the individual was fluent in English and comfortable being 
interviewed in this medium. The clinicians’ experience in this field ranged from 5 to 
25 years. Four worked in the outpatient service, two worked across both in- and 
outpatient services and four worked with the inpatient service. 
Given the size of the team is small; a more detailed description of the clinicians 
would not be possible without compromising confidentiality and anonymity. Table 13 
describes the service provision for step 5 and 6 of the NICE guidelines (2006) also 
described in Fig 2. The clinicians will be referred to as (health care professional) 
HCP and denoted by a number to preserve anonymity. Also due to the male: female 
ratio being very small the gender neutral “they” will be used. 
Table 13:  Provision of Stepped care model (NICE, 2006) 
Feature of model        Step 5       Step 6 
Focus of care Outpatient (Regional) Inpatient (National) 
Duration 20-30 sessions Average 4 months – maximum 
6 months 
Method of delivery 1:1 face to face 1:1 face to face; group; 24 hour 
nursing care 
Treatment offered CBT, medication, EMDR, 
Family work 
CBT, medication, EMDR, family 
work, OT. 
Level of severity YBOCSBDD>20 YBOCSBDD >30 
Treatment provided by CBT, medical staff. CBT, nurses, OT, medical staff 
How service is accessed IAPT, CMHT referrals CMHT referrals only 
 
The main difference in service provision relates to the level of severity (Fig 2, pg. 
22). Patients at step 6 require 24 hour nursing care due to the severity of their 
disorder causing them significant functional impairment; risks to themselves or 
others and /or complications due to co-morbidities. Service criteria also require that 
patients at step 5 and 6 will already have had previous CBT and medication. In-
patients have the benefit of additional support through the communal environment 










Organisational requirements  
Organisational restrictions 
Pressures of organisation 
Lack of resources  
Time constraints  
Guidelines 
Policies 









Limited public awareness  
Not sensitive to patient experience 
Restrictions 
Meeting service delivery aims 
Organisational aspects  
Service requirements 
Clinical provision 
Providing clinical service 
Service delivery 
Lack of opportunity for learning  
Holistic view 
Patient-centred 










Belief in treatment model  
Dissatisfied  
Inadequate treatment options  






Belief in treatment 
Values, principles 
 












Lack of early intervention 
Difficulty in tolerating treatment 
Perceived patient experiences 
Therapeutic relationship 









Incorporating other interventions 
Carers or family involvement  
Limited cognitive shift 
Empathy 
Supportive  
Unrealistic expectations  
Patient response 
Improving functioning  
Improving quality of life 
 
6.4 Themes 
Three superordinate themes were identified from the clinicians’ transcripts with four 
subordinate themes associated with them.  
These are illustrated in Fig. 8. 
 








































Superordinate theme 1 
 
6.5 Service delivery 
 
 
Clinicians practicing in this specialist service are required to have sound knowledge 
and expertise of BDD. In addition they provide training, supervision and consultation 
to other healthcare professionals in assessment and treatment of BDD. Furthermore 
given the dual nature of the specialist unit both the NHS Trust’s and NHS England’s 
requirements need to be met in delivering the service (Table 13). Treatment delivery 
follows the NICE (2006) guidelines stepped care model and the Service is cited as 
an example of translating theory into practice on the NICE guidelines website (Figure 




6.5.1 Providing clinical services 
 
The service provides specialist consultation/supervision as required at each level of 
severity in the stepped-care model. Although focus in assessment and treatment is, 
as previously described at level 5 and 6 (Table 13).  
 
HCPs generally indicated positive views of following the NICE (2006) guidelines in 
providing clinical services for BDD. However there are also suggestions of 
dissatisfaction plus doubt that the guidelines are comprehensive enough. This is 
illustrated in the following excerpt from HCP10. The initial statements feel apologetic 
about their limited experience which may be a precursor to the uncertainty 
expressed.  
 
R: “What do you think about current guidelines for treating BDD? 
HCP10: “I don’t have an awful lot of experience to be honest, because I haven’t  
been here for too long. The guidelines seem to work pretty well from what I  
can tell. I don’t really have any positive or negative thoughts about it.” 





HCP10: “Fine. It’s good having the guidance there. I think without it could feel quite 
overwhelming. It gives us more confidence in using the treatments and things like 
that.” 
 
They go on to describe feeling reassured by having the guidance but an indication of 
how challenging the HCP finds it working with this disorder is expressed with the 
“overwhelming” feeling.  
 
The sentiment of being reassured by the guidance is echoed in HCP7’s comments 
but also tinged with some doubt as to relevance for BDD opposed to OCD. However 
the HCP acknowledges this is the only evidence-based guidance for BDD at present.   
 
R: “What do you think about current NICE guidelines for treating BDD?” 
HCP7: “They’ve been well thought through, and they are helpful in guiding what 
treatment is appropriate for BDD by taking you through the different pathways. I don’t 
know if they’re as helpful for people with BDD than OCD but I don’t know what other 
type of help is out there.”  
R: “How do you feel about following the NICE guidelines?” 
HCP7: “It’s helpful to know that there is evidenced based treatment. And it lets you 
know that there’s a strategy around the disorder. So, I do find them helpful as a  
guidance.” 
 
Some of the views of providing a service based on the sole guidance available for 
BDD shows a concern that there is insufficient evidence-based research of BDD to 
make the guidelines as comprehensive as they could be. 
 
HCP6’s comments echo this.  
 
R: “What do you think about current guidelines for treating BDD?” 
HCP6: “There is a relative lack of good quality, adequately powered research in 
BDD. Despite this the current guidance does seem to cover the main therapeutic  








Similarly HCP4 and HCP1 expressed this concern: 
 
R: “What do you think about current NICE guidelines for treatment of BDD?” 
HCP4:”I think the guidelines are helpful but not all patients fit into the 
recommendations.  
R: “How do you feel about following the NICE guidelines?” 
HCP4: “I try to follow them but the complexity of patients with BDD means we need 
to use other interventions.” 
HCP4 recognises that the guidelines provide some recommendations but cannot be 
used as a protocol of treatment as patients require a needs-led package of care. 
 
This is mirrored in HCP1’s comment. 
 
R: “What do you think about current NICE guidelines for treatment of BDD?” 
HCP1: “I think it’s quite good, the only problem that it doesn’t take into account is 
that most of these people have associated conditions, like personality disorders and 
such.” 
 
There is a sense that HCP6, HCP4 and HCP1 are appreciative of having guidance. 
However all three voice concerns that the guidelines are not comprehensive enough 
particularly when comorbidities with additional needs are present. 
 
Furthermore some HCPs seem especially affected by the difficulties patients with 
BDD have in using the treatments recommended. The response of HCP2 expresses 
dissatisfaction with the use of the guidelines despite reluctantly admitting that 
medication helped (“…to an extent…”). The emphasis is on the lack of benefit as 
shown in repeated statements to this effect (“…never really changed…”; “…didn’t 
make any huge progress, by no means”; “…she didn’t feel like she made any 
difference”).  
 
R: “What do you think was most beneficial in treating patients with BDD? 
HCP2: For one lady who had BDD on our ward awhile back, I would say it was the 





did the exposure work but still felt very anxious after it, and that never really changed 
for her. So, medication helped with her, to an extent, to engage with the CBT and OT 
work. But she didn’t make any huge progress, by no means. There was some 
difference, but she didn’t feel like she made any difference”. 
The HCP’s perception of how the patient responded generated strong emotions in 
the HCP and contributes to the sense of frustration and helplessness. 
 
Similarly HCP8’s impassioned views show dissatisfaction with the guidelines 
informing service delivery.  
R: “What do you think about current NICE guidelines for treating BDD?” 
HCP8: “I don’t pay too much attention to them to be honest. I have read them a while  
ago. They recommend CBT, but they’re not very specific about what to do. And 
they’re lumped with OCD. I think BDD needs its own NICE guidelines independent of 
OCD. The evidence for medication is different. And also the specific CBT methods 
are different. There are some similarities, but there’s very little research out there. I 
would say they’re vague and they don’t influence my practice massively.  
R: “How do you feel about following the NICE guidelines?” 
HCP8: “I do follow them, and as a team, we do follow them. But because they are  
vague, I feel indifferent.” 
 
The use of the word “lumped” to describe the combined guidelines shows frustration 
and the feeling that BDD is disregarded as a serious condition. The HCP responds to 
the guidelines by not paying them “too much attention”. The HCP feels BDD needs 
consideration in its own right but instead has been subsumed into the guidance 
without allowing for ways BDD differs from OCD. Feeling “indifferent” is not a true 
reflection as the preceding comments indicate strong feelings of discontent. Although 
when seen in context – it is a way of conceding that the team has to follow the 
guidance as the service model is based on the NICE (2006) guidelines but as a 
clinician they do not feel it informs their way of working. 
 
There are no clear evidence-based alternatives if the patient does not benefit from 
the recommended treatments. This could lead to HCPs experiencing frustration and 





the guidelines are helpful, one gets the increasing sense that in practice the 
clinicians find the guidance inadequate to inform clinical service provision for BDD. 
 
6.5.2 Clinical challenges 
 
The specialist service was re-modelled in accordance with the NICE stepped care 
model to ensure that patients throughout the spectrum of OCD/BDD symptoms 
receive optimal evidenced-based treatment (Drummond et al 2008; Boschen et al., 
2008). This has been easier met for OCD with the service producing numerous 
research articles and presentations on standard and novel approaches to treating 
OCD over a number of years (Govender et al., 2006; Turner, Drummond, 
Mukhopadhyay et al., 2007; Boschen et al., 2008; Boschen et al., 2010; Drummond 
et al., 2012). On the other hand, the focus on BDD is markedly limited within the 
service (Tyagi et al., 2013; Govender et al., 2017). 
One of the challenges highlighted is the limited referrals of patients with BDD. This 
HCP emphasises the need for health care professionals to be more aware of BDD.  
HCP7: “If you’re in the profession and you know about it, that’s fine, but if  
you’re not; I don’t think people in general know a lot about BDD. So, for example if 
health professionals could know more about them, then they would know the right 
things to ask people, in terms of their symptoms and directing them accordingly.” 
 
The lack of awareness generally and within health care is one of the reasons people 
with BDD are misdiagnosed and the disorder goes unrecognised (Phillips, 2008). 
This perspective is expressed in the following excerpts: 
R: “How do you feel about following the NICE guidelines?”  
HCP1: “Maybe I don’t treat enough patients with BDD to really know. In the past 
year, I only treated 1 patient with BDD.  
R: “Is there anything that I haven’t asked you about treatment provided by the 
service for BDD that you would like to discuss?” 
HCP1: “..we have very few that manage to get here to be treated by us. So the only 
cases of BDD that were getting to us were the ones that needed 24 hours care, that 





The HCP expresses a feeling of helpless in trying to provide a service for BDD 
patients. The words “few…manage; only cases…getting to us” emphasis this feeling 
that there is an abyss between the patients and the service. Those who are referred 
have declined further into the course of the disorder with so much impairment in 
some cases that their needs require inpatient admission with nursing care.   
HCP6 also voices this view expressing concern that the stepped care model may 
actually cause a delay for these patients who need specialist help. 
R: “How do you feel about following these guidelines?” 
HCP6: “In general they make sense but I am concerned about a few patients who 
are extremely ill from the start and who have to wait to proceed through the stepped- 
care model whereas they may be best served by moving rapidly into more 
specialised services.” 
Where the appropriate treatment is not available, the patient care pathway does not 
indicate a clear process for patients to advance through to access a suitable service. 
HCP8 also expresses concerns about the limited number of referrals and links this to 
limited awareness.  
R: “Is there anything that I haven’t asked you, about treatment for BDD provided by 
the service that you would like to discuss? 
HCP8: “We’re not getting as many referrals at the moment, it’s really reduced. …I 
don’t think people in the CMHTs recognised BDD as something they would ask 
about when assessing patients. …So, it’s could be there are people out there with 
BDD, undiagnosed, untreated and suffering. And that’s down to public awareness, 
GP awareness and I think we need to be doing more at that level. …But because 
we’ve been understaffed, we haven’t gone out and sought any extra referrals. I think 
we could put together a pack on how to treat BDD, like a type of manual. We advised 
referrers for our group to use those screening questions from NICE, if they were 
unsure. So, the feedback was that was really helpful for some people to have those 
pointers. Our service is known, and we have BDD in our title, so I would have 
thought that professionals in our trust know about us, so I don’t know why our 
referral rate has dropped. There may be just a lot of people misdiagnosed.” 
From the HCP’s experience, providing information on how to screen for BDD has 





being unable to help “…those people out there with BDD, undiagnosed, untreated 
and suffering.” However there is also recognition that more could be done to promote 
awareness and disseminate knowledge but resource constraints make this 
challenging. The HCP is reduced to working on the assumption that people will know 
where to refer as “…we have BDD in our title.” 
One of the factors to ensure people with BDD receive the help they need is early 
intervention which could promote better prognosis and a better quality of life. Given 
the onset of BDD symptoms tends to be adolescence, it follows that this is a crucial 
phase when information should be made available (Phillips, 2008).  
HCP4 emphasises imparting knowledge to young people to promote early 
intervention.  
R: “If given the opportunity, how would you improve on the NICE guidelines for 
BDD?” 
HCP4: “I haven’t read them recently, but I would want to catch it earlier. So more  
education in schools, more of an acknowledgment of how the current media, social 
media and TV have massive impact on younger people’s views of their appearance.” 
 
HCP4 also considers the influence of the media and a generation that has grown up 
in the age of social media. In addition to direct interpersonal communication, 
Generation Y and Z view relationships in terms of virtual communication 
(Subrahmanya, Greenfield, 2008; Bolton, Parasuraman, Hoefnagel et al., 2013; 
Buzzetto-Hollywood, Alade, 2018). This needs to be recognised for possible 
implications for teens with BDD to avoid interacting in the tangible social arena 
(Czincz, Hechanova, 2009). 
 
A similar thread runs through HCP7’s views, highlighting earlier intervention. 
 
R: “If given the opportunity, how would you improve on the NICE guidelines for 
BDD?” 
HCP7: “I would want the NICE guidelines to work for younger people. I think 
strategies that help earlier on in life, with boys and girls, with BDD, self-esteem and  





already got the disorder, you’ve kind of missed the boat. So, things like self-
confidence classes, and promoting more self-awareness, at a time where people are 
more vulnerable would be something I would like to improve on.” 
 
There is an indication of feeling that more could be done and wanting to be 
instrumental in this with the use of “I” rather than a general statement of areas to be 
improved on. The HCP sees BDD as more difficult to address once the patient is an 
adult as the more malleable developmental stages have passed.  
 
Additional challenges are found in trying to provide interventions which are specific 
to the disorder whilst working within organisational policies. HCP1 described feeling 
unsupported by the organisation in aspects of their clinical work. 
 
R: “What do you think was least beneficial in treating patients with BDD?” 
HCP1: “The inability of the NHS to provide proper tools to work, like mirrors. So, we  
were unable to apply part of the CBT type treatment. We had all these plastic 
ones that were so distorted, I was afraid to look in them (exclaims). We tried to bring 
some better ones, but were told that we couldn’t use them, as they would be 
unsafe to use with patients.” 
 
The idiosyncratic nature of the disorder requires specific tools however in 
accordance with Trust’s health and safety protocols, glass mirrors are not allowed in 
clinical areas. The HCP expresses frustration at these restrictions. From the HCP’s 
response, one senses the ridiculousness of the situation when plastic mirrors reflect 
a distorted image making it more anxiety-provoking for patients who already have a 
distorted view of themselves.  
 
The unique nature of the service based on the NICE guidelines (2006) also poses a 
challenge when HCPs consider the recommended treatment does not meet the 
individual needs of the patient. 
 
R: “Is there anything that I haven’t asked you about treatment provided by the 





HCP2: “There was another BDD patient that the treatment worked really well for. So, 
it goes to show if you do have someone that is driven and engages with the model, 
they can progress. And she reached the top of her hierarchy. But for me, I’ll always 
remember the other person that really struggled with the suggestions and found it all 
too extreme for her. So, perhaps it is about accepting where the patient is at and 
finding out what they can and can’t do. And maybe further down the line, they might 
be able to push their boundaries and challenge it. When dealing with someone’s 
appearance, I think the exposure practice that we do for BDD patients’ touches such 
a raw nerve, that we should be a bit more sensitive to that. This particular patient 
had other diagnoses that impacted on how she engaged with the model, like 
depression and personality traits that made things more complicated. But I think 
most BDD patients would have found the suggested exposures quite difficult.” 
HCP2 recalls a patient who progressed with treatment giving credence to the 
effectiveness of the treatment guidelines. However the HCP finds the experience of 
working with a patient who did not benefit from treatment more profound. The 
language used to describe how the HCP perceived the patients’ experience e.g. 
“touches such a raw nerve” indicates the intensity of the HCP’s experience. The 
HCP is frustrated, feeling the patient is not really being heard and the treatment 
protocols expected to be followed not sufficiently taking complicating factors into 
account. 
 
Even for those HCPs who seem more signed up to the treatment guidelines, they still 
question aspects of the approach meeting patient’s needs and the lack of sufficient 
research in treating BDD.   
R: “Do you think that there’s anything that you’ve used in treating BDD that hasn’t 
been beneficial?”  
HCP3: “There have been patients who were unable to deal with certain types of CBT 
due to becoming increasingly dependent and not being able to tolerate the stress of 
the therapy.” 
 “It almost reaches that level of severity to the point that a person has lost insight 
completely. And I think that that can be quite difficult to work with. So someone might 
see disconfirmation around them, but that still wouldn’t change the rigidity they 





levels don’t go down and they don’t habituate because it’s such a fixed belief that 
they hold and it’s not likely to change. I think that is something the CBT literature and 
training could talk more about. The delusional nature of it, people not habituating, 
anxiety not going down and is that because of emotional dysregulation, distress 
intolerance, is it their rigid beliefs always driving their anxiety and it doesn’t change?  
It’s not to say CBT doesn’t work, but to say that it is an area for development.” 
 
The HCP’s initial response places more responsibility for treatment effectiveness 
with the patient yet recognises the process is stressful. As they continue to reflect on 
their experience, they begin to question why interventions are not always effective. 
By the conclusion of this response, the strength of conviction is reduced with 
recognition that some factors in BDD are not being addressed by the current 
treatment guidelines: “it is an area for development”. Once again the concern is 
raised about insufficient research and training.  
 
Superordinate theme 2 
 
6.6 Clinical role identity 
 
It is important to explore the clinicians’ role identity regarding their clinical functions 
especially since the team has diverse expertise (Blake, Ashforth, Harrison et al., 
2008). A strong role identity has been linked to values and beliefs that influence the 
clinician’s performance of their roles and interaction with other team members and 
patients (Gilburt, 2016). This pattern has been observed through the responses of 
the HCPs which could have implications for patient outcomes which will be 
discussed in the synthesis chapter.  
 
6.6.1 Beliefs and values  
 
HCPs interviewed expressed varying degrees of confidence in the treatments for 
BDD and the treatment guidelines. Their responses indicated their values regarding 





This excerpt from HCP3’s interview shows a passionate belief in the treatments 
provided and seems defensive to any suggestion of lack of benefit.  
R: “Do you think that there’s anything that you’ve used in treating BDD that hasn’t 
been beneficial?”  
HCP3: “Every treatment we do has been useful; it’s just a matter of if the patient is 
able to maintain it.” 
“Patients that are able to tolerate their stress and regulate their emotions are able to 
engage better with the standard CBT therapy and get the most from it.” 
“To me, it’s less about the CBT technique and process and more about the individual 
and how they’re able to engage with the therapy itself. These are more client factors 
rather that CBT factors.” 
 
The HCP describes CBT almost beyond reproach with the patient needing to fit in 
with it. One of the essential performance objectives is to follow a patient-centred 
approach. However from HCP3’s response, the strength of belief in the technical 
aspects of the clinical intervention has overshadowed the principles of practicing 
collaborative working. 
HCP9 on the other hand seems less embedded in the approach and expresses a 
need to adapt treatment to engage patients.  
 
R: “What do you think was most beneficial in treating patients with BDD?” 
HCP9: “When people are very fixed in their beliefs with BDD, it’s good to work on a 
motivational level to improve on their quality of life. I would work more on the 
motivational and recovery side of things, rather than pushing people too far with 
exposure treatment in the first instance. To get a good formulation, gauge 
someone’s motivation and to do a good piece of cognitive work before going into 
exposure side of things is really beneficial for me.” 
 
The HCP is flexible with their approach which is: “...beneficial for me” indicating a 
sense of feeling comfortable with this approach.  Despite the service demands for 
showing improvements at specified stages in treatment the HCP prefers to work 






HCP8 also considers the guidelines for BDD need more clarity as it seems to be 
overshadowed by OCD. The HCP also expresses their view on media influences 
which they see as promoting the ideal appearance. 
 
R: “If given the opportunity, how would you improve on the NICE guidelines 
for BDD?” 
HCP8: “I would have separate guidelines as a first. The treatment that IAPT offers 
should specify what could be offered at each step. And to have clearer guidelines on 
medication. I don’t think it’s completely clear on what there is evidence for.” 
“Also, more public awareness about BDD, maybe steps 1 and 2. Just labelling it. 
There’s a lot on telly about beautiful bodies and surgery etc. but I don’t hear about 
BDD in the media. In an ideal world, there would be more awareness about BDD as 
a separate condition and what it involves and the treatment available for it.” 
 
Again lack of awareness and insufficient research is highlighted. HCP8 also 
reiterates their call for separate guidance for BDD.  
 
Despite their concerns, the HCPs also express their dedication to the service and 
their belief in the therapeutic approach. HCP5 expresses a fervent belief in using 
CBT as a whole approach rather than separating the cognitive and behavioural 
aspects.  
 
R: “If given the opportunity, how would you improve on the NICE guidelines 
for BDD?” 
HCP5: “I’m unconvinced that long term cognitive therapy in isolation would be 
helpful, for instance, unless it was also accompanied by some robust exposure work. 
I think it’s a profoundly under researched condition, but because of the presentation 
of the client it’s easier to do less difficult therapy. When you’re asking people to put a 
spot on their face, and go out with it on their face, I think it’s really difficult for 
patients, but I also think that it’s very important at the same time. When I’ve attended  
workshops in the past, it’s been quite clear that people who’ve worked with patients 
specifically with BDD -that cognitive therapy on its own, isn’t going to cut the cake. I 
think therapist tend to go with the easy option because it makes them anxious 





don’t want to get their hands dirty. I think to them, therapy is talking therapy and 
getting your hands dirty is something that they struggle with. But I really feel that that 
doesn’t help the client.” 
 
The HCP recognises how difficult the behavioural techniques can be for patients but 
also with commitment it shows positive results. Interestingly the HCP observes that 
therapists may avoid techniques such as ERP as it raises patients’ anxiety levels. 
Therapists need to recognise their own unease and address this in order to help 
patients tolerate then manage anxiety. Otherwise they are merely colluding with the 
patient’s safety behaviours or avoidance.  
 
6.6.2 Clinical performance    
In carrying out their clinical roles, team members have to meet their professional and 
organisational requirements (BABCP, GMC, HCPC, SWLSTG). In addition the 
service identifies specific treatment objectives for clinical staff and these are 
evaluated in their supervision (individual and peer group); case reviews; ward rounds 
and annual reports. Being a specialist service offers a unique position to provide 
longer-term treatment, however there are still expectations that therapy should not 
exceed 30 sessions. Clinicians are expected to provide evidence for therapy to 
continue when 20 sessions has been reached. This also applies to inpatient 
admission with a maximum stay of 6 months. Regular reviews are held at specified 
intervals in treatment to ascertain engagement and progress. Although a degree of 
autonomy is expected from clinicians, there are also clear service boundaries within 
which to operate (SWLSTG, 2010).   
Linking the values and beliefs expressed by HCPs with the emotional content of their 
responses gave a fascinating insight into how they see their role within the team 
whilst trying to meet the clinical objectives of the service.  
HCP2 displays flexibility in considering the patients’ care in holistic terms. 
HCP2: “So, this BDD patient would come to [  ]. Some of which will have an ERP 
basis to it and we used a CBT approach. We also used meaningful engagement and 
activity. Other strategies such as distraction, looking at activity scheduling, 





worked with families, but we would try to include them as much as possible in their 
treatment, because sometimes people can get family to collude with their BDD. And I 
think there is a need for the family to be involved because of the understanding of 
the disorder.” 
 
HCP2 takes a more holistic approach although still remaining true to the 
recommended treatment. The emphasis is on collaboration and “meaningful 
engagement” rather than offering a treatment option that the patient has to comply 
with. In this extract, the HCP is clearly integrating the concept of being patient-
centred into the treatment approach. Taking this position resonates more with HCP2 
than focusing on patient’s outcomes with standard recommended interventions such 
as ERP.  
 
It is explicit in the NICE documentation that recommendations are for guidance to 
promote best practice rather than to replace professionals’ clinical judgement (NICE 
2018). Although the HCPs interviewed conveyed this in their responses on practice, 
they also voiced frustration with limited clinical options available for treating BDD, as 
seen in the following extract: 
 
HCP2: “From my little experience from the two BDD patients we’ve had here, one 
patient didn’t find the exposure particularly useful and the manner in which the 
treatment was done. And I personally, I found the work I was trying to do with her 
quite challenging. I don’t think it fits quite as well as it does with OCD. …but there is 
no other recommendations in terms of treatment, as far as I know.” 
R: “What do you think was least beneficial in treating patients with BDD?” 
HCP2: “With the ERP approach, I think sometimes it can be too challenging and 
sometimes, what we were suggesting for the patients was too much. Maybe that’s 
something to learn from.” 
This extract reveals a lack of assurance about the effectiveness of treatment options. 
They express feeling there are insufficient opportunities to develop experience as 
few patients with BDD are coming through to the service. There is also a sense of 
dissonance – the HCP is aware of what the treatment recommendations are and 





with BDD. Repetition of “I” indicates the personal impact on the HCP in trying to work 
within this model and the frustration that there are no other options. They describe 
feeling the guidelines are more suited to OCD but do not adequately fulfil needs for 
BDD patients. Furthermore the service model putting it into practice does not take 
this into account. 
In this extract HCP5 also comments on the guidelines being more comprehensive for 
OCD with less clarity for BDD. The HCP states they find BDD more difficult to treat 
than OCD and would welcome more detailed guidance for treatment options. 
 
R: “If given the opportunity, how would you improve on the NICE guidelines for 
BDD?” 
HCP5: “Clearer evidence-base on what really does help. So just breaking things  
down a little bit more, with the use of CBT and medication. Certainly, with the  
guidelines for OCD, they are quite specific about ERP. I personally think  
that BDD is a difficult condition to treat, more difficult than OCD. I think the  
guidelines should be more explicit about what helps and what definitely  
doesn’t help in terms of CBT.” 
The HCPs’ responses generally indicate they feel a need to adjust their approach to 
engage patients or to offer something different using their core skills rather than 
following the recommended treatment. 
 
HCP8 also considers the guidelines for BDD need more clarity as it seems to be 
overshadowed by OCD. The HCP also expresses their view on media influences 
which they see as promoting the ideal appearance. 
 
R: “If given the opportunity, how would you improve on the NICE guidelines 
for BDD?” 
HCP8: “I would have separate guidelines as a first. The treatment that IAPT offers 
should specify what could be offered at each step. And to have clearer guidelines on 
medication. I don’t think it’s completely clear on what there is evidence for.” 
“Also, more public awareness about BDD, maybe steps 1 and 2. Just labelling it. 





BDD in the media. In an ideal world, there would be more awareness about BDD as 
a separate condition and what it involves and the treatment available for it.” 
 
Again lack of awareness and insufficient research is highlighted. HCP8 also 
reiterates their call for separate guidance for BDD.  
 
Despite their concerns, the HCPs also express their dedication to the service and 
their belief in the therapeutic approach. HCP5 expresses a fervent belief in using 
CBT as a whole approach rather than separating the cognitive and behavioural 
aspects.  
 
R: “If given the opportunity, how would you improve on the NICE guidelines 
for BDD?” 
HCP5: “I’m unconvinced that long term cognitive therapy in isolation would be 
helpful, for instance, unless it was also accompanied by some robust exposure work. 
I think it’s a profoundly under researched condition, but because of the presentation 
of the client it’s easier to do less difficult therapy. When you’re asking people to put a 
spot on their face, and go out with it on their face, I think it’s really difficult for 
patients, but I also think that it’s very important at the same time. When I’ve attended  
workshops in the past, it’s been quite clear that people who’ve worked with patients 
specifically with BDD -that cognitive therapy on its own, isn’t going to cut the cake. I 
think therapist tend to go with the easy option because it makes them anxious 
because the patient gets so anxious. And I also think a lot of therapist in essence 
don’t want to get their hands dirty. I think to them, therapy is talking therapy and 
getting your hands dirty is something that they struggle with. But I really feel that that 
doesn’t help the client.” 
 
The HCP recognises how difficult the behavioural techniques can be for patients but 
also with commitment it shows positive results. Interestingly the HCP observes that 
therapists may avoid techniques such as ERP as it raises patients’ anxiety levels. 
Therapists need to recognise their own unease and address this in order to help 
patients tolerate then manage anxiety. Otherwise they are merely colluding with the 






Superordinate theme 3 
 
6.7 Patient care 
 
The main purpose of this study is to understand and evaluate patient care for BDD 
not just in providing treatment but in ensuring positive patient experience. The NHS 
and NHS England actively promote patient centred care to support patient choice, 
collaborative working practices and integrated care. However these intentions will 
only be effective for patients with BDD if the disorder is more widely understood and 




Clinicians’ responses indicated patient care to be a major theme with engagement a 
vital component. Apart from the general CBT skills in engaging patients, working with 
patients with BDD requires more specific principles including dealing with past 
experiences of healthcare; validation; not responding to discussions of appearance 
(Linehan, 1993; Veale et al., 2010). 
 
An excerpt from HCP10’s interview demonstrates their view of the engagement 
process. 
 
R: “Is there anything that I haven’t asked you about treatment provided by the 
service for BDD that you would like to discuss?” 
HCP10: “Not really, just to say that when it works, it works really well. I think people  
struggle a little bit to get going in the beginning with BDD treatment, because it can 
be quite hard to get them engaged with the treatment. Engaging can be difficult in a 
sense that it takes longer, so you need that time available to work with them. I’ve 
found the Theory A Theory B works quite well with helping them with engagement. 
Particularly validation, because one of the biggest problems with dealing with 
patients with BDD is that they often feel like they’re not being believed. Especially, if 
they’ve been through a couple of courses of treatment, they feel as if their physical 
symptoms aren’t being recognised. So I found that by validating their physical 





helped with their anxiety. So by encouraging them and letting them know they are 
being believed, not just trying to change their view point, helps to get them on-board 
with the treatment by testing different theories and ideas. So, when it works, it works 
well.” 
 
The HCP emphasises the necessity of time needed in this phase of engagement.  
They also use specific interventions for BDD in this process and demonstrate a belief 
in the value of the approach for engaging patients with BDD with the repetition of 
“…it works well.” The HCP describes validation and dealing with past experiences as 
a precursor to developing a therapeutic alliance.   
 
A similar pattern is found in HCP1’s account: 
 
R: “What do you think was most beneficial in treating patients with BDD? 
HCP1: “Challenging the behaviours and beliefs of how people are accepted and 
offering them unconditional positive regard throughout the therapy. That contributed 
by helping them engage and they felt safe, and able to move on and apply 
techniques to help them take risks.” 
 
The HCP’s approach encompasses the principles of therapy whilst also being 
patient- centred. The extract demonstrates an empathic, supportive approach with 
the focus being on trust as a key for patients to engage with treatment. Feeling “safe” 
and taking “risks” can only be achieved if the individual trusts the therapist’s 
guidance. 
 
HCP5 highlights the need for a dynamic and flexible approach to engage patients. 
 
R: “What do you think was least beneficial in treating patients with BDD?” 
HCP5: “I think new technology is interesting with BDD, as I was working with a client, 
who would look at various pictures of themselves on Facebook and Snapchat. And 
they had 100’s of pictures that they would go over day in and day out, trying to 
change and alter the look of. So what was helpful for this client, was saying ‘I’m 
actually going to stop using these social media programs and stop the comparison 





client who has an alcohol problem and saying to them, why don’t you go into the pub 
3 times a week, to test that exposure. So to me, it has that sort of quality about it. It 
is like an addiction. So, for this client who stopped using the social media programs, 
it was actually really effective. But there’s another side of me that says maybe for 
clients to lead a normal life, we should be teaching them to use these platforms, but 
just in a better way.” 
 
The HCP recognises that patients with BDD tend to be within the generation of 
digital natives. Thus engaging patients needs to involve adapting to changes in their 
needs and their ways of learning. The HCP also expresses the difference in 
treatment with BDD where exposure treatments are not as appropriate as it may be 
for OCD. 
  
6.7.2 Therapeutic alliance 
Once patients are engaged in therapy, developing a strong therapeutic alliance is the 
next essential step which establishes a mutually agreed path through treatment. A 
well-established therapeutic alliance can contribute to maintaining collaboration and 
engagement in often challenging interventions (Goldfried, Davila, 2005). Furthermore 
it is thought to lead to better outcomes and prevent dropouts in conditions that are 
considered difficult to treat (Klein, Schwartz, Santiago, et al., 2003).  
 
Developing the therapeutic alliance is also emphasised in HCP8’s account.  
 
HCP8: “Forming a therapeutic alliance is crucial and overcoming any kind of blocks 
in that alliance. Maybe even more so than OCD, because often the person feels 
they’re justified in behaving the way that they do, because the defect to them seems 
so real. A patient that I’m currently working with has said that she feels quite 
patronised, belittled and she didn’t feel like her efforts were being truly recognised. 
So, shifting that block so that we can work together is crucial.”  
 
People with BDD often describe feeling misunderstood and not taken seriously as 
patients’ accounts attest to (Refer 5.5.1 pg. 136). The therapists in this service 
initially help patients heal from these previous experiences concentrating on the 





removing obstacles to therapy where not forming a therapeutic alliance could be a 
major stumbling block. 
 
Here HCP7 shows how using the therapeutic alliance allows them to tap into the 
deeper needs of the patient in a holistic way rather than merely following the 
treatment guidelines. 
 
R: “What do you think was most beneficial in treating patients with BDD?” 
HCP7: “Lots of work on self-esteem, before trying to do the exposure work. In my  
experience, people tend to have a negative self-image and that really does tend  
to dominate, not only things around their appearance, but can also affect other  
aspects of their lives like their status in life and how they compare themselves to  
other people. It’s more than just their appearance. CBT work and stuff around self-
esteem and being able to nurture and look after themselves and experience pleasure 
with that, I’ve found quite useful. Not just doing an exposure in a social situation and 
helping with self-belief. That doesn’t also feel like a nurturing thing. It can feel more 
like a testing and trying, rather than a nurturing type of treatment.” 
 
This variation to the standard recommended treatment shows a considered response 
to the patients’ needs with use of therapeutic skills beyond techniques for BDD- 
specified interventions. 
 
HCP4 also highlights the advantage of having more clinical time with patients which 
this service model allows to a greater degree than other services. 
 
R: “Is there anything that I haven’t asked you about treatment provided by the 
service for BDD that you would like to discuss?” 
HCP4: “BDD, more so than maybe any other disorder is more about the therapeutic  
relationship. It’s about the trust and the longevity, so making sure that you have a 
longer period to work with people. I don’t think it would work in IAPT or any other 
similar type therapies. Because we have an inpatient unit, we have plenty of time to 
work with patients. Working in a shorter term therapy setting, I don’t think is as 





which I think is massively important when it comes to treatment for people with 
BDD.” 
 
The repeated reference to the therapeutic relationship and developing trust 
highlights how vital the HCP views this for treating BDD. However this takes time 
which the HCP points out is limited in most therapeutic settings.   
 
Developing the therapeutic alliance with patients is described as crucial by the HCPs 
but it is also recognised that patients face difficulties in accessing the appropriate 
care for BDD due to the limited understanding of the disorder. HCP5 admits that 
even as a specialist in the disorder, they consider their understanding of BDD to be 
only reasonable with much to be done to develop the body of knowledge and 
awareness of BDD generally.  
 
HCP5: “I think we as clinicians have a better understanding, but not necessarily a 
good understanding of BDD, because of the work that we do. I think I have a good  
understanding of OCD and I think I have a fair understanding of BDD. So, when I 
think about clinicians in other areas who don’t have the specialist expertise, 
knowledge and access to training, I think there’s a huge amount of work to be done 
out there for BDD clients and the diagnosis of it. And even the recognition of it 
alone.” 
 
The HCP considers that limited understanding of BDD generally amongst clinicians 
can result in patients having negative experiences of healthcare professionals which 
make developing the therapeutic alliance more challenging. 
 
6.8 Discussion of Findings 
The accounts from clinicians interviewed provided a valuable insight into their 
perspectives and feelings about their experiences in the service. Views expressed 
show the passion for their work and belief that they can make a difference. However 
with regards to the NICE guidelines, there is a sense of dissatisfaction that it is 
adequate for BDD. This is not surprising given at the time of publication there were 
only three RCTs of CBT for BDD with a combined total of available data from two of 





for BDD (NICE, 2006). There have been a further seven RCTS conducted on CBT 
for BDD which were described in a metaanalysis but there have been no further 
reviews of the NICE guidelines for BDD (Harrison et al., 2016). The responses of the 
HCPs raises the question of the impact of establishing the service model based on 
the NICE (2006) guidelines. A dichotomy exists as they see no difficulties in 
accepting provision of the service according to NICE (2006) guidelines for OCD but it 
see it as not sufficiently robust for BDD. The overall impression is that clinicians are 
resigned to there being at least some guidance available for BDD given the limited 
knowledge and evidence-based research available. 
However there is also frustration and helplessness voiced in many of the HCPs’ 
comments which can be rooted in the lack of a substantial evidence-based body of 
knowledge for BDD. Clinicians have nothing to draw on when recommended 
interventions are not working. Instead they turn to generic interventions or those 
used in other disorders such as mindfulness, motivational interviewing and working 
on self-esteem etc. Furthermore HCPs reported that in some instances, using goals 
focused on daily living skills allowed the patient to feel some sense of achievement 
especially when they found the CBT interventions difficult. Occupational therapy 
could benefit patients in improving functioning yet this is neglected in the NICE 
guidelines for BDD mainly because there is no published research into occupational 
therapy for BDD.  
 
The gap in knowledge of BDD is clearly recognised with literature calling for research 
into improving on CBT as well as the understanding of the development and 
maintenance of the disorder (Veale, Miles, Anson, 2015; Krebs, et al., 2017). This is 
also illustrated in the findings from the literature review as previously described (2.4 
pg. 39). Additionally research indicates some benefits for SSRIs but also the limited 
number of trials and lack of understanding of the neurophysiological aspects of BDD 
means the evidence is still relatively weak (Phillips et al., 2008; Ipser et al., 2009).  
The inadequate understanding of BDD makes it more difficult to provide the 
treatment that patients need in a timely manner. There are a limited number of health 
care professionals with the expertise to assess and treat BDD. However not all have 
the opportunity to disseminate their knowledge and skills, therefore training for BDD 





into the available training. Therefore most health care professionals do not have the 
opportunity to develop even basic skills in recognising BDD (Phillips et al., 2008; 
Veale et al., 2015). The impact of this is that referrals to appropriate services are not 
forthcoming as reported by the HCPs in this study. Added to this the lack of 
understanding could lead to adverse patient experience, disengaging from services,  
worsening patients’ conditions eventually resulting in more profound needs with 
significant impact on carers/families and further demands on resources. 
Although the stepped care model was designed to improve access in practice, 
patients with BDD who may not have access to appropriate treatment in the initial 
steps have little recourse than to proceed through each step and multiple services 
before accessing specialist care. That is if they remain engaged through this process 
which is less likely due to the nature of the disorder (Veale et al., 1996; Phillips et al., 
1997).  
One of the advantages of multidisciplinary (MDTs) working is the different 
perspectives each person brings to the team. Given all the members of the team 
have core professions, in addition to their role in providing CBT or medical 
management, this enables delivery of holistic care (Mental Health Commission, 
2006). MDTs also provide opportunities to use these alternate views to initiate 
change and strive for improvement. However operational support is also required to 
allow for this to happen. Yet from the expressions of frustration found in clinicians’ 
accounts some seem to feel there is little control over operational factors and no 
support to address shortcomings in recommended treatments along with restrictions 
which pose challenges to achieve the desired outcomes. It is understood that 
providing a clinical service within the NHS has requirements based on organisational 
operational policies and procedures (NHS England, 2018). However there are 
procedures to assess the impact policies have on service delivery, although from 
HCPs’ reports it appears this does not always translate into practice thus not 
accommodating specific needs of this group (SWLSTG, 2016). Despite the 
frustrations described by clinicians, there is a shared culture in the team of providing 
a needs-led service regardless of the organisational demands (Ovretveit, 1993). 
There is a strong sense consensus in providing the best care for the patients even 





HCPs generally demonstrated a commitment and belief in the treatment modalities 
which promotes the unity of the team members.  
 
A factor conspicuous by its absence was any reference to outcome measures. 
Possibly this was not considered as relevant in decision-making regarding treatment 
instead it seems clinicians evaluated patients’ progress in terms of the patients’ 
experiences. However outcome measures were regularly completed and provide 
objective measures of symptoms used in the Unit’s reports and research 
undertakings therefore the clinicians do value the data obtained. However they do 
not discuss this in their personal accounts thus may see outcome measures as a 
service requirement to evaluate effectiveness which relates to the value-for-money 
requirements of commissioners. One of the factors that give CBT stronger appeal is 
the measurable nature of the treatment targets (Bakker, 2008). CBT has been shown 
in researching findings to be a cost-effectiveness treatment across disorders and in 
comparison to medication which has prompted funding into CBT services including 
development of IAPT services in 2008 (NHS England, 2018; Myhr, Payne, 2006). 
Unfortunately there has been less attention given to early intervention for BDD which 
HCPs interviewed highlighted a need for, particularly increasing awareness in 
teenagers as this is the usual phase of onset (Phillips et al., 2006). 
Working with younger adults also raises the aspect of social media which HCPs note 
could have an additional impact on treatment of young adults with BDD. This is not 
addressed in the NICE guidelines (NICE, 2006). Yet there are generations 
(generation X and Y) who have been born into the digital age with a different view of 
relationship contexts with face-to-face social interactions competing with on-line 
communication and social networks based in social media platforms (Cabral, 2011). 
For a young person with BDD, opting for online communication would be an easy 
option as the generation sees social media networks as a norm (Subrahmanya, et 
al., 2008). It could be seen as beneficial in providing social acceptance and inclusion 
whereas direct contact would raise anxiety leading to avoidance and isolation 
(Subrahmanya, et al., 2008). Furthermore internet and computer based treatments 
which have been trialed for BDD may be a way to engage younger people early on 
(Enander et al., 2014; Summers et al., 2016). Still there is the need for real world 
interactions which require social skills which may be underdeveloped if interactions 





With the digital age comes more availability to media images and information which   
HCPs discussed in their interviews. Although the media may be vilified for portraying 
appearance ideals and images to aspire to, the media can play an important role in 
promoting the awareness of BDD. A recent media report that Superdrug launched 
Botox clinics prompted a response by Professor Stephen Powis, medical director of 
NHS England, which was relayed in the media. This resulted in Superdrug granting 
that customers will be screened for BDD (Levine, 2019). The media can therefore be 
instrumental in bringing public attention to BDD and influencing options available for 
assessment, recognition and treatment. 
The main themes that stood out in the HCPs interviews were the frustration at lack of 
evidence based research and knowledge of BDD plus the dedication to patient care 
and developing therapeutic alliance. Working with patients suffering the debilitating 
effects of BDD can be an intensely felt experience as seen in some of the HCPs 







Chapter 7:  
 







The aims of the study were described in 1.8.1 pg. 27, achieving the following: 
• Evaluation of applying NICE (2006) guidelines in treating BDD within a 
specialist service.  
• Eliciting and interpreting experiences of patients and clinicians respectively 
receiving and providing treatment for BDD. 
 
This chapter will present: 
• Summary of findings from the three phases. 
• Discussion of synthesised findings followed by links to literature.  
• Strengths and limitations of the study. 
• Recommendations for future research. 
• Recommendations for refining policies and treatment protocols.  
• Dissemination strategies 
 
7.2 Summary of Findings 
7.2.1 Phase 1: Quantitative Analysis 
Key patterns identified were:  
• Limited alleviation of BDD symptoms for some patients found on standardised 
measures. 
• Impact on quality of life- work, relationships, independence.  
• Limited diversity in ethnic representation of patients referred. 
7.2.2 Phase 2: Patient Interviews 
Key themes identified related to: 
• Engagement in treatment and using techniques effectively. NICE (2006) 
guidelines recommended treatments do not fit everyone with BDD.     
• Lack of early access to appropriate treatment, adverse experiences in 
healthcare from lack of understanding, knowledge plus skills in recognising 






7.2.3 Phase 3: Health Care Professional Interviews 
Key themes identified were: 
• Lack of sufficient evidence-based research resulting in treatment options for 
BDD not comprehensive enough, lacking alternatives when patients’ 
symptoms not improving.  
• Tensions within the organisation related to inflexible policies and procedures. 
• Efficiency of patients’ pathway through the stepped-care model.  
7.3 Discussion of Synthesised Findings 
Synthesis of findings from the three phases produced the following focal points: 
• A predetermined package of treatment vs needs-led care. 
• Implications of deficiency in knowledge and understanding of BDD. 
7.3.1 A Predetermined Package of Treatment vs Needs-Led Care 
This specialist service evolved to implement the NICE (2006) guidelines as a means 
to both provide a specialist service but also to survive in the face of service reviews 
and funding cuts. The inpatient service was presented to NHS England following 
threats of closure due to lack of funding from local CCG bodies. In following the 
guidance, the service was commissioned by NHS England and together with two 
other specialist services at different locations formed a consortium working with this 
model. 
Given the inception of this service and the framework that treatment is provided 
within, tensions arise when the package of treatment does not work. Interviews with 
clinicians indicated difficulties with parameters of treatment guidelines. Healthcare 
professionals express commitment to the therapeutic model but consider 
interventions for BDD to be insufficient especially when patients find the 
interventions too difficult to tolerate. There are no clear alternative recommendations 
for BDD apart from further trials of the same interventions. This creates conflict 
between the organisations’ objectives and the professional’s view of what is in the 
best interests of the patients. Clinicians emphasised the individual needs of patients, 
reverting to their foundation skills and knowledge to look at alternatives to engage 





did not deviate from the NICE (2006) guidelines. Clinicians may decide to remain 
within these confines as this is the only evidenced-based recommendations available 
for BDD and it seems the safer option than to attempt any novel approaches 
especially when patients’ present with complexity, severe symptoms and risks. 
Added to this, clinicians reported that despite it being a specialist service for BDD, 
their opportunity to gain experience treating the disorder is limited due to low referral 
rates. This may influence their decisions on treatment if they feel less confident in 
treating BDD. This is also borne out in responses from patients who found the 
interventions difficult and would have welcomed alternative treatment options.  
A complicating factor is that the outpatient service is commissioned by local funding 
agencies and has more flexibility with referral criteria, reports on measures and 
interventions used whilst the inpatient service is funded by NHS England with strict 
criteria regarding referrals, treatment, outcomes measures and duration of treatment. 
This could raise tensions amongst team members where there are differing views of 
patients’ needs. The clinician participants from the outpatient service reported using 
a host of alternative interventions alongside CBT such as other medications; 
augmentation; EMDR, family work, mindfulness, motivational interviewing, schema 
therapy, solution focused interventions; daily activities and living skills. However the 
impact of this is not formally measured as this does not fall within service directives.  
The interviews with patients may explain results from outcome measures. For those 
patients interviewed BDD ratings indicate improvements but not complete alleviation 
of symptoms in all cases. There is also a discrepancy between scores on measures 
and the patients’ perceptions of their level of progress. Patients describe their 
progress in terms of their living skills, social interactions and quality of life. This 
correlates with sociodemographic findings from phase 1 which shows the disabling 
effects of the disorder on patients’ functioning. The service is based on a framework 
of treatment and care which works well for OCD but for BDD this treatment package 








7.3.2 Implications of Deficiency in Knowledge and Understanding of BDD. 
With the lack of research regarding development; neurophysiological mechanisms; 
maintenance factors, even a definitive model of BDD, establishing treatment options 
is still in its infancy with a sense of trial and error for many of the interventions for 
BDD. The evidence-based research used by NICE for the BDD guidelines was very 
limited which weakens its credibility (Tables 15, 16). Furthermore they have not been 
reviewed despite publication of other studies. Ultimately deficiencies in 
understanding BDD are at the root of difficulties in addressing needs of patients with 
effective treatments. 
Nevertheless professionals promoting the need for advancements in understanding 
and treating BDD have been instrumental in raising the profile of the disorder and its 
inclusion in OCD spectrum disorders is seen as a means to ensure it is not lost 
within diagnostic manuals. Given the similarities between OCD and BDD (Table 2) 
as compared to other disorders, further support for recognition was inclusion of BDD 
in the NICE guidelines (NICE, 2006). Opinion is divided on whether this is the best 
option with most HCPs interviewed stating that they believe BDD should have 
separate guidance. This arises from experience of treating the disorder with 
recommended treatments which are used effectively for OCD but have more 
inconsistent results for BDD. On one hand the NICE guidelines were considered by 
clinicians interviewed as generally helpful and for those patients who respond well to 
treatment they reported significant impact on their quality of life. On the other hand 
for those patients who are unable to find benefit in recommended treatment, there 
are no signposts of what to offer. The clinicians have to concede there are no other 
services or treatment options for BDD.  
This again underlines the deficiencies in understanding and treating BDD which has 
the impact of patients being misdiagnosed or symptoms not being recognised early 
on. Health care professionals reported that referrals for BDD were scarce and 
patients attested to this by their experiences of not being offered the appropriate 
specialist treatment earlier. The duration of the condition was therefore found to be 
lengthy which has a detrimental effect on functioning as seen in the quantitative 
findings. This may also lead to obstacles to treatment where patients resort to using 
substances to cope with the BDD symptoms, which is another factor with little 





Unfortunately there is only a small cohort of healthcare professionals worldwide who 
have expertise in BDD. The literature review bears this out with most of the 
published research conducted by the same authors even across treatment 
modalities (Appendices E, F, G). From patient and clinician interviews their 
experiences echo this concern with both groups expressing the need for more 
awareness of the disorder.  
7.4 Discussion of Findings Linked to Literature 
A metaanalysis of CBT RCTs for BDD discussed their findings in relation to the NICE 
guidance (Harrison et al., 2016). However there are currently no known studies into 
the effectiveness of using the NICE (2006) guidelines for BDD. A common element 
in literature on BDD is a description of it being an under researched condition 
(Phillips, 2000; Williams et al., 2006; Ipser et al., 2009; Harrison et al., 2016).  
7.4.1 Predetermined Package of Treatment vs Patient Needs 
This study’s findings raise concerns about having NICE guidelines for a disorder 
where evidence-based treatment is so limited. It is acknowledged in treatment 
studies that at post treatment, patients with BDD continue to experience clinical 
symptoms (Marquesa et al., 2011; Phillips et al., 2013). However the guidelines do 
not provide recommendations for other interventions nor is there guidance on patient 
presentation that may benefit from a recommended medication regime (Harrison et 
al., 2016).  
Some studies into additional interventions have shown promise however they have 
not been explored in further studies nor have they been included in treatment options 
(Rabiei et al, 2012; Wilhelm et al., 2013; Enander et al., 2014; Summers et al., 
2016). CBT has been described as the most effective psychological treatment for 
BDD based on the available research which indicates improvements in symptoms 
following therapy (Williams et al., 2006, Ipser et al., 2009; Harrison et al., 2016). 
Apart from one study comparing CBT with anxiety management, there are no other 
comparative studies in controlled trials (Veale et al., 2014). Thus CBT appears most 
effective by default. Also the nature of CBT lends itself more readily to being 





Despite these shortcomings the NICE (2006) guidelines does serve to address 
patients’ needs to some degree in providing the opportunity to receive treatment that 
to date is the most evidence-based available (Wilhelm et al., 2013). Although there is 
a lack of expertise in BDD, the guidelines provide some direction for healthcare 
professionals to use CBT skills and trial medication regimes to provide for the needs 
of patients who would otherwise have no options available (Harrison et al., 2016). 
Nevertheless, this raises questions of whether there could be alternatives to the 
NICE (2006) guidelines which will be discussed in recommendations for future 
directions.  
7.4.2 Deficiency in Knowledge and Understanding of BDD 
This deficiency is a common observation described in the literature on BDD 
(Williams et al., 2006; Ipser et al., 2009; Harrison et al., 2016). Yet the root of this 
difficulty is unknown considering this is not a new disorder (Morselli, 1891 in Jerome, 
2001:103). 
 
Questions arising from this are: 
• Is the lack of wider research into BDD due to perceptions of low prevalence 
and low impact? 
• Do general assessments and consultations in mental health or other health 
care settings that people with BDD present at include screening for BDD 
symptoms? 
Perceptions of Prevalence and impact of BDD 
From prevalence studies in the US and Germany it is estimated that from 1.7% to 
2.9% of the general population is affected by BDD (Rief, et al., 2006; Koran, et al., 
2008; Buhlmann, et al., 2010). In the absence of epidemiological studies of BDD in 
the UK, this number could be higher. On the other hand disorders such as 
schizophrenia has a worldwide prevalence rate of approximately 0.28% yet has a 
much higher profile due to the considered burden of the condition (Charlson, Ferrari, 
Santomauro, et al., 2018). Furthermore other body image disorders such as anorexia 





groups and genders still there is more awareness and recognition of these disorders 
(Hoek, van Hoeken, 2003).  
 
Clinical presentation of patients with BDD at severe levels can result in inability to 
meet self-care needs and becoming housebound. This places intense stress on 
carers to help maintain the individual’s functioning (Phillips, 2007; Dunnai, 
Labusechagne, Castle et al., 2010; Phillips, 2015). The individual is unable to make 
any positive contribution to society as they are isolated from any social interactions, 
work or study (Phillips et al., 2008; Veale, et al. 2010). In addition where they have 
sought cosmetic surgery inappropriately, this results in a burden of cost and drain on 
healthcare resources to rectify failed surgical procedures or having to address 
repeated attempts to have further surgery (Phillips, 2015). Most alarming is the high 
risks of harm BDD sufferers pose to themselves particularly performing self-inflicted 
surgery and suicide risk (Cotterill, et al., 1997; Veale et al., 2010; Phillips 2015; 
Lupkin, 2016). Despite the significant impact of BDD on the sufferer, their carers and 
society in general, there is still a meagre knowledge base.  
 
An additional aspect found in the course of this study was the uneven representation 
of ethnic groups in the sample. There is minimal research into ethnicity and BDD but 
studies have shown ethnicity and culture may play a part in symptom presentation 
and may have implications for treatment (Ishigooka et al., 1998; Boroughs, et al. 
2010; Weingarden, et al., 2011). 
 
Do healthcare professionals routinely screen for BDD? 
 
Screening questions for BDD is not part of routine practice in assessments by mental 
health practitioners (Grant et al., 2001; Conroy et al., 2008; Phillips, 2009).  This has 
also been observed from clinical experience and responses of both patients and 
healthcare professionals. 
 
One of the main reasons for this could be the lack of training in recognising and 
assessing for BDD in the undergraduate training curriculum for healthcare 
professionals. In recent years there have been attempts to redress this with a BDD 





Veale, 2016). Also treatments manuals have been published (Veale et al., 2010; 
Wilhelm et al., 2013). These are progressive steps in increasing awareness and 
knowledge however this has not reached everyone.  
 
One of the areas to consider is the role of pharmacology sponsors in promoting 
dissemination of knowledge about disorders (Mosher, Gosden, Beder, 2004). With 
disorders such as schizophrenia where there is an understanding of the biological 
mechanism and a clear role for pharmacotherapeutic treatment pharmaceutical 
companies have played a significant role in education (Angell, 2000). Though this 
has triggered a critical appraisal of the agenda of pharmaceutical companies in the 
literature including the view that obtaining funding for research can be hindered if 
companies do not see it as a profitable venture (Angell, Relman, 2001; Gosden, 
2001; Lexchin, 2005). For researchers seeking funding for BDD projects, this will 
pose a difficulty as the main evidence-based treatment options at present are 
psychological (NICE, 2006). This provides limited incentives for the corporate sector 
producing health related products to promote research into BDD. In contrast 
treatments that require pharmaceutical, biotechnological or other technological 
devices have generated much support from organisations that have financial 
interests in promoting these products, even patient organisations who may seek 
funding from the corporate sector to continue to operate, resulting in conflicts of 
interest (Mandeville, 2019).  
 
Supporters for psychological therapies described the usual practice for GPs seeing 
patients with depression or anxiety disorders was to prescribe medication but with 
the introduction of stepped care models and IAPT services there are more treatment 
options available (Layard, 2006; NHS England, 2016; NCCMH, 2018). This has 
come about with the increasing recognition of the need for other treatments as 
mental health disorders have a far–reaching impact on society as a whole (NHS 
Confederation, 2014; NHS England, 2016; NCCMH, 2018). Unfortunately it seems 
that focus on BDD has only been prompted by high-profile media reports on 
scandals in the cosmetic surgery industry where there are financial implications 






The nature of the presentation of BDD contributes to the difficulty healthcare 
professionals have in recognising it as a clinical diagnosis (Conroy et al., 2008). BDD 
symptoms can easily be mistaken for a generally occurring experience of 
dissatisfaction with appearance, especially for teenagers, (Fitts, Gibson, Redding, et 
al., 1989; Trekels, Eggermont, 2017). These concerns have prompted a movement 
more recently to include confidence building material as part of the school curriculum 
(Be Real, 2019; The Telegraph, 2017). Reports on appearance related concerns 
state that 37% of females experience appearance dissatisfaction whilst 26% of 
males are dissatisfied with their appearance (Government Equalities Office, 2014). 
However it is defining the difference between dissatisfaction and a diagnosis of BDD 
that requires specific knowledge (Philips, et al., 2006; Phillips et al., 2008). 
 
7.5 Strengths and limitations of the study 
The study has a number of strengths and limitations regarding methods and   
literature review as well as the researcher’s perspectives. 
7.5.1 Methods 
Using a mixed methods approach provided multiple sources of data which allowed 
for different aspects of the service to be evaluated. Although quantitative methods 
are more commonly used in mental health research, incorporating a qualitative 
method provided a context for the descriptive findings from the quantitative phase of 
the study (Powell, Single, Lloyd, 1996). This allowed for a more in-depth exploration 
of factors that affect the patients’ quality of life such as impairments in levels of 
functioning and relationship-building. Although literature describes the disabling 
nature of BDD the lack of qualitative research on BDD does not allow for this 
concept to be fully explored (Phillips et al., 2000; Phillips et al., 2005; Phillips et al., 
2008). Therefore using qualitative methods in this study provides new perspectives 
and possible directions for treatment investigation.  
In addition, providing insights into clinicians’ perspectives and experiences which are 
lacking in the literature highlights areas of deficits in resources available for BDD 
sufferers. NHS England promotes the use of clinician’s expertise in service 





clinicians’ experiences of treating BDD which this study serves to redress by 
including clinicians in the qualitative analysis. 
“There should be even greater emphasis put on people’s experience and how 
experts-by-experience can be seen as real assets to design and develop 
services.”  (NHS England, 2016:18) 
The availability of data from both patient and clinician rated standardised measures 
allowed for a more robust evaluation of the outcomes of treatments. Unfortunately 
not all the medication names prescribed for patients in the quantitative dataset were 
available which limits the information on the overall number of different medications 
used. Also treatment outcome findings cannot give an indication of whether CBT or 
medication was the most effective intervention instead it is attributed to CBT in 
conjunction with medication. Additionally although some clinicians reported using 
interventions not detailed in the NICE (2006) guidelines such as EMDR, family work, 
activities of daily living skills, these were not recorded in a formal way on outcome 
measures. Although the SDS provides a holistic measure of impairment, there are no 
objective measures to determine whether these specific interventions contributed to 
outcomes. On the other hand, the qualitative data provides some insights into the 
impact of some of these interventions. A limiting factor may be that patient 
participants were either treatment completers and discharged or in follow up, which 
would impact on their perspectives compared to patients who were non-completers.  
Using thematic analysis also promotes its use as a standalone qualitative method 
with significant contribution to make in terms of the depth and richness of data that 
can be obtained using this approach. In addition thematic analysis in this type of 




Still this approach faced some limitations particularly in sampling. The relatively 
small sample size could be seen as a limiting factor however the analysis produced 
a wide range of perspectives and the common patterns that emerged indicated that 
saturation was reached. Still patients who chose to participate may have presented a 
bias towards a group who are more engaged and responded more favourably to 





(Phillips et al., 2008; Veale et al., 2010). Conversely some patients may have agreed 
to participate as they had their own agenda to communicate their dissatisfaction, 
which is an area researchers are promoting as well as studies on patient satisfaction 
(Coyle, Williams, 1999). 
Due to resource and time constraints, the researcher was unable to recruit 
participants across the specialist service consortium which would have offered a 
more comprehensive view of the implementation of the NICE (2006) guidelines. In 
addition as one of the centres also provides treatment for children and adolescents, 
this would have provided much needed insights into BDD in young people. Also 
although there was no upper age limit for patients invited to participate there were no 
participants over 49 years old, which provided less representation of older adults. 
However examining the quantitative sample provided an explanation as patients over 
the age of 50 were outliers and none were under care of the service at the time of 
the study. Key findings from the appearance satisfaction survey indicated that body 
satisfaction is at its highest in the 50-64 age groups which is perhaps a reason for 
lower presentation of BDD in older adults (Government Equalities Office, 2014). 
7.5.3 Literature review 
From the outset, it was clear that availability of literature on BDD was scarce (Veale 
et al., 2010). The study includes a comprehensive appraisal of the available literature 
on treatment however no published studies in other languages were included which 
poses a limitation. Often healthcare professionals conducting studies in their clinical 
settings may wish to disseminate their findings but if the sample is small it is often 
rejected by publications (Sullivan, 2015).   
 
 7.5.4 Researcher’s influence 
 
Subjectivists maintain that research is influenced by the researcher’s biases from the 
outset (Hunt, 1993). Certainly in this study the topic of focus was chosen due to the 
researcher’s particular interest. However this may not necessarily be considered bias 
where the researcher is transparent regarding the motivation for the study, 






The influence of being interviewed by a peer can be beneficial as clinicians identify 
with the researcher as a fellow clinician and feel safe to express emotion-laden 
views (Chew-Graham, May, Perry, 2002). However given the researcher was known 
to have specialist interest and expertise in the subject this generated a concern of 
being judged (6.2, pg. 156). The researcher’s clinical experience in the setting may 
also have an influence on patient participants’ responses as they may consider the 
researcher to have a better understanding of BDD and may be more comfortable 
expressing their experiences. On the other hand although it was made explicit that 
their participation would not affect their treatment in any way, they may have 
concerns with being judged and be more considered in their responses (Chew-
Graham, et al., 2002). 
7.6 Recommendations for future research 
 
The study highlighted the following areas for future development: 
• Development of a definitive psychological, biological and social model for 
BDD. 
• Research into treatment options. 
• Education and awareness of BDD. 
 
7.6.1 Development of a definitive psychological, biological and social model 
for BDD 
Several psychological and physiological theories relating to development and 
maintenance of BDD have been proposed but there are still discrepancies and 
factors that require further investigation (Veale et al., 1996; Deckersbach, et al., 
2000; Wilhelm et al., 2002; Feusner, et al., 2007; Feusner, et al., 2010; Wilhelm et 
al., 2010). The focus needs to be on the onset of the disorder which tends to be in 
adolescence (Phillips, 2005). Patient participants shared their view and the 
consequences of not receiving treatment earlier on in the course of the disorder. 
Although not discussed in this study as the service caters for an adult population, the 
guidelines also relate to children and adolescents but research on this population is 
minimal and is confined to single case studies or case series (Phillips, Didie, Menard 






There needs to be further exploration of how body image develops in adolescence 
and factors that may disrupt the normal process that could lead to developing BDD 
(Phillips, 2005). Social factors such as ethnicity and culture also need to be included 
in this search to understand the development of the disorder. Progress in 
establishing a definitive model of BDD will offer more avenues to explore regarding 
treatment.  
7.6.2 Research into treatment options  
The literature review provides a clear indication of the limited research available on 
treatment for BDD. Research comparing treatments is minimal with just two studies 
comparing treatment modalities (Khemlani-Patel, et al., 2011; Veale et al., 2014). 
Despite the literature describing the impact of BDD on functioning, there are no 
studies into other interventions such as Occupational therapy for BDD or Art therapy 
(Armitage, 2016; Berner, 2015). 
Given the limited understanding of the disorder, every avenue should be explored 
even possibly controversial ones such as cosmetic surgery. A study on rhinoplasty 
for BDD showed improvements including at follow up. Although it was a small cohort 
compared to the studies showing no improvement or worsening of symptoms with 
cosmetic surgery, further examination of this group is warranted as it may provide 
information on particular characteristics of the patient group that influenced outcome 
(Felix et al., 2014).  
 
Treatment with medication documented in this study indicated the numbers of 
patients receiving SSRI and augmentation which gave some understanding of how 
the medication recommendations in the NICE guidelines were implemented (NICE, 
2006). Data on specific medications used was not available for all patients in the 
sample; nevertheless the breakdown could point to directions for future research into 
medications that appear more favoured (Appendix V). Fluoxetine was the most 
prescribed SSRI and is described in the literature as a preferred first option SSRI for 
BDD (NICE, 2006; Phillips, Hollander, 2008). In addition Clomipramine and 
Sertraline were both the second most prescribed SSRIs from available data yet 
research is limited to non-existent with Fluoxetine and Clomipramine described in 





Liebowitz, Winchel, et al., 1989; Phillips, 1991). At the time of writing there are no 
known studies comparing SSRIs with other treatments found to be effective such as 
CBT. The link between guidelines recommending these pharmacological treatments 
for BDD with available evidence is tenuous at best. The question arising from this is 
why are these medications not being further investigated? 
The literature suggests SSRIs decrease preoccupation with appearance; reduce 
distress and promote improved psychosocial functioning (Phillips et al., 2008).  
However a metaanalysis finding suggests CBT is more efficacious than medication 
(Williams et al., 2006). Without direct comparisons however, there is no conclusive 
evidence for this. Therefore considering the improvements described from taking 
SSRIs it would appear that relieving patients’ physical symptoms and increasing 
ability to actively control levels of preoccupation would help them to engage in 
psychological interventions such as CBT which work towards addressing cognitive 
aspects as well as behavioural patterns that maintain the disorder. Furthermore if the 
level of distress is reduced, the patient is more able to use problem-solving and their 
support networks to return to an improved level of functioning. However in this 
study’s sample with the high rate of comorbid disorders present, especially 
depression (N=41, 85%), it is unclear whether the medication relieved symptoms of 
BDD or as the symptoms of depression abated, the BDD symptoms were more 
amenable to change with the psychological therapy. Depression is the most 
commonly found comorbid disorder in BDD sufferers which if left untreated will 
impact on level of engagement and result in a range of physical symptoms (Phillips 
et al., 2005). Patients need to be cognitively stable in order to engage in 
psychological therapy; therefore a transdiagnostic approach may be needed (Phillips 
et al., 2008). A query arises of whether these patients are receiving adequate 
treatment for depression initially and if this could help them to address their BDD in 
earlier steps rather than being stepped up to specialist services.  
However to fully understanding how SSRIs are able to influence treatment outcomes 
further studies into their use alongside psychological therapies; holistic interventions 
such as those used in Occupational Therapy and family work will provide much 
needed advances in treating BDD. Also conducting long-term follow ups of patients 





Innovations in mental health such as the role of digital technology in treatment is an 
area to explore especially as the onset of BDD tends to be in adolescence and 
young adults for whom this platform is an area of social interaction and connectivity 
(Phillips et al., 2005; Gould, Munfakh, Lubell et al. 2002). NHS England in 
conjunction with NICE have developed a five year plan to assess digital therapy 
products for IAPT services (NHS England, 2017).  One of the approved products is 
BDD-NET a digitally enabled therapy for individuals to access remotely (Gentile, et 
al., 2019). The concept is based on a study aimed at increasing access to 
psychological therapy for BDD on a global scale which would be ideal given the 
limited resources available for treating BDD (Enander, et al., 2014; Gentile, et al., 
2019). However a concern would be the nature and quality of the therapeutic 
relationship with an online treatment forum which has limited therapist contact. From 
the qualitative findings in this study both patient and clinician participants valued the   
therapeutic relationship above all interventions. It was this aspect of therapy that 
secured patients’ engagement plus increased their motivation to actively use difficult 
interventions. For patients with moderate to severe symptoms of BDD, digital CBT 
would require a high level of self-motivation. Yet with the occurrence of comorbidities 
the level of engagement with online treatment is questionable (Phillips et al., 2005; 
Graph 4, pg. 120).  
 
With a limited number of professionals who currently have expertise in treating BDD, 
another question arises of how therapists will be trained and how their performance 
will be monitored in supporting patients using this therapy program. In addition there 
are issues such as patients in more deprived areas of the globe having access to the 
necessary technology; internet speed; software compatibility; language and cultural 
factors – all these need to be considered. Would there also be a danger of the 
program being a false sense of reality with patients developing a sense of 
confidence within a virtual field without in vivo reality testing? Yet this could provide 
an opportunity to develop an alternative graded step for patients who find the real-life 
exposure too overwhelming to tolerate (5.7.1, pg.147). Also with technology able to 
provide easier and faster access to appropriate services, this could be a way to 
provide early intervention for those patients facing the onset of the disorder. There 
will undoubtedly be setbacks and troubleshooting needed before this form of therapy 






7.6.3 Education and awareness of BDD 
Appearance and body image has been recognised as an important factor in ensuring 
mental health and wellbeing (Burrowes, 2015). Although the promotion of body 
confidence is welcome advancement, the document held no mention of BDD but had 
repeated reference to eating disorders. This is not to detract from promoting 
awareness and recognition of eating disorders instead it is vital that equal focus 
should be on BDD. Often these disorders overlap but the eating disorder may be 
more easily recognised and BDD symptoms assumed to be part of the eating 
disorder (Grant, Phillips, 2004). 
Awareness of BDD is primarily lacking but the media could play a large part in 
disseminating research findings especially with the popularity of reality television 
shows (Mazzeo, Trace, Mitchell, et al., 2007). At present the literature is focused on 
researching possible adverse effects of the media on appearance and body image 
(Tiggemann, Slater, 2004; Grabe, Hyde, 2009). Yet TV shows such as the Gok 
Wan’s reality series have highlighted body and appearance concerns with the 
presenter taking further steps to promote education on appearance and self-
confidence in schools (The Telegraph, 2009). These types of media platforms can 
provide opportunities to highlight signs and symptoms of BDD so that it is more 
recognisable in early stages.  
Alongside this there was a clear theme identified in this study amongst clinicians and 
patients interviewed that there are insufficient professionals who understand and can 
treat BDD. Therefore there needs to be training in BDD from specialist services at all 
levels of the stepped care model so that healthcare professionals are able to 
recognise and offer treatment early on as well as be aware of referring patients on to 
specialist care more rapidly. Some of the clinicians interviewed reported that closer 
working with primary care services such as IAPT have led to establishment of CBT 
groups for BDD which allows for greater access to treatment for patients. There 
needs to be more forums for dissemination of information as well as bringing 
together other disciplines such as Occupational therapists, Social workers, Art 
therapists who can offer a more holistic view of the patient as well as alternative 






7.7 Recommendations for refining policies and treatment protocols  
The themes highlighted by the study findings as well as existing literature clearly 
indicate the scope for further development in policies and treatment protocols. The 
following were the main considerations for refinement: 
• Service treatment protocols 
• NICE guidelines for OCD and BDD (2006) 
• NHS Trust operational policies  
• Wider policy recommendations 
7.7.1 Service treatment protocols 
Further investigation is recommended into effectiveness of treatment for L6 national 
outpatients. From the literature reviewed, the findings appear to be CBT as a 
combined treatment is more effective but due to the practicality, time plus resources 
of providing outpatient treatment to patients based in locations nationally, it is mainly 
a behavioural component that is used in treatment. This works well for the OCD 
patients but from the findings, it clearly does not suit the patients with BDD. It is likely 
the lack of resources to provide treatment is the main difficulty as without the local 
services having skills and expertise to continue treatment, there may be little 
response from patients. The theory behind providing “outreach” treatment in the 
patient’s locality is innovative but unless the resources are available to put into 
practice this is not feasible. Ideally HCPs in different regions should be identified who 
will be trained in recognising and treating BDD and could be the expert for that 
region. Therefore when referrals from that region come through the specialist service 
can set up a treatment plan and work with the local services and local expert HCP to 
implement treatment. 
7.7.2 NICE guidelines for OCD and BDD (2006) 
The NICE (2006) guidelines are considered a valuable resource in clinical treatment 
decisions, yet for BDD it does not have a sound evidence-base (Hurwitz, 2001). 
Including BDD under OCD spectrum disorders in the DSMV (2013) and ICD11 
(2018) as well as including BDD in the NICE (2006) guidelines alongside OCD has 
been discussed and debated in the literature with consensus that the diagnostic 





Phillips, Wilhelm, Koran et al., 2010; Grant, et al., 2004; Phillips, Pinto, Menard et al., 
2007). However although there is some evidence for recommendations made by the 
NICE (2006) guidelines there are reservations about how comprehensive this is 
given the limited research evidence for treating BDD (Harrison, et al., 2016). This 
was also remarked upon by the clinicians who participated in the study. With their 
experience of treating both disorders in the same setting their views were that BDD 
should have separate guidelines or recommendations for treatment. 
There are areas lacking for BDD in the key principles for developing the NICE 
guidelines (Appendix X; 2.4, pg. 39). Where evidence based research of a disorder 
is insufficient, it is not endorsed to develop clinical practice guidelines (Field, Lohr, 
1992). Instead consensus recommendations can be formalised based on available 
research findings; clinicians’ experience and expertise; qualitative information from 
patient responses and views of interventions (Trickey, Harvey, Wilcock, et al., 1998; 
Diamond, Dagna, Hyman, et al., 2014). Development of consensus 
recommendations for BDD could be an area of future development but may require a 
large scale multi-centre study of the implementation of the NICE (2006) guidelines to 
endorse the need for this.  
 
7.7.3 NHS operational policies  
One of the obstacles described by clinicians interviewed was inflexibility in some 
aspects of practice due to Trust policies. Although it is a blanket policy system for the 
Trust’s operation, there are additional policies to allow for systems to be reviewed 
(SWLSTG, 2016). It would be beneficial for the application of the operational policy 
for specialist services to be reviewed in light of clinicians’ views, and agreed 
compromises to be established. The department has previously argued against a 
specific infection control policy requiring handwashing posters and antibacterial hand 
gel dispensers in the Unit as it was contraindicated for patients with OCD to be 
exposed to this. This was agreed by the Trust; therefore similar consideration should 
be given to BDD sufferers where there are specific requirements e.g. the use of 
mirrors for BDD interventions. 
In addition it is recommended to include basic screening questions for BDD (Fig. 1) 
in the routine assessment process in CMHTs and healthcare settings where people 





2015). Furthermore the NICE Quality and Outcomes Framework (QOF) report on 
anxiety and depression highlighted social anxiety as the most common presentation 
of anxiety disorders. However given the propensity for people with BDD to be 
misdiagnosed, including BDD screening as a QOF indicator may provide incentives 
for GPs to recognise and diagnose BDD (Phillips, 2000; Fang et al., 2010; NICE, 
2015).  
 
7.7.4 Wider policy recommendations 
As described in the literature and supported by comments from patients and 
clinicians, it is clear that early intervention to prevent the longer term implications of 
BDD will be the most logical step. Although the causes of BDD are still not fully 
understood, there are links made from clinical presentations indicating common 
factors which may have a bearing on the development of the disorder. Peer 
pressures; bullying; adverse early experiences are among the contributing factors 
described in literature on development of BDD (Phillips, 1991; Veale et al., 2010).  
 
7.7.4a Recommendations for education 
With the recognition of the disabling impact of conditions such as BDD there needs 
to be a stronger drive to promote awareness and early intervention especially in 
schools where the problem initially manifests and can be addressed before 
becoming a fully-fledged disorder (NICE, 2006; NCCMH, 2018). Including topics in 
the curriculum about self-esteem, confidence and resilience-building can help 
teenagers to make sense of their development and experiences. In addition experts 
in the field can be invited to talk in schools to provide the basic information about 
BDD, plus signs and symptoms of the disorder which parents/carers and teachers 
could identify, with a clear pathway to access appropriate services. 
 
However there still needs to be a pathway developed for young people to access 
help if they feel they are vulnerable to developing the disorder. Key stakeholders 
such as school nurses, education welfare officers, paediatricians, GPs and parents 
need the necessary information to be able to recognise BDD and services need to 
be in place to intervene at the onset. Here again the necessary skills and 
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native generation, there are additional avenues of stressors on young people that 
have to be accounted for. Recognising that the use of technology is a part of their 
culture means adapting teaching policies to incorporate promoting safer and 
appropriate use of social media (Subrahmanya, et al., 2008). 
 
7.7.4b Recommendations for physical healthcare services 
In addition one of the quality, innovation, productivity and prevention (QIPP) 
challenges for the NHS is to have more integration between physical health care and 
mental health services (DoH, 2011, 3.26-3.30 pg. 23; DoH, 2010). The role of body 
image especially in young people is cited by the DoH as one of the targets for the 
“no health without mental health” campaign (DoH, 2011, 3.12, pg.19). With the high 
rate of presentation of BDD cases in physical health settings it would be a logical 
step to adjust operational policies to bring these sectors together for closer working. 
This could create an improved pathway of care for BDD sufferers therefore patients 
can access appropriate services earlier on. With the NHS and DoH looking for new 
improved ways of working this interface between health sectors would allow for more 
dynamic use of clinical resources (NHS England, 2017).    
 
From research and reports it is recommended for good practice that the 
psychological needs of patients attending departments such as maxillofacial surgery, 
dermatology, plastic surgery, are addressed to support the medical team (Naylor, 
Parsonage, McDaid, et al., 2012; NHS England, 2015). Research also suggests CBT 
as a beneficial adjunct to medical treatment for patients with head and neck cancer. 
Due to the location of the cancer and the effects of treatment on social interaction, 
patients with head and neck cancer are at particular risk of psychological problems, 






The opportunity to contribute to the knowledge base and field of study is directly 
related to the dissemination strategies used (Boddy, 2011). Communicating findings 





approach taken was not only to present findings but to promote implementation of 
strategies in clinical practice (Bero, Grilli, Grimshaw, 1998).  
 
There are ethical considerations of ensuring findings are made available to the field 
of study and particularly where research involves qualitative data there is a 
responsibility to ensure the stories of the participants are heard in a responsible 
manner ensuring ethical principles are upheld (Boddy, 2011). 
  
The dissemination practice for research findings was challenged in the following 
quote:  
‘Research is of no use unless it gets to the people who need to use it’ Professor 
Chris Whitty, Chief Scientific Adviser for the Department of Health, (NIHR: 2016). 
 
7.8.1 Dissemination activities to date 
 
At the time of writing the findings from this study have been presented to the staff in 
the specialist service. This included the clinical lead, ward manager and outpatient 
team manager who have treatment and service management responsibilities. 
 
Masterclass presentations on BDD were provided for the Trust and primary care staff 
covering the region of South West London. This was aimed at promoting awareness 
of BDD, its recognition, assessment and treatment. Further to this, presentations 
were given on BDD at the Institute Of Trichologists; IAPT services in Wandsworth 
and Merton; one day lectures on BDD at University of Derby; Maxillofacial surgery 
and Orthodontics St George’s Hospital. Aspects of findings and information on BDD 
were also presented at the British College of Aesthetic medicine in 2017.  
 
From the quantitative data analysis and collaboration with colleagues a poster 
presentation on gender differences was produced and accepted at the Annual 
Meeting of the American Psychiatric Association and was subsequently published in 
the Journal of Obsessive-Compulsive and Related Disorders (Tyagi et al.,2013). 
 
One of the most exciting opportunities to transfer research findings into practice 





department. The findings from the screening service were presented at the 2016 
Psychodermatology conference at the Royal College of Physicians. The presentation 
was subsequently published in the British Journal of Dermatology (Govender et al., 
2017).  
 
7.8.2 Future dissemination strategy  
 
The NIHR dissemination plan template was useful as a guide to plan future 
dissemination strategies. Plans for future dissemination are illustrated in Appendix Y.  
 
7.8.3 Looking back, the way forward 
 
Throughout the course of this study, the shortcomings in services provided for 
people with BDD have been highlighted: from limited education and training to lack 
of recognition and treatment.  
Therefore the stepped process will involve bringing together stakeholders from 
multidisciplinary backgrounds from education, children and adolescent services, 
health care and mental health as well as parent and patient groups who can provide 
input into how to address the lack of awareness of BDD and its development.  Early 
intervention is an important aspect of addressing the development of BDD.  
Information needs to be provided in schools to target the most vulnerable group – 
adolescents where the initial onset occurs (Phillips, et al., 2006). Given the initial 
onset is in adolescence it will be beneficial to consider the use of social media 
platforms and technology to engage this population (Bolton et al., 2013). 
Furthermore with the focus on celebrities and media, developing links with celebrities 
can be a way forward in increasing exposure of BDD to the general public.  
Celebrities such as Gok Wan and Alan Carr have publicly described their own 
experiences with BDD and body image difficulties (Wan, 2010; Carr, 2008).  
 
Developing a global network with others interested in BDD, such as Dr Katharine 
Phillips and Prof. David Veale, will be a step forward to work towards a common goal 
of increasing awareness and recognition of the disorder. This could provide a forum 





with BDD. The BDD foundation provides a forum for patients and carers to find 
support and information but there needs to be an increased awareness amongst 
health care professionals. 
 
During the course of my Doctorate I identified the need for an in-house psychological 
service from the pilot project I established to provide screening for BDD to patients at 
the Oral and Maxillofacial Surgery Unit. This was part of a service development 
initiative to establish joint working between mental health and the health care 
service. Most patients were not receiving mental health assessment or treatment and 
the Oral and Maxillofacial surgery team did not have direct access to psychological 
services. The findings from this initiative clearly indicate more joint working is needed 
with physical health care services (Govender et al., 2017).  
 
From this study it is clear that BDD is not recognised until patients have been 
significantly impaired by the disorder (Table 6). This needs to be addressed by 
developing links with health care professionals such as GPs; primary care nurses; 
Liaison Psychiatry services and providing the basic assessment tools to identify 
patients who possibly have BDD. This does not require an expert in BDD but the use 
of the questions in the NICE guidelines within the usual consultation or assessment 
process (NICE, 2006; Appendix C).  
 
This study has proven to be the culmination of the years of working towards 
understanding this disorder and finding a way forward to promote others’ 
understanding and recognition of BDD. This has been the first step in identifying 
gaps in the literature and in the provision of services to people with BDD and 
formulating a future plan to address these. 
 
7.9 Summary  
 
This chapter brought together findings from each phase of the study identifying key 
themes in how participants experience and perceive treatment and the model of 
care. Through exploring commonalities as well as outliers, obstacles to treatment 
and areas of deficiency were identified with ways to improve the knowledge base 





contributed to indicators for future research and practice recommendations. The 
synthesis highlighted the necessity for greater investment in promoting education, 
research and treatment of BDD. This chapter concludes with a description of the 
















This chapter presents the conclusion of this study which includes a final reflection.  
The purpose of this study was to evaluate the implementation of the NICE (2006) 
guidelines in the treatment of BDD in a specialist service. The aims and objectives 
(1.8.1 pg. 32) of this study were achieved as discussed in Chapter 7 (7.1, pg. 186; 
7.3, pg. 187). 
 
Furthermore this study makes a valuable original contribution to the limited body of 
knowledge about BDD as it is the first known study to provide:  
• Evaluation of implementing NICE (2006) guidelines for BDD in practice.  
• In depth exploration of qualitative data of clinicians’ experiences in treating 
BDD. 
• Interpretation of qualitative data regarding patients’ experience of the package 
of treatment for BDD provided in this specialist service.  
 
8.2 Contribution to knowledge 
8.2.1 Application of the NICE (2006) guidelines for BDD  
 
To date this is the only known study evaluating the use of the NICE guidelines for 
BDD in practice (NICE, 2006). The guidelines are a useful adjunct to clinical 
decision-making but to ensure the recommendations remain relevant and most 
effective for the service evaluating the implementation of the recommendations 
provides that context.   
 
8.2.2 Clinicians’ experiences of treating BDD 
 
The clinicians’ perspective in this study provides a unique insight into the provision of 
the service using the NICE guidelines for BDD (NICE, 2006). The view from the 
interaction with patients is generally lacking in the literature. From current research 
there seems to be a trend to find new approaches and interventions to treat BDD 
(2.6.1). However this study focuses back to the individuals involved in the treatment 





the multiple approaches and flexible nature of treatments utilised by therapists. In 
particular the emphasis from clinicians was on engagement, developing a 
therapeutic alliance and repairing any ruptures in the alliance to ensure the best 
outcomes. Furthermore the clinicians’ perspective provided a direction for 
recommendations for refinements in current treatment protocols as well as future 
research. This study therefore provides an original contribution to the knowledge 
base for BDD from an overlooked perspective. 
 
8.2.3 Patients’ experience of treatment for BDD in a specialist service.  
 
This study provides a clear pattern of themes indicating the most beneficial aspects 
of treatment as experienced by the patient. However given that not all patients 
respond to NICE recommended treatments, obtaining the patients’ perspective 
contributes an insight into what patients’ value most in treatment. Of particular note 
is identifying what may lead to disengagement or lack of response. Considering both 
patients and clinicians placed a high value on the therapeutic relationship, this may 
be the key to better understand the needs of this group of patients. In addition this 
revealed the views of patients regarding the challenging nature of the CBT 
interventions used and possible ways to improve the engagement in this process by 
using other interventions and therapeutic skills. The literature reviewed has focused 
mainly on quantifying treatment responses. By providing a rich analysis of patients’ 
responses, this study adds a further layer to the current understanding of BDD.  
8.3 Research Objectives 
The research objectives (1.8.2 pg. 34) have been systematically achieved through 
the three phases of the analysis. This study identified interventions used by the 
specialist service for treating BDD which are mainly CBT and medication as 
recommended by the NICE guidelines (NICE, 2006). However in addition the 
individual clinicians also tailored treatment to suit the individual patient by using 
interventions such as improving daily living skills and family work. Although these 
interventions were not formally rated to allow for a comparison, this identified factors 
for future research. 
Clinical outcomes were analysed indicating significant improvements in the total 





However analysis of each level of the sample indicated some patients were not 
responding to treatment (Table 9, pg.124). Following on from the quantitative 
analysis the second and third phases of the study sought to provide a context for the 
findings. The synthesis of the study findings discussed areas of effectiveness and 
those requiring refinement. 
Salient points 
The qualitative data provided an interesting dichotomy of responses between the two 
groups of participants. Clinicians voiced more frustrations and helplessness 
especially with the limitations in understanding BDD and treatment options (HCP8: 
6.5.1 pg. 160; HCP1: 6.5.2 pg. 164; 6.8; pg. 180).  
Patients on the other hand seemed to have fewer expectations of treatment with 
some exceedingly grateful for the treatment received which sadly suggests the lack 
of positive experiences prior to their treatment (Alice; Gail: 5.5.1, pg.137). However 
there were some patients participants who experienced difficulty with the treatment 
including not seeing it as a collaborative approach which reflected in their outcome 
scores on objective measures and may provide direction for engagement 
approaches such as using motivational interviewing techniques (Fred: 5.5.1 pg.137; 
5.6.1 pg. 142; 5.7.1 pg.147).  
It is clear from the views expressed as well as available literature that in order to 
improve quality of life for BDD sufferers, there is a need for additional treatment 
strategies to address functioning in other spheres (1.2.5 pg.19; Frare et al., 2004; 
Phillips et al., 2006). Vital activities of daily life such as education/occupation, family 
relationships, home management and social and leisure activities are perceived as 
inadequately addressed within the structured CBT and medication treatment 
strategies recommended (6.6.1; 6.7.1). Anecdotal evidence and studies using a 
more individualised approach suggest a more comprehensive package of treatment 
will be beneficial for BDD sufferers (Wilhelm et al., 2013; Khemlani-Patel et al., 2011; 
MHC, 2006).  
Treatment guidelines need to be viewed in an objective and critical way to ensure 
best practice. Also not all stakeholders were included in the panel contributing to the 
NICE guidelines for OCD/BDD (2006). It would have been beneficial to have views 





patients with BDD tend to present at these settings (Sarwer, et al., 1998; Aouizerate, 
et al., 2003; Conrado, et al., 2010). 
8.3.1 Reflexivity 
 
Reflexivity involves the researcher having awareness of their own beliefs and 
personal constructs and how these influence the research topic and the 
representation of the data (Etherington, 2004). Following the semi-structured 
interviews with patients and clinicians, I felt it would be beneficial to describe my own 
reactions and interpretations of the participants’ experiences. This transparency also 
allows an insight into how the interpretations were made and draws in the reader to 
consider their experience of the participants’ comments (Etherington, 2004). This 
links in with the epistemological positions adopted for this study, which recognise the 
influence of the researcher (Trochim, 2006; Weber, 2011). In addition given the 
stance taken with providing my interpretation of the data, this reflection provides an 
additional context for the reporting of the qualitative data (3.7.1., pg. 91; 6.1.).  
 
Reflections on qualitative data from patient participants 
Experiences described by patients who have struggled to find appropriate treatment 
left me saddened e.g. Gail who reported having had a lifetime of suffering with BDD.  
 
Listening to the comments of patients regarding their experiences made me feel a 
mixture of responses. This also influenced the coding process of searching for other 
instances of these experiences which I found in most of the transcripts. The loss of 
all those years due to a lack of appropriate help and a limited understanding of the 
disorder gave further impetus to my drive to educate the general public and 
healthcare professionals about BDD.  
 
On the other hand descriptions of how much they have gained from treatment gave 
me a sense of elation e.g. Alice: “The therapy has saved my life and remade it.” This 
gave me the evidence to validate the treatments provided. This also influenced the 
analysis of the transcripts to find other instances where patients did not feel the 
treatment helped them which inspires me to continue to improve on interventions 






Reflections on qualitative data from clinician participants 
Although we work towards helping people get better, we learn more about becoming 
better clinicians from those who we have not been able to help. I had a sense of the 
frustration and helplessness described by clinicians which I could relate to. This 
influenced my analysis of the data in ensuring that these comments were not 
overlooked as it gave a voice to the clinicians. It is one of the motivating factors for 
this study and to identify the gaps in the service and evidence-base for treating BDD.  
 
However I felt annoyed when I found the views of one of the HCPs to be too 
inflexible and defensive rather than being objective about the shortcomings in the 
treatment (HCP3). This made me think that they were putting their role first rather 
than the patients’ care and not in keeping with the principles of CBT. I therefore 
analysed the data with this in mind to identify any other instances where this was the 
case but found it was the opposite with patient-centred care and collaboration at the 
forefront of clinicians’ views. I re-read the HCP3’s transcript and considered the 
HCP’s comments in a more objective way so that I gave a more balanced 
interpretation of the comments. This made me more cognisant of the influence of my 
own reactions in analysing the data.   
 
8.4 Final reflection 
 
The doctoral process has been a tremendous learning and growth experience from 
reflecting on the motivation for my interest in this subject to the immersion in the 
qualitative data. Prior to this study, my research experience had been restricted to 
pursuing quantitative studies and my initial stance came from a positivist outlook. 
This was mainly due to a culture of producing outcomes research that would be 
more readily accepted by journals. However reflecting on my own experiences of 
treating patients with BDD, I felt it imperative to explore the experiences of patients 
and clinicians which I believed would provide direction for future developments for 
BDD. Having an awareness of my own bias being a CBT practitioner and having a 
strong belief in this model, my choice of transcript excerpts to include in the 
appendices was in keeping with the critical stance taken throughout this study. I felt it 
was important to recognise when services were not meeting needs in order to 
generate improvements. Merely sharing results of when it has been beneficial as 





provision as few lessons can be learnt to promote development. Given the 
movement towards qualitative research is growing this avenue proved exceptional in 
providing a deeper understanding of the experiences of both patients and clinicians 
and areas for improvement. Seemingly a supporter for the misunderstood and under-
represented, my choice of TA as a method of analysis is fitting as it is also an area 
needing further research and acknowledgment despite it being a basis for almost all 
qualitative methods (Braun et al., 2006).  
 
Over the course of preparing this thesis I noticed the development in my writing style 
becoming more concise and refined with the ability to incorporate the critical stance 
in a more seamless way. I also discovered a great deal of satisfaction in the process 
of writing and imparting my thoughts and ideas. During the doctoral journey, life 
circumstances resulted in needing to have a break from study. Furthermore due to 
family responsibilities I decided to resign from my post. However I was able to 
continue my research with an honorary contract and although initially the 
bureaucratic process presented difficulties and delays, it also provided me with a 
new perspective on the service. I am fortunate to able to continue to work with 
patients with BDD as an independent CBT practitioner and continue to have links 
with the service. Interestingly having separated from the service provided me with a 
different perspective which gave more credence to the critical stance taken in the 
study.  
 
Throughout this doctoral journey, supervision was the anchor that helped me stay on 
track and overcome setbacks. I found the doctoral path a lonely one with the 
isolation of distance learning providing little opportunity in later stages to engage in 
sharing of ideas and concerns or stimulating debates. However I also realised my 
passion for the subject and my resilience in the face of difficult personal life events 
and changes in my professional identity. Finally I am proud of all I have achieved 
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Appendix A: Diagnostic Criteria for Body Dysmorphic Disorder (ICD 11, WHO 
2018) 




Body Dysmorphic Disorder is characterized by persistent preoccupation with one or 
more perceived defects or flaws in appearance that are either unnoticeable or only 
slightly noticeable to others. Individuals experience excessive self-consciousness, 
often with ideas of reference (i.e., the conviction that people are taking notice, 
judging, or talking about the perceived defect or flaw). In response to their 
preoccupation, individuals engage in repetitive and excessive behaviours that 
include repeated examination of the appearance or severity of the perceived defect 
or flaw, excessive attempts to camouflage or alter the perceived defect, or marked 
avoidance of social situations or triggers that increase distress about the perceived 
defect or flaw. The symptoms are sufficiently severe to result in significant distress or 
significant impairment in personal, family, social, educational, occupational or other 
important areas of functioning.  
Exclusions  
• Anorexia Nervosa (6B80)  
• Bodily distress disorder (6C20)  
• Concern about body appearance (QD30-QD3Z)  





Appendix B: Diagnostic Criteria for Body Dysmorphic Disorder   
Content removed due to copyright reasons 
(American Psychiatric Association. Diagnostic and Statistical Manual of Mental 
Disorders (DSM-5®), American Psychiatric Publishing, 2013). 
      
Appendix C: Recommended questions to identify individuals with BDD 
symptoms (NICE, 2006: 10.4.2.2, pg. 230) 
 
• Do you worry a lot about the way you look and wish you could think about it 
less?  
 
• What specific concerns do you have about your appearance?   
 
• On a typical day, how many hours a day is your appearance on your mind? 
(More than 1 hour a day is considered excessive)   
 
• What effect does it have on your life?   
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PsychInfo Academic Index
Science Direct iSeek
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Researchgate SSRN
EBSCO host Scopus
The Cochrane Library SciELO
The British Library Embase
Appendix D: Overview of the literature search 
SEARCH 
TERMS
Body dysmorphic disorder, dysmorphophobia, body image disorder, 
muscle dysmorphia, somatoform disorder, BDD.
Psychological treatments for BDD, cognitive behavioural/behavioral 
therapy, psychotherapy, EMDR, cognitive therapy, 
behavioural/behavioral therapy, psychoanalysis, psychodynamic 
therapy, CBT, CT, BT, Internet, computerised treatment.
Pharmacological treatments for BDD, medication for BDD,SSRI, 
antipsychotics, dopamine blockades, SNRIs, MAOIs, augmentation for 
BDD.
Medical treatment of BDD, physical interventions for BDD, somatic 
treatment for BDD.
Cosmetic surgery for BDD, aesthetic procedures for BDD. 
140 articles published in English 
45 studies identified as relevant
26 studies on 
psychological 
treatments
11 studies on 
pharmacotherapy
8 studies on medical 
treatments e.g. surgery 





Appendix E:  Psychological treatment of patients with BDD  
First Author and 
year 
Intervention Sample (n) Gender Age Design Measures Outcomes 
 





Once weekly sessions 













According to the authors the patient 
showed some improvement in her 
functioning.  
2. Rosen, et al. 
(1989) 
CBT in groups; 
Minimal treatment 
control group 





RCT -Body Shape Questionnaire 
-Bulimia Test (BULIT) 
-Body Dissatisfaction Scale of the 
Eating Disorders Inventory 
-Body image behavior questionnaire 
Improvements were shown in all aspects of 
body image perception for the CBT group: 
size overestimation,  p=0.004; Body Shape 
Questionnaire,  
p=0.005; Body Dissatisfaction Scale, 




3. Watts (1990) Behavioural and 
interpretive intervention  
36 sessions 
1 Male 20 Case study None reported Behavioral therapy produced some 
improvement with further progress using 
interpretive methods. This allowed for more 
behavioural work to be done and additional 
improvement. 
        
















-Overvalued Ideation Scale (OVI) 
-Modified Yale Brown Obsessive 
Compulsive Scale (BDD-YBOCS) for 
BDD 
Four patients showed improvement, one 
patient disengaged. One patient had 12 
weeks intensive treatment, showing the 
most improvement at follow up. Four 
patients showed at least a 2 point drop in 
the OVI post treatment.  
 
5. Gomez-Perez 
et al., (1994) 
Behaviour therapy 
(ERP) 
M= 14 hours of therapy 










-Main problem severity  
-Fear Questionnaire (FQ) 
-Work adjustment and Social 
adjustment 
- Intensity of belief in a body defect 
Nine patients (43%) showed much 
improvement in the main problem severity 
with six (28%) slightly improved and six 
(28%) showing no improvement. 
Follow up at 1-3 months (N=17): nine 
patients were much improved with six 
slightly improved and two with no 
improvement. 
At 6-12 months follow up (N=10): eight 
(80%) patients showed much improvement 






























- Semi-structured interview Body 
Dysmorphic Disorder    Examination 
(BDDE) 
- Body Shape Questionnaire 
- Multidimensional Body Self-
Relations Questionnaire (MBSRQ)  
- Appearance Evaluation scale 
- Brief Symptom Inventory 
- Rosenberg Self-Esteem Scale. 
 
 
Out of 27 subjects in the CBT treatment 
group 22 (81.5%) showed clinical 
improvement at post treatment and 20 at 
four and a half months follow-up compared 
to the no treatment control. The main effect 
for the treatment group was significant: 
F=20.01, p = 0.000. MANOVA indicated: 
Significant improvement over time in 
treatment group from baseline to post 
treatment and follow-up: p=0.000. 
 









Individual CBT  







RCT  - Semi-structured interview BDDE  
-BDD-YBOCS  
- MADRS 
-Social phobia and anxiety inventory  
-Hospital Anxiety and Depression 
Inventory  
- Derriford Scales 
 
Seven out of nine in treatment group no or 
subclinical BDD symptoms at end of 
treatment. Participants showed a 50% 
reduction in symptoms on main outcome 
measure (YBOCS-BDD). All subjects on 
waiting list showed clinical level of BDD 
symptoms throughout. 
8. Neziroglu et al. 
(1996) 
CBT (Daily 90min 
sessions over 4 









-Structured Clinical Interview for 




70.6% (n=12) showed an improvement of 
more than 50%. Significant difference on 
BDD-YBOCS across all subjects from pre to 
post treatment t=6.40, p < 0.001. 
 






6 weeks, 5 sessions 
per week, 90 minutes. 















-Structured Clinical Interview for 
DSM-III-R (SCID) 
-Behavioral Avoidance Test (BAT).  
-BDD-YBOCS.  
-Beck Depression Inventory (BDI).  
-Beck Anxiety Inventory (BAI). 
All participants showed improvements on all 
measures: BDD-YBOCS: t = 5.48, p < 
0.001, BAT: t= 7.12, p < 0.001, BDI: t= 
4.12, p < 0.01 and BAI:t = 2.76, p < 0.05. All 
patients remained BDD symptom free at 6 
month follow up although control group had 
higher levels of anxiety and depression 
than the maintenance group.  
 



















Defined by Diagnostic and Statistical 
Manual of 
Mental Disorders 4th Edition, (DSM-















Group CBT, 12 weekly, 
90 minutes. Three 




























Significant reductions in BDD symptoms 
overall. BDD-YBOCS: reduction of M=9.6 
points on the BDD-YBOCS and M=11.3 
points on the BDI. t=3.94, p<0.01. Results 
remained significant when three patients 
receiving additional individual therapy were 
removed: BDD-YBOCS: t=3.58, p<0.01. 
Depression scores showed improvement. 
 
12. Geremia et al. 
(2001) 
 























One discontinued therapy. Three showed 
decreased BDD symptomatology with 
significant difference from baseline to post-
treatment (p < 0.05). The difference from 
baseline to follow-up was also significant (p 
< 0.05). 
 





1 male 23 Case study -BDD-YBOCS.  
- BDI. 
Baseline score on BDD-YBOCS= 32, 
severe level. After treatment reduced to 20, 
moderate level. BDI scores also decreased 




et al. (2011) 
 
Culturally adapted 













-Clinical Global Impression Scale 
(CGI) 
- BDI-II 




One improved to having no BDD symptoms 
and the other improved to subclinical 
symptoms on  
BDD-YBOCS. 
15. Khemlani-
Patel et al. (2011) 
 
CBT for BDD-
comparison of CT 
versus Behaviour 
therapy (BT) and CBT 
vs BT. 
Individual therapy 12 
sessions CT 
12 sessions BT 
Total of 24 sessions 
three times per week 
for 90 minutes.  










cohort study.  
Group 1 CT and 





-Quality of Life Inventory (QOLI) 
-Social Avoidance and Distress Scale 
-Defect Related Beliefs Test  
-The University of Rhode Island 





Results for CT vs BT indicate that all 
participants improved significantly on Y-
BOCS BDD: [F(1,8) = 14.028, p = 0.006]. 
CBT vs BT showed significant gains on 
BDD symptoms overall: [F(1,8) = 16.846, p 
=0.003]. Improvements were found 
regardless of whether treatment was CT, 
BT or CBT.  Improvement of CT/ CBT group 
from baseline to post treatment on 
YBOCSBDD was 48% (M= 13.6) and 37% 











CBT- 18 or 22 
individual therapy 
sessions of 60minutes, 
twice weekly for 4 



















18 or 22 session 
groups. 














Those completing treatment (n=10) showed 
mean percentage decrease of 53% on 
BDD-YBOCS with significant difference 
from baseline: 
t =6.08, p <0.001. The significance was 
maintained for intention to treat: mean 
reduction of 47.1% on BDD-YBOCS: t 
=5.41, p <0.001 CGI. Nine provided follow 
up data at 3 and 6 months which showed 
improvements to be maintained. According 
to the CGI 80% of the completers remained 
stable. 
 
17. Rabiei et al. 
(2012) 
Metacognitive Therapy 




2 males  
16 -37 
(M = 25.2, SD 
=6.5) 
RCT waiting list 
control 
- Defined by Diagnostic and Statistical 
Manual of 
Mental Disorders 4th Edition, (DSM-
IV) Specific measure not stated. 
-BDD-YBOCS 
-Thought Fusion Instrument (TFI) 
-Patients’ satisfaction 
Post treatment 70% of sample scored 20 or 
under (mild to subclinical symptoms) on 
YBOCS BDD. All the patients in the wait-list 
control group remained at clinical levels. At 
follow-up, it was 60% in the treatment group 
with mild to subclinical symptoms and no 
change in the control group. 
 




















- Inferential Confusion Questionnaire 
– Expanded Version (ICQ-EV) 
 
The post treatment score showed M= 13.4 
(p<0.001) improvement of BDD symptoms. 
Significant reduction in depressive 
symptoms and overvalued ideation. There 
was no significant change in the BAI and 
ICQ. 
19. Veale, et al., 
(2014) 
 
















-Appearance Anxiety Inventory (AAI) 
-  Patient Health Questionnaire (PHQ) 
-  Generalised Anxiety Disorder-7 
(GAD-7) 
-  Body Image Quality of Life 
Inventory (BIQLI)  
 
CBT significantly better than AM at 12 
weeks on BDD symptoms. At 12 weeks 
48% in the CBT group were responders 
with an increase to 52% at 16 weeks and 
maintained at 1 month follow up. The AM 
group showed 12% responders at 12 weeks 









































17 randomised to CBT-BDD, and 19 
randomised to waitlist.  By week 12, CBT-
BDD  participants showed 50% were 
responders, compared to 12% of 
participants on waitlist (p = 0.026).  
 




12 weeks group and  














-Quality of life Inventory (QOLI) 




At post treatment 68% of completers 
showed a significant improvement in BDD 
symptoms. 















Four participants showed clinically 
significant improvement in BDD symptoms. 
At 6 month follow up the overall 
improvement for the four responders 
ranged from 57%-81% reduction in scores 
on the BDD-YBOCS. Two non-responders 
showed none to minimal improvement. 
 

















- Body dysmorphic disorder 
diagnostic module (BDDDM) 
- BDD-YBOCS 
-Body dysmorphic symptoms 
inventory (FKS: Fragebogen 
korperdysmorpher symptom) 
- BDI-II 
-Semi-structured interview  
 
Four participants were responders. The 
whole group showed a significant decrease 
in BDD symptoms of 19% after imagery 
rescripting. Treatment responders showed 
a decrease in BDD symptoms of 24% post 
treatment (p<0.001).There was a further 
12% reduction at follow up showing a 
significant improvement from baseline to 





     
(Appendix E 
contd.) 






























































































- Global Assessment of Functioning 
(GAF) 
- Body Dysmorphic Dimensional 
Scale (BDD-D) 
- Montgomery-Åsberg Depression 
Rating Scale, self-report (MADRS-S) 




Using ≥30% decrease on the BDD-YBOCS 
as a response rating, 82% of completers 
were responders post treatment. The mean 

























































- Depression Anxiety Stress Scales 
(DASS -21) 




- BDDQ;  
- Dysmorphic Concerns 
Questionnaire (DCQ) 
- Alcohol Use Disorders Identification 
Test (AUDIT) 
-Drug Use Disorders Identification 
Test (DUDIT)  
- BDD-YBOCS 










IBM group indicated a 35% improvement 
on BDD symptoms whilst the placebo 
control group showed a 20% improvement. 
Depression and anxiety measures 
indicated minimal changes for both groups. 
 
Improvement baseline to week 6 p<0.001. 
Further improvements 
were seen at post-treatment p<0.001. 
Maintained at 3 months follow up. 
Significant improvement 




Appendix F:   Pharmacotherapy for patients diagnosed with BDD      
First Author and 
year 
Intervention Sample (n) Gender Age Design Measures Outcomes 
1. Hollander et al., 
(1999) 
Length of trial: 16 
weeks Clomipramine 

















-  Structured Clinical Interview for 
DSM-IV (SCID) 
- Y-BOCSBDD 
- National Institute of Mental 
Health Global Obsessive-
Compulsive Scale (BDD-NIMH) 
-  Clinical Global Impression scale 
(CGI) adapted for BDD 
- Hamilton Depression Rating 
Scale (HAM-D) 
- Social Avoidance and Distress 
Scale 
- Fear of Negative Evaluation 
Scale 
- Fixity of Beliefs Questionnaire 
modified for BDD 
- Schneier Disability Scale 
 
Both medications showed an 
improvement in symptoms but 
Clomipramine treatment resulted in 
significantly greater reduction on Y-
BOCSBDD:  M=16.2 (SD 8.5) than 
Desipramine treatment: M= 20.7 (SD 
7.7) p = 0.003.  Clomipramine had a 
response rate of 65% compared to 
35% for Desipramine.  
2. Phillips et al., 
(1996a) 
Length of trial: 8 
weeks. 
Buspirone 





Open label trial -SCID 
-CGI 
-Semi-structured interviews 
Six (46%) patients improved. Three 
reduced dosage or stopped taking 
Buspirone resulting in increased 
symptom severity. One resumed the 
higher dose and improved again. 
Response time was M=6.4 weeks 
(range 5-9 weeks) 
        
3. Phillips et al., 
(2002) 
 
Length of trial: 
12 weeks. 
Fluoxetine   
Dosage from 40 to 80 













-  BABS  
- BDD Diagnostic Module based 
on DSM-IV criteria 
- SCID-P 
- BDD Form Semi-structured 
instrument for clinical 
characteristics of BDD 
(unpublished Phillips, 1992) 
- Electrocardiogram (ECG), 
Physical examination and standard 
blood tests and drug screening. 
Fluoxetine was significantly more 
effective than placebo on the Y-
BOCSBDD after 12 weeks of 
treatment. The baseline for the 
fluoxetine group was M= 31.5 (SD= 
5.6) reducing to M=21.0 (SD=9.8) at 12 
weeks, which represented a 33% 
reduction on the main outcome 
measure.18 (53%) of subjects 
responded to fluoxetine compared to 6 
(18%) response to placebo. 






4. Amâncio et al., 
(2002) 
 














Patient was reported to be 
asymptomatic 30 days after starting 
Venlafaxine 75mg twice daily. Followup 
at six months showed the patient to 
remain asymptomatic. 
 
5. Phillips et al., 
(2003) 
Length of trial:  








Case series - YBOCS BDD 
-CGI 
-BABS 
-Quality of Life Enjoyment and 
Satisfaction Questionnaire (Q-
LES-Q) 
- Global Assessment of 
Functioning (GAF) 
73.3% (N=11) of subjects responded to 
treatment. The YBOCSBDD showed an 
improvement of M=15.4 from baseline 
to completion. The CGI, showed 40% 
(N=6) of subjects were very much 
improved, and 26.7% (N=4) were much 
improved. There was also significant 
improvement in psychosocial 
functioning and mental health-related 
quality of life.  
 
 
6. Phillips, (2005a) Length of trial:  
8 weeks. 
Pimozide  
Dose at endpoint: 
M=1.7mg/day 
(SD=1.0) 















-Brief Psychiatric Rating 
Scale 
Pimozide was not more efficacious 
than placebo for body dysmorphic 
disorder severity or on any other 
measure.  Out of 11 subjects, two 
(18.2%) responded to Pimozide and 
three (17.6%) in the placebo group 
(n=17) were responders. 
 
7. Phillips, (2005b) Length of trial:  
8 weeks. 
Olanzapine   









Open label trial -Y-BOCSBDD 
-CGI 
 
Olanzapine showed minimal 
improvement of BDD symptoms on the 
CGI in two patients and unchanged in 
four. 
8. Phillips, (2006) Length of trial:  
12 weeks 
Escitalopram  















-Global Assessment of Functioning 
On intention to treat analysis 73% 
(n=11) of subjects were responders.  Y-





-Social and Occupational 
Functioning Assessment Scale  
- Longitudinal Interval Follow-up 
Evaluation (LIFE) 
- Short Form Heath Survey  




9. Allen, et al., 
(2008) 







maintained at this 
dose for 8 weeks. 
(17) 11 
completed 





Open label trial  -Y-BOCSBDD 
-CGI 
- BABS  
-Overvalued Idea Scale  
-Schneier Disability Scale.  
-Body Dysmorphic Disorder 





64% response rate. Y-BOCSBDD 
score reduced by ≥33% (n=5). 
10. Rashid, et al., 
(2015) 





Risperidone, (n=6)  








Not reported Retrospective 
Case note study  
-Y-BOCSBDD Group 1: n=11 no antipsychotics given. 
Five patients (45%) improved, five 
disengaged and one showed no 
response. 
Group 2: antipsychotics given (n=21) 
13 (62%) improved. Two disengaged, 
six did not show response. 




Phase 1: Length of 
trial: 14 weeks 
Escitalopram  
 
Phase 2: Length of 








Phase 2  
























-Range of Impaired Functioning 
Tool 




Phase 1: 81.1% improvement on BDD 
symptoms for 74 completers.   
p<0.0001 on Y-BOCSBDD, BABS, Q-
LES-Q, HAM-D, Impaired Functioning 
Tool. 
Phase 2 outcome for 28 subjects 
randomised to continuing escitalopram, 
showed further significant improvement 
on Y-BOCSBDD with M=4.1 points 
reduction on scores (p<0.036). 
Relapse rates: escitalopram treated 
group 18% by end of 6 months 
compared with relapse rate of 40% for 




   




Intervention Sample (n) Gender Age Design Measures Reported Outcomes 




BDD n= 6 
88% female, 12% 
male 
 
22-63 (M= 36) Retrospective 
cohort study  
No measures reported Satisfaction with surgery n= 6.  
DIY surgery n= 9. All 
dissatisfied. 
 
2.Phillips, et al., 
(2001) 
Cosmetic surgery and 
MI procedures 



















-Schedule for Affective 
Disorders and 
Schizophrenia for School-
Age Children-Present and 
Lifetime Version (K-
SADS-PL): 
66% (n=165) received cosmetic 
procedures. 
484 treatments received. No 
change in BDD symptoms   in 
326 (72%) of treatments 
received. 68.7% (46) of 
treatments showed no 
improvement or worsening of 
BDD symptoms. 
Children/adolescents: 56.3% 
(n=9) received procedure. No 
changes in BDD severity or 
preoccupation/   
 
3.Veale, et al., 
(2003) 

















-Nose imperfection was 
rated by the patient on 








Follow up post-surgery: 3 
months n=2 ‘possible BDD’.  
9 months n= 0 rated as 














































-Medical outcomes study 
-Quality of life enjoyment 
and satisfaction 
Questionnaire 
-Social adjustment Scale 
self-report 
 
N=128 patients underwent 
nonpsychiatric medical 
treatment. 91.0% showed no 
improvement in BDD 
symptoms. 3.6% showed 
improvement and 5.4% 
indicated worsening of BDD 
symptoms. Four subjects 
(2.0%) reported the medical 
treatment triggered the onset of 
BDD. 
5.Tignol  et al., 
(2007) 
Cosmetic surgery (30) 24 followed 
up 
10 BDD  
14 non-BDD 
10 BDD: 




BDD: M=42.5 (SD 
= 11.6). 
Non-BDD: M=51.9  




-SCID-BDD Module  





N=7 BDD patients underwent 
cosmetic surgery. Follow up 
n=6 remained at clinical range 
of BDD.  
N=8 of the 14 non-BDD 
underwent cosmetic surgery. 







200 137 females,  
63 males 
 









N=87 procedures  
Long term: Y-BOCSBDD: 
surgery received (n=42): 
M=24.7(SD=11.1).  
Not received (n=158): M=28.4 
(SD=9.7) 
Short term improvement= 
43.4% (n=37) 
Long term = 2.3% (n=2) 
Long term, no change or worse:  
97.7% (n=85). 
Non-surgical/MI procedures: 





therapy (ECT) 6 
sessions ECT over 2 
weeks. Average length 
of seizures was 62 
seconds. Seizures > 
25 seconds was 
defined as a 
therapeutic level. 
1 Male 24 Case report No measures reported The patient’s mood, anxiety 
symptoms and delusional 
symptoms improved. At six 
months follow up patient not 







8.Felix, et al., 
(2014) 





25 (80.6%) of the sample 
showed complete remission of 
the BDD symptoms at 1 year 
follow up with 28 (90.3%) 












Appendix H: A convergent mixed methods parallel design of the phases of the study (Adapted from Creswell, et al., 2011). 
 
          Phase 1:      Phase 2:      Phase 3: 
Procedures:      Procedures:           Procedures:      
Identify participants                 Recruit participants          Recruit participants     
N=48       N=7            N=10  
Collate data       Semi-structured            Semi-structured     
from measures       interviews           interviews 
and case notes.       Products:           Products:  
Products:      7 transcripts           10 transcripts    
Dataset variables      Procedures:            Procedures: 
Procedures:      Coding,             Coding, 
Input dataset       categorising,           categorising,  
into SPSS (v 25).      identify themes.                         Identify themes. 
Conduct analysis      Products:           Products: 
Products:       3 main themes           3 main themes    
Descriptive and            
statistical results 
























Identify patterns in all data sets and compare and 
contrast in synthesis of results through discussion. 
 
 
Interpret merged results 
Discuss interface between results providing clearer 
understanding and addressing research aims. Consider 
implications for treatment protocols, policies, future 






Appendix I:   University ethics approval  
 
 
RE: Ethics form resubmission   
 
 




Thank you for your amended documents and information/confirmation of service evaluation. I can 
confirm you are able to proceed with your project and wish you every success. 
 
Please note if any changes to the study described in the application or to the supporting 
documentation is necessary you are required to make a resubmission to the College of Health and 
Social Care Research Ethics Committee. 







Chair College of Health and Social Care Research Ethics Committee 
College of Health and Social Care 













Appendix J: Organisation registration of study and ethics approval 
 
Wed 21/10/2015 14:55 
 




Thank you for registering your audit* which has been approved by your supervisor.  
  
Please send me the audit tool you intend to use before starting to collect any data. 
This is to ensure that there is no duplication of work or missed opportunities for joint 
projects.  
  
Please note it is important you have a consultant/ team manager to supervise 
the audit so they can ensure that any recommendations from the audit can be 
turned into actions and I am pleased that Dr. Lynne Drummond has agreed to 
supervise this project. 
  
Please ensure you send me the audit report, along with any action plans once the 
audit has been completed. This should include a date for re-audit and details of 
where the audit report has been discussed (ie local team meeting). An audit report 
template is available on InSite http://insite.xswlstg-
tr.nhs.uk/Clinical/ClinicalGovernance/Pages/Clinical-Audit-Resources.aspx 
I will then be happy to send you a Certificate of Completion.     
  








Clinical Effectiveness Manager and Quality Improvement 
  
T: 020 3513 5881 
M: 07739322275 
F: 0208 772 5519 
E: Maggie.Conway@swlstg-tr.nhs.uk 
A: Quality Governance 
     South West London and St George's Mental Health NHS Trust 
     Ground Floor, West Wing, Building 15, Springfield University Hospital 
     61 Glenburnie Road, London SW17 7DJ 
  
 





Appendix K: Information sheet for patient participants 
      
 
 
NATIONAL and TRUSTWIDE OCD and BDD SERVICES 
MORRISON BUILDING 9E 
SPRINGFIELD UNIVERSITY HOSPITAL 
61 GLENBURNIE ROAD 
LONDON 
SW17 7DJ 
Telephone: 020 3513 6961 
Fax: 020 3513 6965 
Out of Hours Crisis Line:0800 028 8000 
 
Dear  
INFORMATION SHEET FOR PARTICIPANTS (Patients) 
 
Service Evaluation Title: An evaluation of a specialist service model for treating Body Dysmorphic 
Disorder (BDD): application of the National Institute for Health and Clinical Excellence (NICE, 2006) 
Guidelines for BDD. 
 
Invitation and brief summary 
 
I would like to invite you to be involved in this service evaluation which is part fulfilment of my 
Doctorate. Before you decide whether you want to take part, it is important for you to understand why 
the service evaluation is being done and what your participation will involve.  Please take time to read 
the following information carefully and discuss it with others if you wish.  Please contact me if anything 
is unclear or if you would like more information. Thank you for reading this. 
 
What is the purpose of the service evaluation? 
 
This service evaluation is to evaluate treatments and obtain patients’ experiences of treatments 
received in this specialist service for Body Dysmorphic Disorder. The research into treatments for 
BDD is limited and this service evaluation aims to contribute towards the understanding of what 
treatments patients find most beneficial.  
 
What will participation involve? 
 
As you are aware the data from the questionnaires you have completed during the course of your 
treatment is stored anonymously on our database. This information will be used to evaluate the 
treatment we have provided and help us to make changes where needed so that we can provide the 
best service possible to our patients. All information is anonymised, pseudonyms will be used if 





In addition you will be invited to participate in an interview which will comprise of seven questions and 
will take between 30-40 minutes. It is intended as an opportunity for you to express your views on the 
treatments you have received for BDD and what your experience has been. The interview will be 




Although the service evaluation may not have any direct benefit for you, the information you provide 
will be used to help improve the services for treating patients suffering from BDD. It will also be useful 
with providing help to people in the early stages of the disorder to prevent their condition becoming 
worse. 
 
If during the course of the interview, you become distressed for any reason, the interview will be 
stopped. You will be given time to discuss your concerns or upset and your therapist will be available 
if you wish to discuss this further with them.  
 
You will be asked if you wish for your GP or other health care professional to be contacted. You will 
be asked if you still wish to have your responses included in the service evaluation or if there is any 
information you do not want to be used. 
 
If you have any queries regarding your current treatment you will need to direct these to the 




All information you provide will be held in confidence within the limitations of the investigator’s 
professional duty of care. 
 
As part of the presentation of results, your own words may be used in text form in publication. This will 
be anonymised, so that you cannot be identified from what you said.  
 
All of the service evaluation data including audio recordings will be stored in electronic format on a 
secure IT system in keeping with the Data Protection Act (1998) and the Trust’s data protection policy 
at South West London and St George’s Trust OCD/BDD Service for 2 years and will then be securely 
destroyed.  
 
Please note that: 
• You need not answer questions that you do not wish to. 
• All the information will be anonymised. It should not be possible to identify anyone from my 
reports on this service evaluation.  
 
It is your choice whether to take part or not. If you decide to take part you are still free to withdraw up 
to when the data is analysed which will be 3 months after your interview. You can contact me by 
emailing or by telephone and withdraw without giving a reason and without prejudice. If you withdraw 
from the service evaluation all data will be withdrawn and destroyed. If you decide to take part please 
keep this information sheet and sign and return the consent forms in the envelope provided.  
 




Cognitive Behavioural Psychotherapist 












Appendix L: Information sheet for clinician participants 
  
 




NATIONAL and TRUSTWIDE OCD and BDD SERVICES 
MORRISON BUILDING 9E 
SPRINGFIELD UNIVERSITY HOSPITAL 
61 GLENBURNIE ROAD 
LONDON 
SW17 7DJ 
Telephone: 020 3513 6961 
Fax: 020 3513 6965 
Out of Hours Crisis Line:0800 028 8000 
 
Dear  
INFORMATION SHEET FOR PARTICIPANTS (Clinicians) 
 
Service Evaluation Title: An evaluation of a specialist service model for treating Body 
Dysmorphic Disorder (BDD): application of the National Institute for Health and Clinical 
Excellence (NICE, 2006) Guidelines for BDD. 
 
Invitation and brief summary 
 
I would like to invite you to be involved in this service evaluation which is part fulfilment of my 
Doctorate. Before you decide whether you want to take part, it is important for you to 
understand why the service evaluation is being done and what your participation will involve.  
Please take time to read the following information carefully and discuss it with others if you 
wish.  Please contact me if anything is unclear or if you would like more information. Thank 
you for reading this. 
 
What is the purpose of the service evaluation? 
 
This service evaluation is to obtain clinicians’ (psychotherapists, psychiatrists and 
occupational therapists) views of implementing the NICE recommended treatments in this 
specialist service for Body Dysmorphic Disorder. The research into treatments for BDD is 
limited and this service evaluation aims to contribute towards the understanding of what 
treatments are most efficacious. This service evaluation will also obtain patients’ 







What will participation involve? 
 
Participating in a semi-structured interview which will comprise of seven questions and will 
take between 30-40 minutes. It is intended as an opportunity for you to express your views 
on the treatments you have provided for BDD and what contributions it may have to your 
service.  All information is anonymised, pseudonyms will be used if quotes are reported and 
no identifiable details will be presented in the report. 
 
If you have any queries outside of the service evaluation remit you will be directed to your 




All information you provide will be held in confidence within the limitations of the 
investigator’s professional duty of care. 
As part of the presentation of results, your own words may be used in text form. This will be 
anonymised, so that you cannot be identified from what you said. The interview will be audio 
recorded to ensure the accuracy of the data. 
 
All of the service evaluation data will be stored in electronic format on a secure IT system in 
keeping with the Data Protection Act (1998) and the Trust’s data protection policy at South 
West London and St George’s Trust OCD/BDD Service for 2 years and will then be securely 
destroyed. Please note that: 
• You need not answer questions that you do not wish to 
• Your name will be removed from the information and anonymised. It should not be 
possible to identify anyone from my reports on this service evaluation.  
 
It is your choice whether to take part or not. If you decide to take part you are still free to 
withdraw up to when the data is analysed which will be 3 months after your interview. You 
can contact me by emailing or by telephone and withdraw without giving a reason and 
without prejudice. If you withdraw from the service evaluation all data will be withdrawn and 
destroyed. If you decide to take part please keep this information sheet and sign and return 
the consent forms. 
 




Cognitive Behavioural Psychotherapist 



















Appendix M: Consent form for patient participants 
 
 
                             
 
NATIONAL and TRUSTWIDE OCD and BDD SERVICES 
MORRISON BUILDING 9E 
SPRINGFIELD UNIVERSITY HOSPITAL 
61 GLENBURNIE ROAD 
LONDON 
SW17 7DJ 
Telephone: 020 3513 6961 
Fax: 020 3513 6965 
Out of Hours Crisis Line:0800 028 8000 
 
Participant Identification Number for this trial: 
CONSENT FORM (Patients) 
Title of Project: An evaluation of a specialist service model for treating Body 
Dysmorphic Disorder (BDD): application of the National Institute for Health and 
Clinical Excellence (NICE, 2006) Guidelines for BDD. 
 
Name of Investigator: Anusha Govender 
    Please tick box  
1. I confirm that I have read the information sheet dated 13/12/15 (version 2)  
for the above service evaluation. I have had the opportunity to consider the 
information, ask questions and have had these answered satisfactorily. 
       
2. I understand that my participation is voluntary and that I am free to withdraw 
until data is analysed without giving any reason, without my medical care or 
legal rights being affected. 
 
3. I understand that where it is relevant to my taking part in this service  
evaluation, sections of my medical notes, specifically questionnaire  
responses will be looked at by the chief investigator (Anusha Govender).  






4. I understand that where it is relevant to my taking part in this service  
evaluation, an audio record will be made and will only be used by the chief 
investigator (Anusha Govender) for the purpose of the service evaluation.  
I give permission for this individual to audio record my interview.  
 
5.   I understand that my comments may be quoted anonymously or by use of a  
      pseudonym in publication of the service evaluation results and give permission    
      for this. 
 
6. I understand that all information I provide will be held in confidence within the    
    limitations of the investigator’s professional duty of care.    
       
     7. I agree to take part in the above service evaluation.    





            
Name of Participant  Date    Signature 
 
 
            






















Appendix N: Consent form for clinician participants 
 
               
 
 
NATIONAL and TRUSTWIDE OCD and BDD SERVICES 
MORRISON BUILDING 9E 
SPRINGFIELD UNIVERSITY HOSPITAL 
61 GLENBURNIE ROAD 
LONDON 
SW17 7DJ 
Telephone: 020 3513 6961 
Fax: 020 3513 6965 
Out of Hours Crisis Line:0800 028 8000 
 
Participant Identification Number for this trial: 
CONSENT FORM (Clinicians) 
Title of Project: An evaluation of a specialist service model for treating Body 
Dysmorphic Disorder (BDD): application of the National Institute for Health and 
Clinical Excellence (NICE, 2006) Guidelines for BDD. 
 
Name of Investigator: Anusha Govender 
                Please tick box  
1. I confirm that I have read the information sheet dated 13/12/15 (version 2) for  
the above service evaluation. I have had the opportunity to consider the information, 
ask questions and have had these answered satisfactorily. 
 
2. I understand that my participation is voluntary and that I am free to withdraw up 
until data is analysed without giving any reason and without any prejudice. 
 
3. I understand that where it is relevant to my taking part in this service evaluation, 




(Anusha Govender) for the purpose of the service evaluation. I give permission for 
this individual to audio record my interview.  
 
 
4.   I understand that my comments may be quoted anonymously or by use of a 




5. I understand that all information I provide will be held in confidence within the 
limitations  
of the investigator’s professional duty of care.      
     
    
6. I agree to take part in the above service evaluation.                   




            
Name of Participant  Date    Signature 
 
            























Appendix O: Semi-structured interview schedule for patient participants 
 
 
NATIONAL and TRUSTWIDE OCD and BDD SERVICES 
MORRISON BUILDING 9E 
SPRINGFIELD UNIVERSITY HOSPITAL 
61 GLENBURNIE ROAD 
LONDON 
SW17 7DJ 
Telephone: 020 3513 6961 
Fax: 020 3513 6965 
Out of Hours Crisis Line:0800 028 8000 
SEMI-STRUCTURED INTERVIEW SCHEDULE- Patients 
 
Interview length: 30-40 minutes 




Thank you for agreeing to take part in an interview for this service evaluation. I would like to assure 
you that you will remain completely anonymous and no records of the interview will have your name 
or identifying details on them. With your consent I would like to audio record this interview. The main 
reason is to have an accurate account of your views and experiences which will also aid in the 
analysis of the data.  
 
Semi-structured interview questions 
1. What was the main treatment/s you received from this service for BDD? 
2. How do you feel about the treatment you received for BDD? 
3. What do you think was the most helpful part of the treatment? 
4. Which aspects did you feel were not helpful? 
5. Would you recommend others to have this type of treatment if they had BDD? 
6. What would you have liked to be different in the treatment? 
7. Are there any other aspects I have not asked about regarding your treatment that you 
would like to tell me about? 





Appendix P: Semi-structured interview schedule for clinician participants 
       
 
 
NATIONAL and TRUSTWIDE OCD and BDD SERVICES 
MORRISON BUILDING 9E 
SPRINGFIELD UNIVERSITY HOSPITAL 
61 GLENBURNIE ROAD 
LONDON 
SW17 7DJ 
Telephone: 020 3513 6961 
Fax: 020 3513 6965 
Out of Hours Crisis Line:0800 028 8000 
           SEMI-STRUCTURED INTERVIEW SCHEDULE- Clinicians 
 
Interview length: 30-40 minutes 




Thank you for agreeing to take part in an interview for this service evaluation. 
I would like to assure you that you will remain completely anonymous and no records of the interview 
will have your name or identifying details on them. 
With your consent I would like to audio record this interview. The main reason is to have an accurate 
account of your views and experiences which will also aid in the analysis of the data.  
 
Semi-structured interview questions 
1. What do you think about current guidelines for treating BDD? 
2. How do you feel about following these guidelines? 
3. Which interventions if any, have you used outside of these guidelines? 
4. What do you think was most beneficial in treating patients with BDD? 
5. What do you think was least beneficial in their treatment? 
6. If given the opportunity how would you improve on the NICE (2006) guidelines for BDD? 
7. Are there any other factors that I have not asked about regarding treatment provided by the 
service for BDD that you wish to describe? 






Appendix Q: Debriefing information for both groups of participants 
 
                           
 
 
NATIONAL and TRUSTWIDE OCD and BDD SERVICES 
MORRISON BUILDING 9E 
SPRINGFIELD UNIVERSITY HOSPITAL 
61 GLENBURNIE ROAD 
LONDON 
SW17 7DJ 
Telephone: 020 3513 6961 
Fax: 020 3513 6965 
Out of Hours Crisis Line:0800 028 8000 




Thank you for contributing as a participant in the present service evaluation. 
 
This service evaluation is aimed at determining what standards of care the service 
achieves in applying the NICE (2006) guidelines for BDD. In addition the service 
evaluation also explores the experiences of patients suffering with BDD and 
perspectives of clinicians applying the NICE (2006) guidelines in the specialist 
service.   
 
This service evaluation could provide direction as to the best ways of engaging 
patients in treatment and highlighting interventions that will enable them to continue 
to progress even after treatment is ended. Additionally, as there are very limited 
resources available for treating BDD, the findings from this service evaluation will 
lead to further research opportunities into early intervention and treatment of BDD to 
be spread across other services. 




Again, thank you for your time and co-operation in this service evaluation. If you 
have any questions regarding this service evaluation, please feel free to ask the 
investigator. 
 
If you wish to contact the investigator at a later time, these are my contact details: 
 
Anusha Govender (email:  A.Govender1@unimail.derby.ac.uk or telephone: 
0203 513 6961).   
 




Cognitive Behavioural Psychotherapist 





Appendix R: Characteristics of the qualitative patient sample  




Cathy  Dan  
 
Eve  Fred 
 
Gail 
Level of care Level 5 
outpatient 






Level 5  
outpatient 
Level 5  
outpatient 
Gender Female Female Female Male Female Male Female 
Age 18 23 27 49 37 20 45 
Ethnicity 
 
White White White White White White White 
Marital status Single Single Single Single Married Single Partner 






















15 16 14 14 15 12 12 
 










Depression Depression OCD, 
depression 
Drug/Alcohol use Alcohol None Alcohol None Drug use None None 



















*Patients are given pseudonyms to anonymise data and maintain confidentiality. 


















































































Appendix S:  Example of coding process for TA: excerpt from patient participant’s transcript 
Fred 
1. R: What was the main treatment/s you received from this service for BDD? 
2. Fred: “I received a range of strategies and explanations used to aid understanding and  
3. control over negative thoughts about my appearance. R: (Such as..) These included 
4. Theory A and B, the vicious flower model, attention refocusing, relaxation techniques, 
5. exposure therapy, pendulum diagram, weekly sessions, regular exposures for 
6. habituation.” 
 
7. R: So how do you feel about the treatment you received from this service for 
BDD?  
8. Fred: “I felt many methods of targeting my BDD were attempted to see which one would  
9. be most effective for me.”  (R: Mmm, how did that work for you?)  
10. Fred: “Overall I made big improvements regarding going out but still had some anxiety 
11. present regarding my appearance although not as severe as before. It’s less likely to  
12. deter me from going out.” 
 
13. R: What do you think was the most helpful part of the treatment? 
14. Fred: “I think the regular exposure was the most beneficial, practice wise, especially  
15. when accompanied with attention refocusing which aided in dealing with  
16. exposures by occupying thoughts.” (R: I see, anything else that was helpful?)  
17. Fred: “In terms of helping me understand the disorder, the habituation and vicious flower  
18. model aided understanding of the stages and consequences of my BDD and why  
19. it would be beneficial to deal with it sooner rather than later. The hierarchy was  
20. also helpful in realising milestones that show my progress and what should be  
21. the next target to obtain.” 
 
22. R: Which aspects did you feel were not helpful? 
23. Fred: “Well, I felt the theory A and B concept was the weaker of the explanations as it's  
24. quite difficult for someone with BDD to initially come to terms with. (R: Hmm, I  
25. can see that could be difficult) Also to fully change ones mindset is a  
26. challenging and daunting task. R: How did you cope with that?  





Passive, use of same 
wording as R  
} Listing, lack emotive 
content  
 
Passive recipient  
Treatment not seen as 
collaborative. 
“My bdd”  
Language diff from 
describing treatment. 
Not entirely convinced 
–conflicting statements   
 









emotive not using 












Lack of ownership 
Detached, disconnected 
Telling me what thinks I 
want to hear? 
May be reading from review 
report?? These are listed in 
report as interventions 
used. 
BDD Part of self-   
Lack of ownership, passivity 





Almost as though it’s a test- 
disconnected from own 
experience. 
–sounds like reciting from 
textbook 
 
Use of other interventions 
for engagement 
 
But eager to please and say 















(Appendix S contd.) 
 
AG: Would you have liked anything to be different in the treatment? 
 
36. I felt that at times the treatment felt too much, especially with the regular exposures.  
37. AG: Exposure exercises can be difficult because it initially raises your  
38. anxiety. What did you feel could be different? 
39. Although it was very beneficial to my treatment and helped a lot, maybe if there  
40. were other less intense ways to introduce me into regular exposures it would have 





















Appendix T:   Example of coding process for TA: excerpt from HCP’s transcript  
HCP2  
20. R: What do you think was most beneficial in treating patients with BDD? 
21. HCP: “For one lady who had BDD on our ward awhile back, I would say it was the medication,  
22. because it got her to a position where she could start to do the CBT. She did the exposure work but  
23. still felt very anxious after it, and that never really changed for her. So, medication helped with her, 
24.  to an extent, to engage with the CBT and OT work. But she didn’t make any huge progress, by no  
25. means. There was some difference, but she didn’t feel like she made any difference. 
 
 
26. R: What do you think was least beneficial in treating patients with BDD? 
27. With the ERP approach, I think sometimes it can be too challenging and sometimes, what we were  
28. suggesting for the patients was too much. Maybe that’s something to learn from. We were getting  
29. this patient to do extreme things, like walk around with coloured make-up on her face, or her  
30. eyebrows not done. I know that’s what we had to do as the treatment model, but for someone with  
31. BDD, it seemed very emotive for them. So they felt like, you’re wanting them to go that step a little  
32. too far. I think with OCD it’s easier to take people further and pull people back. Whereas with BDD,  
33. that particular patient found that really difficult. So, when us as therapists are questioning, if we  
34. would do that ourselves, we have to ask should we be asking that of patients to push it that far. But  
35. then again, the evidence says if we don’t, the relapse is higher. 
 
36. R: If given the opportunity, how would you improve on the NICE guidelines for BDD? 
37. I would put OT in there for a start, because I don’t think OT is in the NICE guidelines. But I do think  
38. there is a role for OT in there, for building confidence, self-esteem work and all of the meaningful  
39. engagement and activity. And also, I think that there needs to be more of a distinction between  
40. BDD and OCD. 
 
 
Medication- as per 
guidelines – to help 
engage in cbt but again 
not seeing as beneficial.  
 
Emphasis on lack of 
benefit. 
Expressing more that 
unhappy with compared 
to what is satisfied with. 
Expecting too much from 
patients. Learning 
opportunity. 
Treatment model- needs 
to fit the patient rather 
than trying to fit patient 
into model. 
Not feeling comfortable 
with treatment methods, 
not convinced of benefit. 
But nothing else 
available, so confused as 
to what to do in patients’ 
best interests.  
Lack of representation of 
other interventions and 
treatment options. 















realistic for patient 
to achieve 
ERP too extreme 
to use as would in 
OCD 
More complex – 
treatment not 
taking this into 
account. 
Patient’s needs 












Appendix U:  Risk profiles and substance use of total patient sample 








13 Alcohol 16 
Self–harm  
Cutting 
15 Cannabis 8 
Violence towards 
others 
5 Cocaine 3 
Suicidal ideation 19 LSD 1 
Suicidal attempts 11 Heroin 1 
Self-surgery 
 
4   
 
Self-surgery is included due to the risk of serious injury patients pose to themselves. 
A high proportion of patients had a history of self-harm (58%) and an even higher 
percentage indicated suicide risk (62.5%). More than half the patient sample (54%) 




Appendix V: Comparison of medications prescribed by the service for patients 
with BDD and total of research studies on these medications to treat BDD  
Medication    Patients prescribed  Research studies 
      (N) 
Fluoxetine      14    1 
Citalopram      4    1 
Sertaline      5     none  
Clomipramine     5    1 
Paroxetine      2     none  
Escitalopram     2    2 
Dopamine blockades (Augmentation) 
Aripiprazole      6    1 
Risperidone      4    1 
Olanzapine      3    2 
Buspirone      1    1 





Appendix W: Level 6 national outpatient demographics and clinical factors 
Variables Patient 1    Patient 2 Patient 3 Patient 4 
Age 70    24 37 28 




   Unemployed Unemployed Unemployed 
Marital Status Married    Single Single Single 
Dependents None    None None None 
Accommodation Living with 
spouse 
   Supported     
accommodation 
Living alone Living with 
parents 
OCD Present    Present Absent Present 
Depression Present    Absent Present Present 
Anxiety disorder 
unspecified 
Present    Absent Absent Absent 
Asperger’s 
Syndrome 
Absent    Present Absent Absent 
Self-harm Absent Present Present     Present 
Overdose Absent Absent Present     Present 
Cutting Absent Present Absent     Present 
Suicide: Ideation (I) 
Attempt (A) 
Present (I) Present (A) Present (A)     Present (A) 
Violent Absent Present Absent     Absent 
Alcohol misuse Absent Absent Present     Absent 
Cannabis Absent Absent Present     Absent 
Cocaine Absent Absent Present     Absent 
LSD Absent Absent Present     Absent 






Appendix X: Key principles for developing NICE guidelines (NICE, 2018:1.4 pg. 
14-15). 
NICE develops guidelines according to the following core principles:  
• Guidance is based on the best available evidence of what works, and what it 
costs. 
• Guidance is developed by independent and unbiased committees of experts.  
• All our committees include at least 2 lay members (people with personal 
experience of using health or care services, including carers, or from a 
community affected by the guideline). 
• Regular consultation allows organisations and individuals to comment on our 
recommendations.  
• Once published, all NICE guidance is regularly checked, and updated in the light 
of new evidence or intelligence if necessary. 
• We are committed to advancing equality of opportunity and ensuring that the 
social value judgements we make reflect the values of society. 




























*Producing easy to read 
leaflets to promote 
recognition of 
symptoms/treatment 
options and advice on 
who to approach for 
help and support. 
Providing information 
and simple screening 
recommendations for 
GPs to use in 
consultations.  
Promoting interest 
in BDD research 
and strategies to 
overcome 
obstacles. 












To contribute to 
body of knowledge. 






Journal articles. Peer 
reviewed journals have 
a national and 
international range to 
reach a wide audience. 
Provision of training 






To continue presenting 
the BDD lecture at 
University of Derby. 
Presentation at 





To promote introduction 






and training in 
collaboration with 
colleagues- at the time 
of writing Dr Tyagi at 
Queen’s Square, UCL is 
developing an OCD- 














Proving information on 
my field of expertise; 




*An additional aim is to incorporate patients’ accounts or comments in the leaflets but 
this is dependent on their willingness to participate and ethical considerations will 
need to be addressed: consent, confidentiality, clear and transparent objectives in 














Measures routinely used by the service to identify symptom severity  
Appendix Z.i: Content removed due to copyright reasons. 
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